See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Diabetes Health Reference Charts
Medications Archives

Diabetes Medications Article Archives

April 2014

You Can’t Bring Your Supplies to Prison

If you’ve been reading my articles for a while, you may remember that my oldest son has drug addiction issues-http://diabeteshealth.com/read/2011/07/10/7206/a-brand-new-bottle-of-my-insulin-went-missing/.  We have tried everything to keep him on the right path.  Sadly, his path ended him in prison.  While I’m devastated on one hand, I’m grateful on the other.  He is safer there than on the street because he is not on drugs.

comments 3 comments - Posted Apr 24, 2014

420: Cannabis Observance Day and Diabetes

If you are unfamiliar with the code language 420, it's a sub-culture of people who observe and describe themselves as cannabis users. 

comments 1 comment - Posted Apr 20, 2014

Diabetes Drug Shows Promise in Reducing Alzheimer's Disease

In the United States, the Centers for Disease Control and Prevention (CDC) estimates that as many as half of all Americans who are alive today will end their lives in nursing homes, although it won’t be because their bodies cease to function, but because of their brains.

comments 0 comments - Posted Apr 16, 2014

Robotics Allow Pharmacists to Spend More Time with Customers

There was a time when most people knew their corner pharmacist - like Mr. Gower in It's a Wonderful Life - and visits to the drug store included personal conversations to catch up on neighborhood and news, besides the dispensing of medications.

comments 1 comment - Posted Apr 14, 2014

Inhaled Insulin to Treat Diabetes Earns FDA Committee Recommendation

The inhaled insulin Afrezza has been recommended for approval by a Food and Drug Administration (FDA) advisory committee.

comments 0 comments - Posted Apr 12, 2014

Life With Type 2: The Power of Naming

This is not a religious essay, so please don't take the example below wrong.

comments 0 comments - Posted Apr 9, 2014

Why We Need Them

Endocrinologists are in a funny position when it comes to people with diabetes. We spend so much time with our diseases that we don't really need them to manage things on a daily basis, but we can't write our prescriptions on our own. 

comments 0 comments - Posted Apr 4, 2014

Statin Stats

A British study of 46,262 people concludes that statin side-effects are minimal. Of all the statins reviewed, rosuvastatin (Crestor) was found to be the most efficient at raising HDL (good cholesterol) levels while fluvastatin was the least likely to cause muscle pain, a common symptom of statin use. Only one in five of the side effects in the test group was caused by statins.

comments 0 comments - Posted Apr 1, 2014

March 2014

Saxagliptin- Oral Medication Caution

The FDA wants to take another look at a pill approved in 2006 for control of glucose levels in people with type 2 diabetess. In a trial study published in the New England Journal of Medicine, saxagliptin (brand name Onglyza) was shown to coincide with an increased rate of hospitalization for heart failure of 27 percent compared to type 2s taking a placebo. The FDA has not asked prescribers and patients to stop taking saxagliptin, but to use caution while a review is underway.

comments 0 comments - Posted Mar 30, 2014

Women Sue Pfizer Over Increased Diabetes Risk from Lipitor

KANSAS CITY, Kan., PRNewswire/ -- Two Kansas women who took Lipitor to reduce their cholesterol levels and later developed type 2 diabetes have filed lawsuits against Lipitor's maker, Pfizer. The announcement was made by the attorney filing the suit, Robert K. Jenner, who is with the Kansas City, Kan.-based firm of Janet, Jenner & Suggs, LLC.

comments 0 comments - Posted Mar 26, 2014

FDA Delays Final OK for Type 2 Drug Empagliflozin

The FDA will delay allowing the type 2 drug empagliflozin to enter the U.S. market until "previously observed deficiencies" at the plant where it is manufactured are fixed.

comments 0 comments - Posted Mar 23, 2014

Do We Really Need Statins?

Ten years ago, I was asked by my endocrinologist to begin using statins to lower my cholesterol. I was barely over 20 years of age and was afraid of possible side or long-term effects. I was nervous about adding yet another drug to my list of daily medications, so I told him I would consider it and went home feeling like a medical disaster. Hello, diabetes complications: We meet again.

comments 0 comments - Posted Mar 22, 2014

Promising Results Reported for New Insulin

A new kind of long-acting insulin, developed by pharmaceutical giant Sanofi, has shown promising results in clinical trials, according to information released by the company.

comments 0 comments - Posted Mar 17, 2014

Marijuana May Help Blood Sugar Control, Study Says

For residents of Colorado and Washington state, 2014 brought a profound legal and societal change. Marijuana is now available, legally, in both of those states. While the drug is cleared for medical use elsewhere, and other jurisdictions have decriminalized it, these two states have taken the profound, extra step of full legalization.

comments 0 comments - Posted Mar 15, 2014

FDA Backtracks Over GLP-1s' Effects on Pancreas

The U.S. Food and Drug Administration reports that its review of various animal and human studies does not show a link between GLP-1 drugs used to treat type 2 diabetes and pancreatic maladies, including acute pancreatitis and pancreatic cancer.

comments 0 comments - Posted Mar 4, 2014

February 2014

Weekly Type 2 Drug to Be Delivered Via Needle Patch

A recent agreement between Zosano Pharma, Inc. and Novo Nordisk could lead to the introduction of a once-weekly drug for type 2s that is administered via a micro-needle patch system.

comments 0 comments - Posted Feb 24, 2014

Weekly Potpourri

Blame The Media

comments 0 comments - Posted Feb 23, 2014

12 Tips for Traveling With Diabetes

Are you ready for a challenge? Then let's take a trip together--just me, you, and diabetes. Another travel season is upon us, with all of the challenges and frustrations that it entails for those with type 1 and type 2 diabetes. It might not simple or easy to manage, but it should be rewarding if we handle it right.

comments 0 comments - Posted Feb 21, 2014

Weekly Potpourri

Sock It To You

comments 0 comments - Posted Feb 15, 2014

Pump Problems? Here Are Some Helpful Pointers

If you use an insulin pump, every now and then you may experience the unfortunate event of watching it send you the message, "No Delivery." You're no longer receiving insulin from your pump.

comments 0 comments - Posted Feb 13, 2014

Kris Freeman in Sochi: Type 1 Diabetes Skier- 4th Time Olympian

I remember first seeing Kris Freeman when he was 21 at a diabetes conference. Two years after he was diagnosed with type 1 diabetes, Eli Lilly began sponsoring his dream of becoming an Olympic cross-country skier. During his off-season, you can find Kris at diabetes camps inspiring children to follow their dream. He is the only person with diabetes to compete in a winter endurance sports event at the Olympics.

comments 0 comments - Posted Feb 7, 2014

Stress-Induced Hormone Imbalances Go Far Beyond Insulin in Diabetes

Virtually anything from the stress of a long checkout line to the first signs of menopause can trigger hormone imbalances, which reveal themselves through mood swings, fatigue, migraines, memory problems, and a lackluster sex drive.

comments 0 comments - Posted Feb 3, 2014

Skin Cream Could Treat Peripheral Neuropathy

One of the most debilitating risks of diabetes is peripheral neuropathy, which can impact millions of people each year and often leads to amputation.

comments 0 comments - Posted Feb 2, 2014

January 2014

Assessing a New Class of Type 2 Drugs

The name alone is a mouthful. Sodium-glucose cotransporter-2 inhibitors are one of the newest class of drugs meant to treat type 2 diabetes, but you can be forgiven if the name doesn't trip lightly off your tongue. The conspicuously vowel-free abbreviation--SGLT2--isn't much better.

comments 0 comments - Posted Jan 30, 2014

Type 1 Drug Wins Orphan Status

DV-100, a drug designed to halt the body's autoimmune attack on pancreatic beta cells that leads to type 1 disease, has won orphan drug status from the U.S. Food and Drug Administration.

comments 0 comments - Posted Jan 16, 2014

FDA OKs Dapagliflozin as Type 2 Drug

The Food and Drug Administration has approved the entry of dapagliflozin, a drug for treating type 2 diabetes, into the U.S. market.

comments 0 comments - Posted Jan 9, 2014

New Type 2 Drugs Change Treatment Decisions

Metformin, the cornerstone in treating type 2 diabetes, saw an increase in usage among type 2s from 23 percent of that population in 1997 to 53 percent in 2012. But that increase has since plateaued due to the introduction of additional drugs that target insulin secretion and glucose regulation.

comments 0 comments - Posted Jan 4, 2014

FDA Opens Way for Diabetic Macular Edema Device

The Food and Drug Adminsitration, reversing itself on a decision it made in October, has opened the way for a new treatment for diabetic macular edema to reach the U.S. market.

comments 0 comments - Posted Jan 1, 2014

December 2013

Takeda Ceases Development of Type 2 Drug

Japanese drug maker Takeda, Asia's largest pharmaceutical company, and a major player in the global diabetes medication market, has ceased development of its type 2 drug, TAK-875 (fasiglifam).

comments 0 comments - Posted Dec 30, 2013

Danish Drug Improves Blood Sugar Control in Type 2s

Danish pharmaceutical manufacturer Novo Nordisk's drug Ryzodeg, which includes two different insulin products, has been shown to significantly lower rates of hypoglycemia and has led to improved blood sugar levels for those with type 2 diabetes compared to those taking a single insulin, according to the results of a new study.

comments 0 comments - Posted Dec 27, 2013

Holiday Classic: A Diabetic Chihuahua Is a Child's Christmas Angel

(Editor's Note:This article originally ran in Diabetes Health on January 27, 2008.)

comments 0 comments - Posted Dec 25, 2013

Drug Improves Weight and A1c in Patients With or Without Diabetes

According to a study gauging the benefits of the diet drug Qsymia, those who took the drug not only lost weight, but also saw their A1c levels improve, even if they weren't diabetic.

comments 0 comments - Posted Dec 24, 2013

Topical Diabetic Neuropathy Gel Enters Phase 3

Clonidine, a topical gel designed for the treatment of painful diabetic neuropathy, will begin phase three studies early in 2014 after its maker, North Carolina-based BioDelivery Sciences International, Inc., garnered fast-track approval from the Food and Drug Administration for the trials.

comments 0 comments - Posted Dec 20, 2013

Q&A With Dr. Richard Bernstein

What role does tumor necrosis factor play in insulin resistance? Have you noticed improved insulin sensitivity when you use an anti-TNF agent such as Etanercept ? Do you recommend Etanercept for all your type 2 patients?

comments 0 comments - Posted Dec 19, 2013

Life With Type 2: In Praise of Metformin

The fellow who writes one of the blogs I visit each morning often features links to articles about the wonders of bacon. Whenever he runs one of these items, showing yet another great thing about pork bellies, he asks, "Bacon: Is there anything it can't do?"

comments 0 comments - Posted Dec 17, 2013

Mail-Order Pharmacy Users Less Likely to Visit Emergency Rooms

Getting your drugs by mail rather than meeting face-to-face with a pharmacist may not have a negative impact on your health, according to a new study.

comments 0 comments - Posted Dec 15, 2013

Metformin May Offer Defense Against Dementia in Type 2s

Not only can the diabetes drug metformin help control blood sugar levels, it may also reduce the risk of dementia, a health risk that's elevated for those with diabetes.

comments 0 comments - Posted Dec 14, 2013

Skin Disease Drug Holds Promise for Type 1s

File this news under "potential breakthrough you didn't see coming." Researchers have tried--and seem to have succeeded--in slowing the destruction of beta cells by treating recently diagnosed people with type 1 diabetes with alefacept, a drug usually prescribed to treat psoriasis, a disorder that leaves skin red and itchy.

comments 0 comments - Posted Dec 8, 2013

"Artificial Pancreas" Could Benefit From Inhaled Insulin Therapy

For people with type 1 diabetes who follow medical research, development of a closed-loop, "artificial pancreas" has always been the Holy Grail. Such a system would combine an insulin pump with a continuous glucose monitor to provide constant control of blood glucose levels. But what if such a system was only a start? What if it might work better when combined with another therapy altogether?

comments 0 comments - Posted Dec 5, 2013

Q&A With Dr. Richard Bernstein

Do thyroid levels affect how people are able to control their diabetes?

comments 0 comments - Posted Dec 3, 2013

Antibiotics May Be as Effective as Surgery in Treating Foot Osteomyelitis

A recent study found that surgery may not always be the best course of action to treat people with diabetes who have foot osteomyelitis.

comments 0 comments - Posted Dec 1, 2013

November 2013

Another Step Toward Replacing Daily Injections

Researchers at North Carolina State University and the University of North Carolina at Chapel Hill have are looking at nanoparticles and ultrasound as a way to do away with the need for daily injections of insulin via syringes and needles.

comments 0 comments - Posted Nov 24, 2013

Report Shows Diabetes Drug Best Sellers

"Top 100 Selling Drugs Through September," an article in the October 31 issue of Medscape (sourced from IMS Health), shows that while eight diabetes medications are in the nation's top 100 best-selling drugs, none are in the top 10.

comments 0 comments - Posted Nov 17, 2013

Promising New Type 2 Drug on Horizon

A new drug being developed by Eli Lilly Co. that duplicates the effects of a hormone may soon be added to the growing arsenal of pharmaceutical weapons available to treat type 2 diabetes.

comments 0 comments - Posted Nov 16, 2013

Drug Non-Adherence Prevalent in Type 2s

A new study shows that a majority of people taking drugs to treat type 2 diabetes stop taking their medications within six months, while almost all of them stop taking them within a year.

comments 0 comments - Posted Nov 7, 2013

Life With Type 2: How (Non-Diabetic) Others See Us

It's always fun to get a different take on things. You sit for years a few rows up from first base and then one day you decide to go sit out by left field. Who knew the game could look so different?

comments 0 comments - Posted Nov 3, 2013

Common Diabetes Drugs May Carry Risk, Study Suggests

When it comes to the treatment of type 2 diabetes, metformin may be a safer choice than sulfonylureas, according to the results of a new study.

comments 0 comments - Posted Nov 2, 2013

Study Finds No link Between Insulin and Breast Cancer

While recent research suggests that having diabetes increases the risk of developing breast cancer, another new study shows that the use of insulin to control blood glucose levels may not be a factor.

comments 0 comments - Posted Nov 1, 2013

October 2013

A New Approach to Healing Diabetic Foot Ulcers

Ulcers are caused due to a breach in the skin which fails to heal. Initiated by injuries, skin infections, poor blood circulation, or sensory loss, foot ulcers may become a serious complication in up to 15 percent of all diabetic patients. Chronic diabetic foot ulcers (DFUs) need prolonged treatment and may even lead to amputation.

comments 0 comments - Posted Oct 24, 2013

Life With Type 2: "Nano, Nano," as Mork Almost Said

Comedian Robin Williams got his start on TV in 1978 in the comedy "Mork and Mindy," about a wacky alien, Mork (Williams), who comes to live in a boarding house run by a cute young woman (Pam Dawber). In that popular sitcom, Mork would always greet people by saying, "Nanu, Nanu," which was "Hello" on his home planet of Ork.

comments 0 comments - Posted Oct 23, 2013

Sanofi Meter Tracks A1c's at Shorter Intervals

Sanofi has introduced a blood glucose meter that allows users to track their A1c levels over shorter intervals, giving them the information they need to accurately gauge their insulin intake.

comments 0 comments - Posted Oct 22, 2013

Sanofi Meter Tracks A1c's at Shorter Intervals

Sanofi has introduced a blood glucose meter that allows users to track their A1c levels over shorter intervals, giving them the information they need to accurately gauge their insulin intake.

comments 0 comments - Posted Oct 22, 2013

First-World Type 2 Drug Market to Reach $47 Billion by 2022

A Massachusetts-based research firm concludes that the first-world market for type 2 drugs and treatments will increase from $27 billion in sales in 2012 to $47 billion in 2022.

comments 0 comments - Posted Oct 18, 2013

A New Dawn for Inhalable Insulin?

Few treatments for type 1 diabetes have been as elusive and long-promised as inhalable insulin. The concept has always sounded remarkable: Instead of jabbing themselves with needles, type 1s (and insulin-using type 2s) could take a quick puff on an inhaler to get a dose of insulin.

comments 0 comments - Posted Oct 12, 2013

Life With Type 2 The Desire for Control Has to Make Sense

For several years now I've been following the controversy surrounding a lawsuit by California parents to force public school districts to allow people who aren't nurses or doctors to be able to give insulin shots to diabetic children. (The California Supreme Court recently ruled that non-nurses can now give such injections. You can find background information here and here.)

comments 0 comments - Posted Oct 10, 2013

Experimental Drug Holds Promise for New Type 1s

One of the most intriguing areas of type 1 diabetes research focuses on newly diagnosed patients. Given that the disease occurs after an autoimmune response damages the body's insulin-producing beta cells, scientists have looked to new type 1s as fertile ground for experimentation.

comments 0 comments - Posted Oct 8, 2013

Automatic Bolus Calculator Pays off With A1c Drops

For people with type 1 diabetes (and some with type 2), the question is simple-and crucial: How much insulin should you give yourself with a meal?

comments 0 comments - Posted Oct 5, 2013

Byetta for Type 1s? It Could Be Possible

Many people with type 2 diabetes are familiar with Byetta, a drug that helps raise their insulin levels. But a new study in the journal Diabetes Care suggests that the drug, known generically as exenatide, might have a role to play for people with type 1 diabetes as well.

comments 0 comments - Posted Oct 3, 2013

September 2013

FDA Approves Medtronic’s Artificial Pancreas

The FDA has approved a new, automated artificial pancreas system from Minneapolis-based Medtronic, Inc.

comments 0 comments - Posted Sep 30, 2013

Dapagliflozin Teams Well With Metformin, Sulfonylurea

According to researchers, dapagliflozin, a diabetes drug developed jointly by two pharmaceutical companies has shown significant benefits when teamed with metformin and sulfonylurea.

comments 0 comments - Posted Sep 28, 2013

Dapagliflozin Teams Well With Metformin, Sulfonylurea

According to researchers, dapagliflozin, a diabetes drug developed jointly by two pharmaceutical companies has shown significant benefits when teamed with metformin and sulfonylurea.

comments 0 comments - Posted Sep 28, 2013

Metformin Boosts Survival in Men With Diabetes, Prostate Cancer

The drug of choice to treat type 2 diabetes may have uses beyond the treatment of diabetes alone, according to the results a new study.

comments 0 comments - Posted Sep 21, 2013

Eye Drug's Success With Diabetic Macular Degeneration

A drug traditionally used to treat age-related macular degeneration has been successful in also treating diabetic macular edema in recent trials.

comments 0 comments - Posted Sep 20, 2013

Type 2 Drugs in the Pipeline: an Update

If you Google "type 2 diabetes drugs," one website lists the names of 92 drugs that medical professionals have prescribed at one time or another to treat diabetes.

comments 0 comments - Posted Sep 17, 2013

Early Diabetes Interventions May Also Reduce Heart Disease Risk

Lifestyle change, medication both linked to cholesterol improvements

comments 0 comments - Posted Sep 15, 2013

Statins May Lower Amputation Risk in Diabetes

Some cholesterol-lowering drugs may help reduce the risk of amputation for those with diabetes, according to a new study.

comments 0 comments - Posted Sep 12, 2013

Protein Deficiency Linked to Type 2 Insulin Resistance

People with type 2 diabetes who use insulin to help control elevated blood sugar might be able to end their dependence on it if new research progresses.

comments 0 comments - Posted Sep 11, 2013

Glucagon Study Shows Promise for Type 1s

In the healthcare field today, perhaps no area holds as much promise and as many perils as weight control. Researchers see the same statistics that the rest of us do. They see the upcoming wave of obesity and diabetes diagnoses. They see the myriad complications that spring up from these conditions. And they want to address the problem in a simple way.

comments 0 comments - Posted Sep 8, 2013

Metformin Better Than Insulin for Gestational Diabetes?

Insulin may not be the best first line of defense for women who develop gestational diabetes, according to the results of a new study.

comments 0 comments - Posted Sep 4, 2013

Learn To Control Your Diabetes, Before It Controls You

A Diabetes Health Classic. This article originally was published on June 20, 2007.

comments 0 comments - Posted Sep 2, 2013

August 2013

What to Expect With Medicare Open Enrollment Changes

There are only a few weeks before the Medicare annual open enrollment period begins Oct. 15. This year's Medicare season crosses calendars with the rollout of the Health Insurance Marketplace, so it's important Medicare-eligible beneficiaries understand the differences between the two government programs.

comments 0 comments - Posted Aug 28, 2013

Q&A With Dr. Richard Bernstein

Is it important to determine the exact type of diabetes you have if you're already on insulin and maintaining very good blood sugar control, and if so, why?

comments 0 comments - Posted Aug 21, 2013

Promising Topical Nail Fungus Treatment Performs Well in Phase 3

Hard-to-treat toenail fungus is one side effect of diabetes, a condition brought by decreased circulation and increased susceptibility to infection. The condition, called onychomycosis, afflicts some 35 million people in the United States.

comments 0 comments - Posted Aug 19, 2013

Maryland Researchers Enrolling Type 2 Patients in Long-Term Drug Study

BALTIMORE-Researchers at the University of Maryland School of Medicine are enrolling patients with type 2 diabetes into an NIH-funded clinical trial to evaluate the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication.

comments 0 comments - Posted Aug 18, 2013

Diabetes awareness mission takes flight

Jason Harmon had dreams of taking to the skies as a commercial pilot, but a diagnosis of type 1 diabetes crashed his plans.

comments 0 comments - Posted Aug 13, 2013

Dietary Changes Could Preserve Beta Cells

Type 1 diabetes doesn't happen all at once. Scientists have shown that it's usually a gradual process, in which the insulin-producing beta cells eventually fade out. So wouldn't it be marvelous if the function of those beta cells could be preserved, allowing people newly diagnosed with diabetes to produce some of their own insulin for a longer time?

comments 0 comments - Posted Aug 3, 2013

"Bionic Pancreas" Project Sets 4-Year Goal

Could a "bionic pancreas"-a combination of insulin pump, continuous glucose monitor and predictive software-be on the market within four years? That 2017 date is the ambitious goal of a project from researchers at Boston University and Massachusetts General Hospital.

comments 0 comments - Posted Aug 2, 2013

July 2013

Cannabis-Derived Drug for Type 2 Enters Phase 2

A British drug company is looking to medical marijuana- or at least a derivative of it-to help treat a variety of different diseases, including type 2 diabetes.

comments 1 comment - Posted Jul 20, 2013

Experts Target Hypoglycemia at ADA Conference

Hypoglycemia remains a complex issue for diabetes patients and their healthcare providers, according to the focus of a recent symposium.

comments 1 comment - Posted Jul 14, 2013

The Growing Number of Diabetes Therapies

While there is still no cure for diabetes, there is a growing number of therapies available to those battling the disease-and even more are in the works, according to experts who spoke at a recent symposium.

comments 0 comments - Posted Jul 13, 2013

My Pal Paul and the Type 2 Jitters

My down-the-street neighbor, Paul (not his real name), has type 2. We often stop to talk about our numbers, our latest visits to the endocrinologist, and our concerns.

comments 0 comments - Posted Jul 12, 2013

Obesity Drug Beloranib Shows Promise

Massachusetts-based Zafgen, a biopharmaceutical company devoted to treating obesity, may have taken a big step toward making the growing health concern obsolete.

comments 0 comments - Posted Jul 9, 2013

Have Boston Researchers Found Type 1's Root Cause?

Will people with type 1 diabetes ever see an end to their need for insulin?

comments 2 comments - Posted Jul 7, 2013

Diabetes Patients on Insulin Sensitizers Run Lower PAD Risk

Insulin sensitizers--drugs that increase sensitivity to insulin such as Avandia and Actos--could help lessen the risk of peripheral arterial disease (PAD) for those with type 2 diabetes, according to a new study.

comments 1 comment - Posted Jul 5, 2013

June 2013

FDA Approves Invokana, a New Type 2 Drug

A new, first-in-its-class drug for type 2 diabetes has just been approved by the Food and Drug Administration. Invokana works by blocking re-absorption of glucose by the kidneys and stimulating urination, which removes glucose from the bloodstream.

comments 0 comments - Posted Jun 27, 2013

Are Patients Being Misled About Cholesterol-lowering Drugs

The main question that doctors---and patients---ask about a prescription drug is simple: Does it work? Does this medicine improve the condition it's prescribed for?

comments 0 comments - Posted Jun 25, 2013

How to Help Overweight Kids

(Editor's Note: This article was orginally published in the April 2008 edition of Diabetes Health and later online as article 5658. We are reproducing the article in light of the American Medical Association's recent decision to treat obesity as a disease. That decision will spur much debate, and we think this article will help add some perspective to the discussion.)

comments 1 comment - Posted Jun 20, 2013

12th Q&A With Dr. Bernstein

Can Januvia Trigger Cancer Symptoms?

comments 1 comment - Posted Jun 12, 2013

My Life as a Guinea Pig

About five years ago during a visit to a local endocrinologist, he asked if I might be interested in participating in a Phase 3 study of a new type 2 drug. It didn't take long for me to say yes, especially once he explained how being a study subject worked.

comments 1 comment - Posted Jun 10, 2013

FDA Panelists Vote to Ease Up on Avandia

A significant majority-20 of 26 members attending a combined meeting of FDA advisory committees-has voted to modify or remove the current restrictive label and distribution regulations affecting the type 2 drug Avandia.

comments 0 comments - Posted Jun 9, 2013

Ready for a Diabetes Drug Tune-Up?

People with diabetes know the score. We've all seen "revolutionary" drugs and treatments introduced with fanfare, and we know that that much of the time they're evolutionary at best. But something has changed in the world of diabetes care.

comments 2 comments - Posted Jun 1, 2013

May 2013

Juggling More Than Three Pins

I've been type 1 diabetic for 15 years. It hasn't been easy and I'm still grasping to keep my feet on the ground medically. Every time I think I've got this disease figured out, something new gets thrown at me and I stumble over and over again.  From insulin resistance to pump failures to carbohydrate/insulin sensitivity changes to exercise regimens to health insurance issues to medical bill payments to a seemingly innocent cut on the sole of my foot, etc., I'm getting worn out.

comments 8 comments - Posted May 29, 2013

How Dottie Kept Her Prediabetes in Check

You may be in jeopardy. You may be in danger with blood sugar levels higher than normal. You may have prediabetes.

comments 0 comments - Posted May 28, 2013

Type 1 Glucose Production Pill on the Horizon

According to research out of a lab in North Carolina, there's more to worry about for type 1 diabetes than a lack of insulin.

comments 1 comment - Posted May 23, 2013

Two New Promising Type 2 Drugs in the Pipeline

Two new drugs originally developed by Eli Lilly are showing promise when it comes to treating type 2 diabetes.

comments 0 comments - Posted May 19, 2013

What are your thoughts on insulin pumps?

I spent a month in a major insulin pump center and saw several things. Many of the female patients seemed to have wings on their sides where the pump tubing was inserted and they got lipohypertrophy from localized injections, but that was the least of it. None of them actually had remotely normal blood sugars. 

comments 21 comments - Posted May 15, 2013

Community’s Positive Effect on Diabetes Management

People today have an incredible array of methods for finding the latest news and information about diabetes: the Internet, social media, and print publications. But perhaps the most powerful is the strong relationships they develop within the tight-knit diabetes community.

comments 0 comments - Posted May 10, 2013

8th Q&A With Dr. Richard Bernstein

Diabetics with dental infection should have a longer course of antibiotics, up to a year. Is there an optimal timing of antibiotic that should be used?

comments 0 comments - Posted May 8, 2013

At the Crossroads, I Choose Insulin

I was diagnosed with type 2 diabetes 10 years ago. My response to the news, very typical, was to begin a routine of vigorous exercise and dieting. With a beginner's enthusiasm, I lost almost 30 pounds (down from 220) and drove my A1c three months after my diagnosis down to 5.6%.

comments 0 comments - Posted May 6, 2013

Reduced Insulin May Prevent Exercise-Related Hypoglycemia

People with type 1 diabetes who exercise may need to reduce their insulin to counteract the effects of their workouts, according to a new study.

comments 0 comments - Posted May 4, 2013

April 2013

An Interview With My Husband, Rick

I wanted to interview my husband about my diabetes. He played a huge part in helping me accept my type 1 diabetes and he has never made me feel inferior for having it. Rick and I just celebrated the 15th anniversary since our first date, and since I've only had diabetes for 18 years, he's been there for most of it.  He was there during the times I was out of control and in denial, and he's been there while I work on treating myself right and trying to take good care of myself. 

comments 0 comments - Posted Apr 27, 2013

Living With Type 1 Diabetes

Insulin, shots, meter, blood 
Emotions are about to flood
DKA - Hospital stay
I just don't know what to say

comments 0 comments - Posted Apr 20, 2013

Smaller, Lighter OmniPod Earns FDA Approval

The FDA recently approved the next-generation OmniPod from Insulet, giving people with insulin-dependent diabetes an even less invasive way to manage their diabetes.

comments 0 comments - Posted Apr 19, 2013

We’re Not Bad, We’re Human

I've had type 1 diabetes for 18 years and whenever I hear bad news about someone with diabetes it hits me hard.

comments 3 comments - Posted Apr 3, 2013

March 2013

The Penalty of Not Being Able to Afford Care Is Too Expensive

Diabetes is insanely expensive. I often wonder how much it has cost me over the 18 years I've been funding it. Sometimes I had enough money to purchase all my supplies, sometimes I didn't.  I felt like a loser every time I had to leave supplies at the pharmacy. You'd think I'd have gotten used to it at some point, but no, I cried every single time.  

comments 12 comments - Posted Mar 22, 2013

Can you please explain the dawn phenomenon, and how best to manage it?

Dawn phenomenon is the situation where the liver removes insulin from the blood in the morning hours, which causes morning blood sugars to go up, even if breakfast is skipped.

comments 0 comments - Posted Mar 21, 2013

Idol’s Randy Jackson: “It Always Happens to Somebody Else, Right?”

Twelve years after it began as a summer placeholder designed to keep Fox TV viewers hanging around until the fall season, "American Idol" has become one of this young century's most renowned cultural phenomena. From the show's modest beginning, record producer and musician Randy Jackson has been at its heart, the memorable judge who has popularized such greetings as "Dawg!" and such praises as "I believe she's in it to win it!"

comments 0 comments - Posted Mar 19, 2013

Can you please explain the dawn phenomenon, and how best to manage it?

Dawn phenomenon is the situation where the liver removes insulin from the blood in the morning hours, which causes morning blood sugars to go up, even if breakfast is skipped.

comments 0 comments - Posted Mar 13, 2013

February 2013

Type 2 Insulin Users: No Need to Wait to Eat After Injecting?

For people who take insulin, one of the hardest parts of their routine is injecting themselves before a meal, then having to wait 20 or 30 minutes before eating. For anybody who's hungry and raring to dine, the wait can be frustrating.

comments 0 comments - Posted Feb 27, 2013

My Love-Hate Relationship With Food

I heart carbohydrates, and sometimes, I hate carbohydrates.

comments 0 comments - Posted Feb 18, 2013

Sean Glass: Dancing—and Juggling Life—to His Own Tunes

Sean Glass learned about the time he was in kindergarten that his type 1 diabetes was ultimately his alone to manage.

comments 0 comments - Posted Feb 15, 2013

Am I the Only One Who Panics About Having Blood Drawn?

My previous boss once said to me as I freaked out about having to get some blood work drawn, "They should do a study on you."

comments 0 comments - Posted Feb 7, 2013

Pre-Diabetes: Exercise and Diet Are Your Keys to Freedom

If you have been diagnosed with pre-diabetes, you have to start looking seriously at how you live your life. Talk to any persons who are insulin-dependent and they will tell you how much they wish they could be in your situation: a point where you can make changes to avoid getting to their stage of the illness.

comments 0 comments - Posted Feb 6, 2013

Choosing an Insulin Pump: My Personal Debate

I have decided to start using an insulin pump.

comments 4 comments - Posted Feb 5, 2013

Exenatide Bests Insulin Detemir in Head-to-Head Test

Sooner or later most type 2s face the choice of whether they should begin using insulin. As the effectiveness of metformin or sulfonylureas fades, physicians often look to insulin as the safest, most effective means of asserting control over blood sugar levels.

comments 0 comments - Posted Feb 3, 2013

Mike Fisher, Competitive Snowboarder

Mike Fisher is a 23-year-old from Ontario, Canada, who's been snowboarding since he was 13 years old. At the age of 18, he was involved in a motorcycle crash that necessitated the amputation of one leg below the knee. He says, "At first, I felt that my life was coming to a crashing halt. But I just pushed myself to recover as fast as possible and get my life back on track, go to school, get back into snowboarding and motorcycles-just anything so that my life wasn't affected at all. I had a lot of support, and I would say that I was pretty optimistic about it and took it almost as a challenge. By the time that I was 19, I was happy. I was walking again, I was back in college in London, Ontario, and everything was good. The accident was a minor setback to me, and I rose above it. I was just continuing with my life."

comments 8 comments - Posted Feb 2, 2013

Type 2: FDA OKs Canagliflozin But Has Concerns About Heart Risk

In a 10-5 vote, an FDA panel has recommended that the agency approve the marketing of Johnson & Johnson's InvokanaTM (canagliflozin), an oral once-daily drug for treating type 2 diabetes in adults.

comments 0 comments - Posted Feb 1, 2013

January 2013

“Molecular Handshake” Key to Insulin’s Interaction With Cells

Scientists have known for almost 100 years that insulin is the key to achieving both the control of blood sugar and its metabolization by the body. But what they have not figured out is exactly how insulin interacts with the body's cells.

comments 0 comments - Posted Jan 31, 2013

#Six and Diabetes: Jay Cutler On Numbers

As an NFL quarterback, Jay Cutler makes his living putting a football into the hands of an open receiver before getting slammed to the ground by a huge defensive lineman.  It's a stressful occupation, all about timing, a little luck, and seeing the big picture in a split second.  

comments 9 comments - Posted Jan 29, 2013

The Hidden Gift of a Diabetes Diagnosis

Michelle Gaylord has lived more than 30 years with type 2 diabetes, but the diagnosis is one that she now sees a bit like a gift.

comments 1 comment - Posted Jan 22, 2013

Novo Nordisk and Two-Time Super Bowl Champion Kendall Simmons Kick-Off Search for Type 2 Diabetes Patients Who Give Back to Their Communities

Share Your NovoLog® (insulin aspart [rDNA origin] injection) Community Star Story for the Chance to Win a Donation to the Charity of Your Choice!

comments 0 comments - Posted Jan 22, 2013

Metformin Bests Glipizide in Reducing Cardio Events

A Chinese research study of diabetes patients with coronary heart disease concludes that metformin is more effective than glipizide in reducing the risk of major cardiovascular events, such as stroke and heart attack.

comments 0 comments - Posted Jan 20, 2013

Each One of Us Inspires the Other

Every spring since 1999, the Diabetes Education and Camping Association (DECA) has distributed our publication to their young campers. In honor of their youthful enthusiasm, our springtime issue always focuses on people who inspire us, from the young to the old. In this issue, we bring you the stories of people who refuse to let their diabetes limit them, people whose example re-ignites our determination to live our very best and healthiest lives. As a publisher, I am always seeking inspiration, and each of these individuals is a fresh reminder of what we can do if we put our minds to it.

comments 1 comment - Posted Jan 19, 2013

Crystal Bowersox: Striving to Live Without Limitations

Nobody thought for even a second that Crystal Bowersox's second-place finish on "American Idol 2010" meant that the 26-year-old was headed back to her native Elliston, Ohio, to resume a quiet life.

comments 1 comment - Posted Jan 17, 2013

Type 2: Oramed Sends Oral Insulin Test Request to FDA

Israel-based Oramed announced that it has sent an application to the Food and Drug Administration for permission to enter Phase 2 trials of its oral insulin product. The company has been working on developing a means of delivering insulin orally, which would allow people with diabetes to avoid having to inject themselves with the hormone.

comments 1 comment - Posted Jan 16, 2013

He’s a Type 1 on TV and in Real Life

Forty-three year old stage and TV actor Stephen Wallem is a jack of all trades when it comes to entertainment. Best known for his one-man musical review, "Off the Wallem," he is also a playwright, composer, and director. Currently, he plays Thor, a gay nurse with type 1 diabetes, on the Showtime series "Nurse Jackie."

comments 1 comment - Posted Jan 12, 2013

Riding on Insulin

Professional snowboarder Sean Busby started competing at age 14 and began training for the Winter Olympics at 16. But in 2004, at age 19, Sean's troubling bouts of thirst and weariness were revealed as symptoms of type 1 diabetes.

comments 0 comments - Posted Jan 8, 2013

December 2012

An Interview With Mike Golic

Mike Golic is the co-host of ESPN's wildly popular radio show, "Mike and Mike in the Morning." Before beginning work as a broadcaster in 1995, he played for nine years as a defensive tackle in the National Football League, including stints with the Houston Oilers, Philadelphia Eagles, and Miami Dolphins. About five years ago, he was diagnosed with type 2 diabetes. Since then, he has become involved in getting the word out about type 2, including the potential danger of hypoglycemia. He is a spokesman for "Blood Sugar Basics," a website and outreach program co-sponsored by Merck and the American College of Endocrinology.

comments 0 comments - Posted Dec 21, 2012

Traveling With Diabetes

My diabetes and I have traveled a lot of miles together in nineteen years. Racing Ironman triathlons in Australia, Europe, the Carribean and all over North America, climbing and camping at the top of 14,000 foot Mt. Whitney, and of course dozens of family vacations and business trips. Packing equipment and supplies for an Ironman triathlon and 3 weeks in Australia requires a bit of planning and preparation, but when you have diabetes you feel like you do that for just a weekend out of town. Meters, strips, insulin, syringes, infusion sets, pump supplies, snacks . . . a simple weekend trip becomes a lunar expedition.

comments 0 comments - Posted Dec 18, 2012

Halle Berry Says She's Worked Her Way Up From Type 1 to Type 2 Diabetes

No less an authority than the New York Times wrote in May 2006 that Halle Berry has type 1 diabetes, listing her as one of several "stars who have type 1 - Gary Hall, the Olympic gold medal-winning swimmer; Adam Morrison, the Gonzaga University basketball star; [and] Halle Berry."

comments 1 comment - Posted Dec 17, 2012

Metformin May Boost Cancer Survival, Curb Depression

Like aspirin, metformin is one of those drugs that over the years keeps proving itself beneficial in ways it wasn't originally intended to be.

comments 0 comments - Posted Dec 16, 2012

Children with Diabetes, You Are My True Inspiration

Jay Hewitt is 41 years old and has lived with type 1 diabetes since 1991. He is an elite Ironman triathlete (2.4 mile swim, 112 mile bike ride, 26.2 mile run) and three-time member of the U.S. National Team for Long Course Triathlon. He is a lawyer, the father of a 16-month-old daughter, and a motivational speaker. He speaks to people with diabetes and others all over the world on fitness, nutrition, and achieving goals in life and business. Jay is also captain of Team Joslin at the Joslin Diabetes Center in Boston, MA. Visit Jay's website at www.jayhewitt.com.

comments 1 comment - Posted Dec 12, 2012

Incorporating Exercise Into a Busy Life

I would exercise if I had more time... if I had a health club membership... if it didn't hurt so much... if I knew what exercises to do... if I could do it with my family... if I could control my blood sugar...

comments 1 comment - Posted Dec 10, 2012

Molly Martin, Motocross Racer

Molly Martin is a vibrant and energetic 18-year-old from Texas who's had type 1 diabetes since the age of two. Five years ago, Molly took up motocross racing. She says, "I love riding motocross---it's just you and the bike. I feel free when I ride, like I don't have to think about diabetes. I do have to make sure that I test before I get on and during breaks, to make sure my sugar is doing what it's supposed to be doing. But when I get out there, it's just me and the bike, going."

comments 0 comments - Posted Dec 7, 2012

Behind the Wheel, But Still in Control

Last May, 24-year-old Charlie Kimball was in Car #35, taking Turn 3 at the Indianapolis Motor Speedway during the Firestone Freedom 100. He was in radio contact with his pit crew, who informed him that he had a headwind coming out of the turn and onto the 5/8 mile "straight." Charlie kept an eye on the car next to him, moving closer and beginning to crowd it on the inside. Having raced professionally for six years, he knew that he had to make a move, and soon. He shifted into sixth gear and accelerated.

comments 1 comment - Posted Dec 4, 2012

EU OKs Insulin Delivery Device for Type 2s

CeQur SA, a Swiss company that develops insulin delivery devices, has received approval to market its PaQ® insulin delivery device in Europe.

comments 0 comments - Posted Dec 2, 2012

November 2012

Diabetes Heroes Come In All Ages

Last summer, I led the third annual swim-run biathlon for the Barton Center for Diabetes Education, which hosts two Massachusetts camps for children with type 1-Camp Joslin for boys and Camp Clara Barton for girls. It was at Camp Joslin that I met a memorable eight-year-old boy who exemplifies what being a diabetes hero is all about. I'll call him "Adam.'

comments 1 comment - Posted Nov 29, 2012

Study Says Iron May Contribute to Type 2 Onset

Danish researchers report that high levels of transferrin may contribute to the destruction of insulin-producing beta cells in the pancreas. Transferrin is a glycoprotein that binds with iron and transfers it to cells.

comments 1 comment - Posted Nov 28, 2012

Stem Cell Research Points Way to Possible Type 1 Cure

Australian researchers have released a study on stem cells that potentially could lead to type 1s being able to make their own insulin, erasing the need for regular injections.

comments 1 comment - Posted Nov 27, 2012

Don’t be a Turkey on Thanksgiving, Plan Ahead!

I really look forward to Thanksgiving. For me, it’s a great time to spend with family and friends, watch some ballgames on TV and eat. All those wonderful traditional dishes that taste so good are ready for my undivided attention. But for a diabetic, Thanksgiving dinner can be a bit tricky when it comes to controlling your blood glucose levels.

comments 2 comments - Posted Nov 21, 2012

Lilly Says Its New Injectible Outperforms Three Popular Diabetes Drugs

Good news for Eli Lilly & Co., as well as for type 2s who appreciate the addition of new drugs to treat their condition: Lilly says its once-weekly injectible drug, dulaglutide, has outperformed three other widely taken diabetes drugs in three just-concluded Phase III studies.

comments 0 comments - Posted Nov 20, 2012

Fighting For Test Strips

Recently while I was out shopping with my sister, I tested my blood sugar and found that I had a high reading of 217. Because I had just downed a non-fat pumpkin spice latte and still had active insulin in my bloodstream, I skipped correcting it with an insulin shot and went on trying on clothing and chatting with my sister. When I got to my car afterward, I realized that I felt a little like I was drunk, so I figured that I'd better test my blood sugar again. It was 58.

comments 9 comments - Posted Nov 19, 2012

Super-Tight Control of Blood Sugar After Kidney Transplant May Be Counterproductive

To see if tightly controlling blood sugar provides improved results in patients who received a kidney transplant, a group of diabetic post-transplant patients were followed for three days. A subset of the randomly assigned group had their blood glucose kept in tight range with IV insulin, while a control group received insulin as they ordinarily would, via injections.

comments 0 comments - Posted Nov 14, 2012

My Husband Tries Type 1 Diabetes for a Day

It started at 7:45 a.m., when I heard my husband's phone alarming. Since it was his scheduled virtual type 1 for a day challenge with JDRF, I grabbed the phone as he kept snoring. Sure enough, it was his first text from JDRF, reminding him to gather his testing supplies before leaving the house. I shook his leg. "Wake up, sleepy, you have a text about your diabetes." He lay there, continuing to snooze. I tried again with "C'mon, you have to get up, your diabetes needs you!" He hollered between snores, "My diabetes is fine!" Oh, how I wish I could silence my diabetes in the morning with those words.

comments 3 comments - Posted Nov 13, 2012

Penny Hildreth: Finally Facing Diabetes

It was more than two decades ago, and Penny Hildreth was already feeling overwhelmed by life when she learned that she had type 1 diabetes. She was pregnant with her second child and worried about the baby’s safety after a car accident that had left Hildreth with a broken collarbone, a broken rib, and a punctured spleen. It was the spleen injury that ultimately led to her diagnosis of diabetes, but she was more concerned about the baby, a little girl who was born healthy despite the automobile accident. “I always say that she’s my miracle,” says the 46-year-old Portland resident.

comments 1 comment - Posted Nov 6, 2012

Lilly Says Its New Injectible Outperforms 3 Popular Diabetes Drugs

Good news for Eli Lilly & Co., as well as for type 2s who appreciate the addition of new drugs to treat their condition: Lilly says its once-weekly injectible drug, dulaglutide, has outperformed three other widely taken diabetes drugs in three just-concluded Phase III studies.

comments 0 comments - Posted Nov 5, 2012

October 2012

My Glucagon Security Blanket

As a little girl, I was scared at night that something evil might be under the bed. If I had to get up to go to the bathroom, I made sure to leap as far away from the bed as possible. As an adult, I'm still afraid that something will get me at night, but it's no longer a monster: It's the life-saving insulin that I take.

comments 1 comment - Posted Oct 28, 2012

Oral Agents for Lowering Blood Sugar in Type 2 Diabetes

Author’s note: Throughout this series, I will inject my own opinion, which frequently differs from that of the medical establishment in this field. Having had diabetes for more than 66 years, I place my emphasis on the well-being of fellow patients.

comments 0 comments - Posted Oct 21, 2012

Spreading Diabetes Awareness Isn’t as Easy as It Looks

You might not realize this, but I'm actually pretty shy. I often find myself wishing that I had my husband's confidence. He doesn't worry about drawing attention to himself at parties or work. He embraces the mindset that if you don't like him, it's your problem, not his, and he shows himself to everyone just as he is.

comments 0 comments - Posted Oct 18, 2012

Under Physical Stress, Insulin-Producing Cells Regress

Scientists generally think that decreased insulin production by the pancreas, a hallmark of type 2 diabetes, is due to the death of the organ's beta cells. However, scientists at Columbia University Medical Center report that the beta cells do not die, but instead revert to a more basic cell type.

comments 0 comments - Posted Oct 16, 2012

ACCU-CHEK Combo Insulin Pump Now Available in U.S.

Roche Diagnostics says that its ACCU-CHEK Combo insulin pump system is now available in the US market. The system uses Bluetooth wireless technology to allow a glucose meter/insulin pump combination exchange data.

comments 0 comments - Posted Oct 10, 2012

Lantus and Levemir: What's the Difference?

Lantus and Levemir have a lot in common. Both are basal insulin formulas, which means that they last for a long time in the body and act as background insulin, with a slow feed that mimics the constant low output of insulin produced by a healthy pancreas.

comments 2 comments - Posted Oct 7, 2012

Q&A: How to Lower your Blood Sugar when it's Over 200 mg/dl

Q: How do I lower my blood sugar when it goes over 200 mg/dl? I have Type 2 diabetes.

comments 0 comments - Posted Oct 6, 2012

Continuing the Glucose Revolution

When I became a type 2 diabetic, I wanted to find a way to manage my weight and blood sugar with diet and exercise. I tried the high carb diet recommended by my doctor and dietitian for a time. It worked wonderfully well while my blood sugar level was high, but when my blood sugar stabilized and I was able to go off medication, I started gaining weight again. The next thing I tried was low carbohydrate dieting. I found it to be a very effective way to lose weight rapidly, but I was unable to endure the regimen for more than a short time.

comments 6 comments - Posted Oct 2, 2012

September 2012

Your Experience With Symlin

The following letter to the editor asks Diabetes Health subscribers to share their experiences with Symlin. If you use Symlin, please tell us about it in the “Comments” section. Have you had more success in managing your diabetes with Symlin?  How has your insurance company treated you regarding your prescription cost?

comments 7 comments - Posted Sep 27, 2012

FDA Approves New Neuropathy Pain Drug

The US Food and Drug Administration has approved US sales of NUCYNTA® ER (tapentadol), a twice-daily extended-release oral analgesic for the treatment of pain from diabetic peripheral neuropathy. The drug, produced by New Jersey-based Janssen Pharmaceuticals, Inc., provides around-the-clock management for moderate to severe chronic neuropathic pain. Janssen says that it is currently the only opioid on the US market that has been approved for treating the condition.

comments 1 comment - Posted Sep 11, 2012

An Amazing Race Winner Connects With the Diabetes Community

To a casual observer, Dr. Nat Strand might look like an over-achiever. After all, she and her partner won Season 17 of her favorite television show, "The Amazing Race." Winning the race opened her world up to the diabetes community, which, interestingly enough, inspired her to take better care of herself. Her mission now is to encourage everyone with diabetes to connect with the diabetes community and benefit from knowing others who understand the daily challenges of managing type 1 diabetes. When I caught up with Dr. Strand, we began by talking about what drove her to enter the Amazing Race.

comments 1 comment - Posted Sep 5, 2012

Mayo Clinic Says Simple Lifestyle Changes Can Forestall Type 2

The Mayo Clinic Health Letter for August 2012 has published three lifestyle changes that could stave off the progression of prediabetes to full-blown type 2 diabetes. The list isn't new, but its periodic reiteration indicates that healthcare researchers and providers have settled on a simple prescription for staying diabetes-free.

comments 1 comment - Posted Sep 4, 2012

August 2012

Why Do We Crave Carbohydrates?

We’ve all heard a lot of discussion about low carbohydrate diets and whether they are effective for weight loss and blood sugar control.. What most of us do not understand, however, is how diabetes affects the way that we process carbs. Beta cells make more than insulin: they also make another satiety hormone: amylin. If we are beta-cell deficient, then we are amylin-deficient as well. When the amylin hormone is not available to tell our brain that we are full, we crave more food, especially carbohydrates. Carbohydrates act as a mood stabilizer, making us feel good when we’re stressed.

comments 1 comment - Posted Aug 31, 2012

Paula Deen: Cooking Up a New Life With Diabetes

Paula Deen, a celebrity Southern chef known for her unrestrained love of butter and sugar, is no stranger to the media. She received a flurry of bad press recently when she revealed that she had been diagnosed with type 2 diabetes three years earlier. Shortly thereafter, she became a spokesperson for Novo Nordisk's Victoza. Following these developments, some critics said that she was a poor role model. 

comments 2 comments - Posted Aug 28, 2012

US Sale of Generic Actos Gets FDA Nod

The Food and Drug Administration has approved US sale of generic pioglitazone (trade name Actos) for the treatment of type 2 diabetes. Actos, originally developed and trademarked by Takeda Pharmaceuticals, works by decreasing insulin resistance in type 2 patients. The prescription drug, which belongs to the class of drugs known as thiazolidinediones (TZDs), has enjoyed great commercial success in the United States since its introduction in 1999, posting estimated sales last year of $2.7 billion.

comments 0 comments - Posted Aug 27, 2012

Playing God

Recently, while scrolling through discussions posted on an online diabetes forum, I came across one from a man in his thirties who wrote about how paramedics had found his twin brother face down in a sauna, in an insulin shock coma.  How did he end up in such a state?  The appalling answer is, he didn't have enough glucose strips to test before he got into the hot tub.  A few weeks before the sauna incident, his insurance company had limited his glucose strips to just four per day.

comments 26 comments - Posted Aug 25, 2012

Am I Taking Too Much Insulin?

The other day, I read a post in which someone wrote that he had to take a "ton of insulin" to cover some carbs in his meal, and he disclosed the exact dose. The funny thing is, I have often taken that amount to cover my meals. Admittedly, they were higher carb meals, but I never really thought of it as being a "ton" of insulin. When you read something like this, you can't help but wonder if you are doing something wrong on a regular basis. I suddenly felt that maybe I was out of line in taking that particular dose at a normal meal.

comments 3 comments - Posted Aug 23, 2012

The New Accu-Chek Nano Blood Glucose Meter

The new Accu-Chek Nano was approved for diabetes patients in January 2012, and distribution of the product began in April. Jennifer Aspy, the director of product marketing and operations, sat down with me at the American Association of Diabetes Educators to talk about the merits of this new medical device.

comments 1 comment - Posted Aug 21, 2012

Type 2 Trudges Across America to Defeat Diabetes

Right from the start, Andy Mandell thought of walking the perimeter of the US to raise awareness for diabetes as a military objective, a special ops mission to draw attention to the dangers of the disease. As someone who has lived with type 2 diabetes for more than 20 years, Mandell saw his role as that of an educator, and he took it seriously, wanting to help others avoid the mistakes he had made after his diagnosis. An active guy who loved running, he followed his doctor's orders--to a degree. He checked food labels to make sure that he wasn't consuming too much sugar, and he continued his vigorous lifestyle. He felt good, so he saw no reason to worry.

comments 4 comments - Posted Aug 17, 2012

Social Media, Partnerships Are Top Topics at AADE12

As diabetes climbs to epidemic levels in the United States, and finding adequate resources to fund future U.S. healthcare remains in question, the need for an already existing "boots on the ground" group that can address the disease is greater than ever.

comments 0 comments - Posted Aug 15, 2012

Sharps Disposal: Will Pharmacies End Up Footing the Bill?

As CEO of a company that manufactures insulin syringes and pen needles for the US and Canadian markets, I have been closely monitoring the regulations and trends pertaining to the safe disposal of the products we produce. Surveys indicate that less than five percent of the over three billion sharps devices sold in the US annually are disposed of in some type of closed container. Most of the remaining 95 percent are deposited, unprotected, in the household trash. Significant changes may be pending with regard to the disposal of used sharps devices, and it's likely that pharmacists will be affected by these changes.

comments 12 comments - Posted Aug 14, 2012

An Interview With Robert Cuddihy, MD, of Sanofi US

Endocrinologist Robert Cuddihy, MD, joined Sanofi US over a year ago to be the company’s Vice President and Medical Diabetes Head in the United States. He is responsible for developing and executing the US strategy for Sanofi’s Diabetes Division, including pharmaceuticals, devices, and other technologies. He previously served as the medical director for several organizations, including the International Diabetes Center-Park Nicollet in Minnesota.

comments 0 comments - Posted Aug 13, 2012

BD Introduces Ultra-thin 27-gauge Needle

Jersey-based BD Medical, a division of  Becton, Dickinson and Company, has introduced the Hyflow™ needle, a 27-gauge thin-wall needle designed for use with the company’s prefillable syringe systems.

comments 1 comment - Posted Aug 11, 2012

July 2012

My Pump Almost Killed Me... Twice

One of the greatest technological advancements in diabetes care has been the insulin pump.  For one, it gives you the illusion of being "normal" because you no longer have to inject insulin throughout the day. Instead, you "bolus" by pushing a button on the pump itself or using a remote control. It allows better glucose management because you can adjust your basal rate (the "background" insulin dose) by increments of one thousandth of a unit every hour.  Especially when you're moving from the peaks and valleys of NPH or the restraints and hazards of Lantus, the freedom of living with an insulin pump is incredible.  But pumps do not come without their kinks.

comments 9 comments - Posted Jul 31, 2012

Workers Who Take Their Medicine Are More Productive

Editor's Note: Portions of this report were taken from a press release from CVS-Caremark.

comments 0 comments - Posted Jul 26, 2012

Closed-Loop Insulin Delivery Improves Nighttime Control in Young Type 1s

In a small study of 10 type 1 children under the age of seven years, closed-loop insulin delivery improved their nighttime glycemic control. The therapy, delivered at Children's Hospital Boston, used an algorithm-controlled pump and continuous glucose monitor to deliver insulin on an as-needed basis as the children slept.

comments 0 comments - Posted Jul 23, 2012

Type 2: Early Therapy Helps Retain Beta Cell Function

Immediately starting intense therapy for newly diagnosed type 2s preserved their beta cell functioning for 3.5 years, according to a University of Texas Southwestern Medical Center study.

comments 0 comments - Posted Jul 18, 2012

Sugar Intake and Cardiometabolic Health in Children

On a Sunday morning, a busy couple and their school-age children enter a superstore for their weekly grocery shopping. As they move through the center of the store, their shopping cart fills with packs of flavored yogurt, fruit sauces, fruit bars, fruit juices, flavored milk, prepared school lunches, snacks, and family meal packs.

comments 0 comments - Posted Jul 15, 2012

Adding Liraglutide to Insulin May Help Obese Type 1s

New York researchers have reported that obese patients with type 1 diabetes who do not respond well to insulin may be able to improve their blood sugar control by adding liraglutide to their therapy. Liraglutide (brand name Victoza) is an injectible GLP-1 analog* that was introduced to the US market in 2010 to treat people with type 2 diabetes.

comments 0 comments - Posted Jul 14, 2012

Stylish Diabetes Supply Cases From Myabetic.com

Kyrra Richards, who has type 1 diabetes, has transformed her desire for a stylish diabetes carrying case into a thriving business. Her sense of style has struck a chord with a large audience, including a company that is working with her to customize her line to its pump. It’s been several years since Diabetes Health interviewed Kyrra at an AADE conference (http://www.diabeteshealth.com/tv/play/182.html).  I spoke to her recently to catch up and see how things were going.

comments 1 comment - Posted Jul 8, 2012

Diabetes: Hospital Bills Cost U.S. $83 Billion A Year

Diabetes affects nearly 25 million Americans, and that number is expected to grow substantially every year. It's the fifth leading cause of death in America, more than breast cancer and AIDs combined. And according to a report released last week from the Agency for Healthcare Research and Quality (AHRQ), it's a disease that’s costing Americans $83 billion a year in hospital fees — 23 percent of total hospital spending.

comments 3 comments - Posted Jul 5, 2012

Metformin Lowers Breast Cancer Risk

Metformin is the aspirin of the diabetes world, an almost-wonder drug that proves itself again and again the longer it's around. This time, a new study shows that postmenopausal women with diabetes who have taken metformin for several years are 25 percent less likely to develop breast cancer than nondiabetic women.

comments 0 comments - Posted Jul 1, 2012

June 2012

Stem Cell Treatment for Type 1 Diabetes

A small Chinese study has reported that 15 of 28 young type 1 patients, aged 14 to 30 years, who underwent an experimental adult stem cell procedure were able to stay off insulin injections for an average of 18 months. Though not conclusive, the study highlights an interesting avenue of research that could eventually dramatically reduce insulin dependence among type 1s.

comments 7 comments - Posted Jun 29, 2012

Patient Injection Adherence Improves Under Pharmacist Guidance

A Walgreens study during which pharmacists counseled patients about taking injectable diabetes medications improved the patients' adherence by 24 percent.

comments 0 comments - Posted Jun 27, 2012

Things I Can't Stand About My Insulin Pump

My insulin pump has changed my life. My A1C has improved, I've felt more energetic, and I've controlled my diabetes more effectively overall. It has been the biggest and best change in my diabetes treatment since I started on insulin a quarter-century ago.

comments 2 comments - Posted Jun 25, 2012

I Hear You, But I'm Not You

I've had type 1 diabetes for nearly 14 years. I have fallen off the wagon a few times, battled diabulimia, survived numerous insulin shock comas and ketoacidosis episodes, and struggled with acceptance: I have my scars. Despite these mistakes, I've picked myself up countless times and have prevailed. I've persevered with a disease that doesn't take vacations for even a minute, and I've come out on top. I'm alive and healthy, with a full life and a child of my own.

comments 5 comments - Posted Jun 21, 2012

Dexcom Proudly Sponsors Historic Diabetes Flight Formation Trip To Raise Juvenile Diabetes Research Foundation Funds Dexcom Proudly Sponsors Historic Diabetes Flight Formation Trip To Raise Juvenile Diabetes Research Foundation Funds

SAN DIEGO - June 15, 2012 - Dexcom, the leader in continuous glucose monitoring, is proudly sponsoring the efforts of the Diabetes Formation Flight USA(DFFUSA.org) - three pilots with insulin-dependent diabetes using Dexcom's Seven Plus as part of their effort to set new transcontinental world speed records while raising funds for the Juvenile Diabetes Research Foundation (JDRF).

comments 0 comments - Posted Jun 20, 2012

Another Day, Another Battle

Last year, I gave birth to my daughter and shared my pregnancy and birthing experiences with you. The pregnancy was a very difficult but extremely rewarding experience. A few months after our daughter was born, my husband and I discussed whether we'd have another child. On one hand, I went through several insulin shock comas, severe insulin resistance, and pre-eclampsia, ending in an emergency cesarean section. Because my first pregnancy was so tough, we weren't sure if we wanted to risk another one. On the other hand, if we did have two children, we wanted them to be very close in age so that they could bond well. We figured that if the two children were around fifteen months apart, then my daughter would be too young to feel any tension about having another baby in the house. We hoped they'd be close enough in age that they would always have one another as a companion.

comments 3 comments - Posted Jun 18, 2012

Clinical Study Begins on Insulin Delivery Device for Type 2s

A clinical study has begun of a wearable device that continuously delivers basal insulin to people with type 2 diabetes. The device, PaQ®, is manufactured by CeQur SA, a Swiss company that has operations in Denmark and Massachusetts. Designed to provide three days of basal insulin delivery along with on-demand bolus insulin, the device incorporates a disposable insulin infuser reservoir attached to a reusable insulin monitor.

comments 2 comments - Posted Jun 16, 2012

Six Mistakes That Marketers Make When Communicating With People With Diabetes

This is an open letter to marketers who target people with diabetes. From the point of view of a person with diabetes, marketers often make the following mistakes when promoting their products to us.

comments 5 comments - Posted Jun 15, 2012

Intensive Wellness Approach Helps Type 2s Lower Drug Doses and Costs

A Florida-based endocrinologist and his team have reported that an intensive 16-week wellness program aimed at type 2 patients yielded some dramatic results: Patients were able to decrease their insulin by 46 percent and their oral medication by 12 percent.  They saw their 30-day prescription costs drop by an average of more than $140 per month, reduced their BMI by 3.07, and experienced a drop of 0.7% in their A1C.

comments 1 comment - Posted Jun 14, 2012

The Game Plan: Blood Sugar Basics

How would you like an online interactive resource for type 2 diabetes that teaches you blood sugar basics? The American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) have come together to develop "the Game Plan" diabetes management program. By going to the website at bloodsugarbasics.com/the-game-plan, you can get everyday tips, watch a video, take a quiz that tests your understanding of high and low blood sugar, and find advice on how to approach your healthcare team.

comments 0 comments - Posted Jun 12, 2012

Type 1: FDA OKs Levemir for Two- to Five-Year-Olds

The US Food and Drug Administration has approved the use of Novo Nordisk's Levemir basal insulin for type 1 children aged two to five years. The FDA decision makes Levemir (insulin detemir [rDNA origin]) the only basal insulin approved for use in this age group.
Levemir, introduced to the US market in 2006, was previously approved for older children and adults with type 1 diabetes, as well as insulin-using type 2s.

comments 0 comments - Posted Jun 7, 2012

A Spiritual Approach to Diabetes Care

The following article documents a very personal way of approaching diabetes.  Always check with a healthcare professional before changing your diet or your diabetes care regimen.

comments 2 comments - Posted Jun 6, 2012

Short Video Shows and Tells Diabetes Basics

A short animated video narrated in a woman's reassuring tone provides a basic look at diabetes. The presentation touches on the science behind the condition and explains important terms, including "pancreas," "glucose," and "insulin." It stresses the importance of regular A1C checks and taking medication if needed, while pointing out the dangers associated with not staying on top of blood sugar levels.

comments 0 comments - Posted Jun 5, 2012

A Celebrity Chef’s Documentary About Diabetes

Not long ago, celebrity chef Charles Mattocks, who was recently diagnosed with diabetes, came across the twitter account that I use to connect with the diabetes community. He called me and told me about his idea for making a documentary about diabetes and asked if I would like to participate. Charles saw the need for an up-close view of our disease that would be very supportive of the diabetes community. Having had type 1 diabetes for 12 years, I jumped at the opportunity to be a part of a film that focuses on the struggles of dealing with diabetes.

comments 3 comments - Posted Jun 2, 2012

The Young and the Reckless

I'm about to tell you a secret that I've kept for 15 years.  I know that we all make mistakes with our diabetes, but the one I made back then was literally a wake-up call.  While I cringe at telling this unflattering story, I hope that it will help others realize how scary things can get quickly if you ignore your diabetes. Thankfully, the scenario that unfolded all those years ago helped bring me out of my reckless state and showed me the way to a better life with diabetes.

comments 2 comments - Posted Jun 1, 2012

May 2012

Women and Diabetes:  Adjusting Your Management Plan to Match Hormonal Changes

I've had type 1 diabetes for six years, and it never fails that during the dreaded "time of the month," I become increasingly insulin-resistant. Just looking at a carbohydrate makes my sugar skyrocket. I'm exhausted, and my mood goes from my usual positive to cranky and sensitive.

comments 1 comment - Posted May 27, 2012

Finding the Right Diabetes Doctor

I once had a doctor ask me what I'd do if someone offered me a drink or a cigarette. I was a teenager, recently diagnosed with type 1 diabetes, and it was the first time that I had seen her. When I told her that I didn't drink or smoke, she kept hounding me with questions as if I were lying. I grew tired of telling her the same thing over and over. She just didn't seem to hear what I was saying. Maybe she was just trying to scare me from starting, but I left feeling annoyed and convinced that I needed to find a different doctor.

comments 2 comments - Posted May 25, 2012

Study Says Best Drug Combo for Type 2 Kids Is Metformin and Rosiglitazone

A university study has concluded that a combination of metformin and rosiglitazone (Avandia) is the best drug therapy for controlling blood sugar levels in type 2 children and adolescents. Metformin alone is the drug most often prescribed for young or recently diagnosed type 2 patients.

comments 0 comments - Posted May 24, 2012

Around the Table: A Dinner Host's Responsibility With Paula Deen

Recently, I was cuddling my sleeping toddler and watching a recorded episode of The View. If you've never seen the show, five well-known women discuss "hot topics" and interview guests. On the day I watched, their guest co-host was Paula Deen, the Southern chef who is best known for adding endless sticks of butter to her recipes.

comments 6 comments - Posted May 23, 2012

Transplanted Gut Organisms Could Prevent Diabetes Onset

Scientists meeting recently at the International Liver Congress in Barcelona, Spain, say that microbiota-tiny organisms specific to a part of the body-transplanted from healthy people to people at risk of diabetes or nonalcoholic fatty liver disease may prevent the later onset of those conditions. The procedure involves implanting small quantities of fecal matter from healthy donors into the colons of pre-diseased recipients.

comments 0 comments - Posted May 18, 2012

Five Ways to Get Back on Track When You’re Burned Out

Burnout is common among people with diabetes, especially those who have had the disease for years, even decades. Diabetes management can be exhausting, confusing, and frustrating, particularly when you think you are doing everything right but your blood sugars still fail to cooperate.

comments 1 comment - Posted May 17, 2012

Taiwanese Study Identifies Top Three Drugs for Type 2 Glycemic Control

Researchers in Taipei, Taiwan, report that they have identified the top three drugs for reducing A1C levels in type 2 diabetes: biphasic insulin, GLP-1 analogs, and basal insulin. They hedged a little on their endorsement of GLP-1 analogs, however, by saying that although they are not decisively better at controlling A1Cs than other oral diabetes drugs, they have the advantage of helping to reduce weight without adding to the danger of hypoglycemia.

comments 0 comments - Posted May 16, 2012

“Reprogrammed” Cells in Mice Reverse Late-stage Type 1 Diabetes

A successful experiment on mice with type 1 diabetes, which involved "reprogramming" their immune systems to stop attacks on pancreatic beta cells, may point the way to an eventual cure for the disease in humans.

comments 5 comments - Posted May 15, 2012

Molecular Switch Could Be Key for Type 2s

With tens of millions of American facing life with type 2 diabetes and many millions more at risk of the disease, scientists are scrambling to unravel novel treatments. The latest breakthrough could come from California's Salk Institute.

comments 0 comments - Posted May 13, 2012

Insulin degludec

Novo Nordisk's new variety of long-lasting insulin, insulin degludec, reduces low blood sugars while improving overall control, according to a pair of studies published in the prestigious journal The Lancet on April 27.

comments 0 comments - Posted May 8, 2012

The State of the States: Adherence Report

Diabetes Health recently submitted some questions to CVS Caremark Corporation regarding its "The State of the States: Adherence Report." The report compiled data from more than 50 million patients to track their level of adherence to drug prescriptions for four chronic diseases: diabetes, depression, high blood pressure, and high cholesterol.

comments 2 comments - Posted May 4, 2012

New Blood Sugar Guidelines Give Older Type 2s More Latitude

It may be better for older people with type 2 diabetes to have less stringent A1C goals than younger type 2s, according to new guidelines from the American Diabetes Association and the European Association for the Study of Diabetes.

comments 3 comments - Posted May 3, 2012

April 2012

FDA Warns Diabetes Patients About Combining Aliskiren

On April 19, the US Food and Drug Administration issued a warning to diabetes patients not to combine the blood pressure medication aliskiren (Tekturna) with ACE inhibitors or angiotensin receptor blockers. The warning also applies to patients who have renal impairment.

comments 0 comments - Posted Apr 30, 2012

All in the Family

My oldest nephew, James, has a double whammy to deal with.  His aunt, yours truly, has type 1 diabetes, and so does his father. I was in the room when my sister had an ultrasound during her pregnancy with James, and I clearly remember the doctor asking her if anyone in her family had diabetes.  We shared a look as she informed the doctor of my diabetes and her husband's diabetes.  I know we also shared a silent prayer as the reality hit us that diabetes might be passed on to her children.

comments 0 comments - Posted Apr 27, 2012

Neuropathy Device Maker Files

NeuroMetrix, Inc., a Massachusetts-based medical device company, has filed a 510(k) form with the US Food and Drug Administration for the SENSUSTM, a pain therapy device for people who suffer diabetic neuropathy. A 510(k) is a "premarket notification" of a company's intent to market a medical product. The FDA then tests the product and provides feedback to the manufacturer. Once the FDA clears the product, its maker can introduce it to the US market.

comments 0 comments - Posted Apr 24, 2012

Summer Eating Tips for People With Diabetes

As we approach the summer season, our thoughts turn to barbecues, picnics, amusement parks, and road trips to the beach.  It is a season of fun, but it can be hard for people with diabetes to enjoy the festivities and still maintain healthy eating habits.

comments 1 comment - Posted Apr 23, 2012

Pregnancy, Parenting, Writing, and Diabetes: An Interview With Cheryl Alkon

The challenges of pregnancy are daunting on their own, but when you're diabetic, they can seem insurmountable. That's one of the reasons Cheryl Alkon wrote a book on the subject. Having type 1 diabetes herself, Alkon knew firsthand the challenges of controlling her disease during pregnancy, and of raising the kids who followed.

comments 0 comments - Posted Apr 13, 2012

To Love a Diabetic

To love a diabetic is to be a doctor. It means helping her to remember her medications. It means driving her for an hour to the only 24 hour pharmacy when she's gotten the flu and can't take the Nyquil in the refrigerator. Or driving her to the hospital when the simple flu turns into bronchitis and her blood turns acidic.

comments 5 comments - Posted Apr 12, 2012

FDA Says Levemir OK for Pregnant Women

The U.S. Food and Drug Administration says that Levemir is safe for use by pregnant women and does not increase the risk of harm to children in the womb.

comments 0 comments - Posted Apr 4, 2012

Imagining the Unimaginable

As I listen to the news of the recent Mega Millions jackpot of over $600 million, my dreams aren't about fast cars, vast mansions, or plush vacations. My thoughts revolve around my diabetes. How awesome would it be to have the best care that money can buy?

comments 0 comments - Posted Apr 1, 2012

March 2012

Generic Insulins Out of Reach for Now

A Diabetes Health reader writes in to ask: Is there a generic alternative to Humalog insulin? If so, what is its cost compared to Humalog?

comments 1 comment - Posted Mar 30, 2012

Am I Doing the Right Thing?

Readers occasionally ask us for advice about drugs they are taking. When they do, we refer their questions to a medical professional. In the question below, a Florida reader expresses concerns about the interaction of her diabetes drug with the medicines she takes for asthma.

comments 0 comments - Posted Mar 29, 2012

Type 1 Diabetes Researchers Reach Important Milestone

Type 1 Diabetes TrialNet, an international network of researchers exploring ways to prevent and delay the progression of type 1 diabetes, has reached an important milestone: screening 100,000 people to detect who among is at risk of developing type 1 diabetes. This is a major achievement because it has helped researchers better predict who will develop diabetes and when it will require treatment. Earlier diagnosis helps patients avoid a severe, life-threatening condition called diabetic ketoacidosis. 

comments 0 comments - Posted Mar 28, 2012

Keep Your Fingers Crossed: FDA Approves Artificial Pancreas Outpatient Trial

The FDA has approved the start of outpatient trials of a smart phone-based monitoring device that functions as an artificial pancreas. If the device, which automatically measures blood glucose levels and adjusts them with insulin, is successful, several million type 1 patients could enjoy a whole new level of convenience.

comments 9 comments - Posted Mar 27, 2012

Spring Break With Diabetes

It's spring break again, when thousands of people head to the beach. A lot of wonderful things come with being out and about on spring break, but if you have diabetes, there are also several things you should consider. There's going to be more traffic, fewer parking places, lots of people, an abundance of uncalculated carbohydrate sources, and longer waits for everything, to name just a few.

comments 0 comments - Posted Mar 26, 2012

Metformin Shines Again: Long-Term Use Helps Prevent Type 2

Long-term use of metformin as a weight loss aid is both safe and effective in preventing or delaying the onset of type 2 diabetes, says the Diabetes Prevention Program Research Group.

comments 0 comments - Posted Mar 25, 2012

Diabetes and Exercise

Do you struggle with controlling your sugar levels during exercise? When my doctor changed my exercise regimen after my heart attack, my biggest struggle was keeping my sugar levels stable. We all like to see low numbers, but no one likes the shaking associated with low blood sugar or that feeling we have for the rest of the day after our levels have fluctuated. So how low is too low before working out?

comments 0 comments - Posted Mar 22, 2012

The First 25

A little more than 25 years ago, I was diagnosed with type 1 diabetes.

comments 3 comments - Posted Mar 21, 2012

Self-Monitoring Benefits New Type 2s in the First Year

If you are newly diagnosed with type 2 diabetes and don't take insulin, a new study says that you are likely to have better A1Cs if you have access to blood glucose testing supplies and use them. The finding comes from a large Cochrane review of previous studies that took place in many countries.

comments 0 comments - Posted Mar 17, 2012

Newly Diagnosed with Type 2 Diabetes? Be Sure Your Doctor Prescribes a Generic First

According to a study of patients newly diagnosed with type 2 diabetes, 35 percent of the time their physicians did not follow the American Diabetes Association (ADA) guideline that calls for prescribing a generic drug first. The study, conducted by researchers from CVS Caremark, Harvard University, and Brigham and Women's Hospital, reviewed the pharmacy claims of 254,000 patients who were started on a diabetes medication in January 2006 and December 2008. One-third of the treatment regimens did not adhere to the ADA guideline.

comments 0 comments - Posted Mar 13, 2012

Little Diabetes Warriors

Sometimes I feel like an idiot. It usually happens when I read a blog by one of my favorite "D" parents telling about how their children are handling life with type 1 diabetes. These brave kids put up with the same things that adults with diabetes do, and some are literally too young to even understand what's going on. Reading about these little warriors makes me regret even more the fact that I wallowed in self pity all afternoon just because my blood sugar didn't cooperate flawlessly during my daily walk.

comments 1 comment - Posted Mar 6, 2012

ACP Guidelines Say Metformin Is the Best Starter Drug for Type 2s

The latest clinical guidelines for treating type 2 diabetes from the American College of Physicians (ACP) indicate that when diet, exercise, and weight loss fail to control blood sugar levels in early type 2 patients, physicians should prescribe metformin as the first drug therapy.

comments 2 comments - Posted Mar 1, 2012

February 2012

Diagnosed After Sixty: Medication Not Required

"I knew I didn't eat a totally healthy diet because bread is a big weakness of mine. Worse, exercise was something I kept planning to do but hadn't gotten around to," recalls 62-year-old Laura M., who lives in a New York City suburb. "I had been feeling more tired than usual and had a cut on my right leg that seemed to be healing slowly, but other than that I felt fine. When during the course of an annual check-up, my doctor said I had diabetes, I practically fell apart."

comments 1 comment - Posted Feb 28, 2012

Girl Finds Strength in Fostering Diabetic Dog

The unconditional love of a dog can be an amazing source of strength and resilience for its owner. Eight-year-old Madalaine Hembraugh and her foster dog, Petey, are living proof of that. They both have type 1 diabetes, and they have formed a bond that is helping to heal them both.

comments 1 comment - Posted Feb 27, 2012

Hear Me, Doctor

During my 14 years with type 1 diabetes and my time spent interacting with the diabetes online community, I constantly hear the same theme: Doctors aren't listening to their patients, and their bedside manners are deteriorating. Every day, it seems, I hear about people who have been treated as if they are simply a number or dismissed as uneducated in their own health conditions.

comments 4 comments - Posted Feb 26, 2012

Neurologists Issue New Guideline for Treating Neuropathy

A team of neurologists has issued a new set of recommendations for the treatment of diabetic neuropathy, including drugs and other treatments that have been found to be the most effective therapies for the condition.

comments 12 comments - Posted Feb 25, 2012

Metformin Could Protect Women Against Endometrial Cancer

British researchers say that metformin, the drug most often used to treat prediabetes and type 2 diabetes, could provide potential protection against endometrial cancer in women.

comments 0 comments - Posted Feb 24, 2012

Men With Diabetes More Likely to Need Invasive ED Treatments

A study of medical claims data from more than 136,000 men shows that men with diabetes are much more likely to require invasive therapies for erectile dysfunction than men without diabetes. The therapies, which are the next steps beyond oral treatments, are second-line suppositories or injections and third-line surgeries to implant prostheses.

comments 1 comment - Posted Feb 23, 2012

Women and Diabetes: A New Book with Fresh Insight

As a woman with diabetes, you may have noticed that you face unique challenges, from where to place your insulin pump, to pregnancy, to hormone fluctuations.   Many diabetes books offer general diabetes advice, but few focus on women beyond just a short chapter.  That is, until now.   

comments 2 comments - Posted Feb 20, 2012

An Update on Bydureon

You've heard of the blockbuster drug Byetta, a daily injection for type 2 diabetes? Byetta's sister product, Bydureon, which is injected just once a week, has just been approved by the FDA and is available in pharmacies.

comments 11 comments - Posted Feb 17, 2012

Diabetes and Anemia:

There are lots of articles about diabetes, as well as all kinds of information about anemia. But what if you have both? About 25 percent of people with diabetes have some level of anemia. This article explains how the two conditions interact.

comments 3 comments - Posted Feb 16, 2012

“You Have Diabetes.” Momentary Panic, Then Dedication and Determination

My best friend from high school, Katherine, married a wonderful man who was diagnosed with type 2 diabetes a little over two years ago. John Schaaf, now 60, lives with Katherine in Berkeley, Calif., and works for Chevron Corporation in nearby Richmond.

comments 4 comments - Posted Feb 13, 2012

The Seasons of Diabetes

Diabetes doesn't confine itself to a single week or month. It's a year-round condition, and each season offers its own challenges and opportunities for those of us with the disease. We should be prepared to change and evolve as the seasons shift--not only to stay healthy, but also to enjoy all the fun that our dynamic world offers.

comments 1 comment - Posted Feb 7, 2012

FDA OKs Sale of Combo Drug JANUMET® XR

The FDA has approved US sales of JANUMET® XR, a daily oral treatment for type 2 diabetes that combines sitagliptin and extended-release metformin. The drug is the fourth oral type 2 diabetes treatment introduced by Merck, which also sells JANUVIA, JANUMET, and JUVISYNC.

comments 0 comments - Posted Feb 6, 2012

FDA Gives Long-Awaited Nod to Amylin’s Bydureon

After several years of delays and setbacks, Amylin Pharmaceuticals has received FDA approval to begin US marketing of BydureonTM. The first once-a-week type 2 therapy to be offered in the US market, Bydureon is expected to be available by February. Amylin says that its wholesale price will be about $4,200 a year.

comments 2 comments - Posted Feb 3, 2012

January 2012

Traveling With My Diabetes

The first time I worried about traveling with diabetes was after the 9/11 tragedy. I had been offered a trip to New York to attend a writer's conference. I jumped at the chance, looking forward to the conference, sightseeing, shopping, and seeing the musical The Producers on Broadway.

comments 9 comments - Posted Jan 30, 2012

DiabetesSisters’ National Conference Set for May 18-20 in Raleigh, NC

RALEIGH, NC- DiabetesSisters is pleased to announce that registration for the 2012 Weekend for Women Conference opened on January 1, 2012, at 8 AM. The conference, a revolutionary weekend designed specifically for women with diabetes, will take place Friday, May 18, through Sunday, May 20, 2012, at the Marriott City Center in downtown Raleigh.

comments 0 comments - Posted Jan 24, 2012

US Government May Force Drug Firms to Report Money Paid to Doctors

When your doctor recommends a new drug or treatment for your diabetes, do you know if the doctor has received payment from the company that markets the drug or device? If the Obama administration has its way, you will. It is proposing a new law that will require drug companies to disclose payments made to doctors for research, consulting, speaking, travel, and entertainment-even something as minor as coffee and bagels delivered to a doctor's office for a meeting.

comments 10 comments - Posted Jan 20, 2012

Lessons Learned About Diabetes and Self-Care

In my work as a prevention health technician in the Lakota community of South Dakota, I encourage people to ask questions and learn the facts about diabetes. Once they are aware of what diabetes is and how they can prevent or control it, they become empowered.

comments 4 comments - Posted Jan 19, 2012

“Grip, Rip, and Sip”

Ethan Lewis, diagnosed with type 1 diabetes at the age of 12, founded GlucoBrands only 11 years later. The company produces a portable, inexpensive, tasty, fast-acting glucose gel that people can take to quickly restore healthy blood sugar levels when they experience hypoglycemia.

comments 1 comment - Posted Jan 16, 2012

New LifeScan Meter Alerts Users About Blood Sugar Patterns

LifeScan has introduced the OneTouch® VerioTM IQ, a meter that not only tracks and displays blood sugar patterns, but also announces them with messages, such as "Looks like your blood sugar has been running LOW around this time."

comments 2 comments - Posted Jan 15, 2012

There’s No Shame in Taking Insulin Injections in Public

Recently, there has been a great deal of discussion on the subject of testing your blood sugar and taking insulin shots in public. A shocking number of people on social networks have commented that their family members don't want them to test their blood sugar or take their shots in public. They report having to inject in restrooms or even through their clothing to avoid drawing attention or offending their families. One hypersensitive husband even objected when his recently diagnosed wife took a shot in the relative privacy of their car.

comments 40 comments - Posted Jan 12, 2012

Riding on Insulin

Professional snowboarder Sean Busby started competing at age 14 and began training for the Winter Olympics at 16. But in 2004, at age 19, Sean's troubling bouts of thirst and weariness were revealed as symptoms of type 1 diabetes.

comments 1 comment - Posted Jan 10, 2012

Recovery

My baby girl had just been born. I was in the postoperation room after going through a cesarean section. My husband went to get my parents, who had been waiting for twelve hours in the waiting room. A nurse laid my little girl in an incubator next to my bed and checked her blood sugar, which was normal, in the mid-40 range. Fifteen minutes later the nurse checked her again, and it registered in the mid-30s. I watched as the nurse fed my baby her first ounces of food. I was still too numb to even know that I had legs, much less to be able to wiggle my toes.

comments 4 comments - Posted Jan 6, 2012

Instructional Video Available for Spring Universal Infusion Set

Spring Health Solutions, Inc., has released an instructional video describing its Spring Universal Infusion Set, recently approved by the FDA and Health Canada. The video, at www.SpringUniversal.com, is designed to help consumers properly use the product.

comments 0 comments - Posted Jan 4, 2012

Pain and Joy

As I explained in my previous articles, I was pre-eclamptic and was admitted to the hospital at 37 weeks. I had a migraine that lasted for ten hours after I entered the emergency room. I had experienced migraines before and knew that Tylenol wouldn't ease the pain, so I went untreated even in the hospital. About twelve hours after admission, I was brought to the women's floor, where I waited for my already injected Levemir supply to diminish in my bloodstream.

comments 1 comment - Posted Jan 2, 2012

December 2011

Birthing Options

Throughout pregnancy and all the way up until labor, I was adamant that I was not having a cesarean section. I was terrified of being cut open because I know that my healing time is longer due to my lowered immune system. In 2009, I had to go to the emergency room for an infection caused by cutting my leg while shaving, so how could I possibly heal after being opened up to birth a baby?

comments 0 comments - Posted Dec 30, 2011

Yeast, Diabetes, and Sex

Vaginal yeast infections are annoying, not dangerous, but they can seriously hamper your sex life, especially if you have diabetes. What's the connection, and what can you do to prevent and treat yeast infections?

comments 3 comments - Posted Dec 29, 2011

Complications in the Third Trimester

Editor' Note: This article continues Katherine Marple's series on pregnancy with diabetes as a complicating factor. For previous articles, enter her name in the search feature at the top right-hand of this website. The next installment, "Birthing Options," will appear on December 30.

comments 1 comment - Posted Dec 27, 2011

Coming Soon: A New and Better Treatment for Diabetic Retinopathy

Diabetic retinopathy is caused by damage to blood vessels of the retina. Almost everyone who has had diabetes for thirty years or more has some sign of the condition. Now, retinopathy researchers have come up with a device that will be implanted behind a patient's eye to deliver medication on demand. "We wanted to come up with a safe and effective way to help diabetic patients safeguard their sight," said lead author Mu Chiao, a mechanical engineering associate professor at the University of British Columbia (UBC) in Vancouver, in Science Daily. "This new device offers improvements upon existing implantable devices for drug delivery."

comments 2 comments - Posted Dec 26, 2011

3 Drugs on the Horizon Could Help the Fight Against Obesity

Health experts are unanimous that obesity or being overweight are major factors in the onset of type 2 diabetes. So it's no surprise that researchers here and abroad are working to develop weight-loss drugs that can help people shed pounds and lessen their susceptibility to diabetes.

comments 1 comment - Posted Dec 23, 2011

Behind the Scenes, Infusion Sets Thrive

Even the best known actors can't make a hit movie on their own. They need people behind the scenes. Just like those stars of the silver screen, the standard insulin pump can't do its job all by itself. No, the classic-model pump needs an infusion set to deliver its insulin to patients.

comments 0 comments - Posted Dec 21, 2011

Are You Prepared for the Holidays?

If you have diabetes, you know all too well what's going to happen between now and the end of the year. You'll be forced to make some quick and painful decisions at sumptuous holiday feasts. Do you refuse the lavish, carbohydrate-rich fare and give up on the fun of the season? Or do you go whole hog, eating everything in sight, and hope that your insulin or medication can take up the slack?

comments 3 comments - Posted Dec 18, 2011

Ask a Diabetes Educator

"I have type 2 diabetes, diagnosed five years ago, and am 67 years old. I have worked very hard to manage this disease, but without the success I would like."

comments 0 comments - Posted Dec 16, 2011

Novo Says Early Use of Victoza Aids Type 2 Control

News from Danish pharmaceutical manufacturer Novo Nordisk reinforces the growing trend toward using a two-drug combination in the early treatment of type 2 diabetes. (See "A Conversation About Janumet and Earlier Combination Therapy Type 2 Diabetes" for more discussion about the phenomenon.)

comments 2 comments - Posted Dec 15, 2011

Why Didn’t Someone Tell Me That?

I wish there were a fail-safe manual for diabetes. Just when I'm thinking about how great my blood sugars have been, bam! I see a 300 on my meter, or a 40. It's so hard to know why: The off numbers could be due to hormones, stress, sickness, an incorrect carb count, varying activity levels, or any combination thereof. With diabetes, you really do learn as you go. Here are a few things I have learned along the way.

comments 2 comments - Posted Dec 13, 2011

New Type 2 Drug Targets Blood Sugar and Cholesterol

Drug company Merck aims to give people with type 2 diabetes two treatments for the price of one. The new therapy, called Juvisync, was just approved by the US Food and Drug Administration. It's not a radical new treatment, but instead a helpful combination of two familiar standbys: Juvisync unites the active ingredients in blood sugar-lowering Januvia and cholesterol-lowering Zocor in a single tablet.

comments 0 comments - Posted Dec 10, 2011

November 2011

Diabetes Supply Costs Rule My Life!

There's nothing quite like wondering how you're going to pay for prescriptions.  I find it odd that we usually don't know what our out-of-pocket cost will be until we're standing in front of the pharmacy staff and praying that we have enough in our wallet to cover it.  I often feel like a reality show contestant waiting for the grand total.  My pharmacy-based reality show would probably be called "The Biggest Payer," or perhaps "The Amazing Guess," or, aptly, "Survivor."  If you've ever walked away from the pharmacy counter embarrassed, panicked, or depressed, you know the feeling I'm referring to.  It's a pain no prescription can cure.

comments 38 comments - Posted Nov 26, 2011

An Interview With Mike Golic

Mike Golic is the co-host of ESPN's wildly popular radio show, "Mike and Mike in the Morning." Before beginning work as a broadcaster in 1995, he played for nine years as a defensive tackle in the National Football League, including stints with the Houston Oilers, Philadelphia Eagles, and Miami Dolphins. About five years ago, he was diagnosed with type 2 diabetes. Since then, he has become involved in getting the word out about type 2, including the potential danger of hypoglycemia. He is a spokesman for "Blood Sugar Basics," a website and outreach program co-sponsored by Merck and the American College of Endocrinology.

comments 3 comments - Posted Nov 25, 2011

Devon Inglee Processes Diabetes Through Art

In one of Devon Inglee's artworks, a teddy bear, the symbol of childhood innocence, lies flat on its back with three menacing syringes piercing its furry tummy. In the background, the bear's owner, a small girl, stands above the teddy eating an apple. Inglee writes, "In ‘Tit for Tat,' a sweet girl contently eats an apple while hiding a large syringe behind her back, oblivious to her beloved, yet murdered toy. This piece deals with the process of anger, mourning, and denial associated with my personal diagnosis of a chronic disease." For the 33-year-old art student, this work is about mourning and letting go of preconceived notions and ideas of what the future will be.

comments 0 comments - Posted Nov 22, 2011

The Holidays With Diabetes

Living with diabetes, you are already hyper-aware of food, but the holidays seem to heighten that awareness. Faced with your aunt's delicious homemade cornbread and your grandma's famous sweet potato casserole, you may find yourself digging through your closet for your old carbohydrate-counting books and guessing at your insulin adjustments. Who wants to go through the holidays with the added stress of high blood sugars and associated mood swings, especially when your family is already driving you nuts? No, thanks.

comments 4 comments - Posted Nov 21, 2011

The New Girl

It's hard being the new person at work.  It's even harder when you're the new person and you have diabetes. Whenever I start a new job, thoughts race through my mind: Will I go low while I'm training?  Will I have quick access to snacks?  Will I be able to check my blood sugar without an audience?  How about taking an insulin injection at the lunch table?  It isn't easy feeling forced to expose so many personal details to people you just met.

comments 2 comments - Posted Nov 20, 2011

An Unexpected Grief Down Under

Anyone who has lost a close family member to type 2 diabetes understands the grief and paralysis it creates, especially when the one who died was only 53.

comments 8 comments - Posted Nov 14, 2011

When Medical Professionals Are Hurtful

Having diabetes means attending medical appointments regularly.  It's entirely possible that at some point, you experienced an incident in which a medical professional hurt your feelings, made a mistake, or told you something completely incorrect.  Medical mistakes do happen.  While most doctors and nurses are amazing and professional, they are also human.  Errors and inappropriate comments can occur.  Some simply don't understand all aspects of diabetes.

comments 17 comments - Posted Nov 11, 2011

Hospitals Moving Toward Greater Use of Insulin Pens

The introduction of insulin pen devices in the 1980s facilitated accurate and simple administration of insulin for people managing their diabetes on an outpatient basis. The use of insulin in hospitals, however, continues to be associated with medication errors and severe adverse events.  Published practice guidelines have helped address insulin error prevention, and the availability of diabetes technologies has presented another opportunity to promote the safe use of insulin in hospitals.

comments 8 comments - Posted Nov 10, 2011

Choosing a Needle to Inject Insulin: What’s the Difference?

For a person with diabetes who is beginning insulin therapy, the range of products can be overwhelming.  The options are often limited by the patient's healthcare plan, however, and the initial selection of a product is frequently influenced by the healthcare provider.  With diabetes education tailored to the individual patient, the delivery of insulin through a particular device is achieved by teaching proper injection technique and selecting an appropriate needle.

comments 3 comments - Posted Nov 6, 2011

Thanks to Technology, We Never Have to Be Alone

If you've had diabetes for a number of years, chances are that you remember when there was no Internet access and no diabetes online community.  You had no way to look up information online and no instant connection to millions of others around the world living with diabetes.  Unless you had a friend nearby with diabetes, there was no one to understand how you felt when your blood sugar numbers were less than stellar, and no one to sympathize with how hard it can be to get your A1C down.

comments 3 comments - Posted Nov 1, 2011

October 2011

The Night I Needed a Glucagon Injection

The one time I needed a glucagon injection, I didn't have any. I had never been given a prescription for it, had no idea how to use it, and was absolutely clueless about what it did.

comments 1 comment - Posted Oct 29, 2011

The Second Trimester- Pregnant with Type 1 Diabetes

Welcome to the second trimester!  By now, many type 1s are experiencing fewer hypoglycemic episodes, and insulin resistance is just beginning to rear its head.  You're on the other side of the miscarriage worry hump and getting settled into the pregnancy routine.  Congratulations!  Take a few minutes each day to celebrate your successes and pat your stomach with a smile, knowing you are doing the best you can to give your growing child everything she needs.  

comments 1 comment - Posted Oct 26, 2011

My Quest for a Smaller Jean Size and A1C

Trying to lose weight as an insulin-injecting person with type 1 diabetes couldn't be more frustrating. It gets on my last nerve that exercise can trigger mind-numbing lows, lows that cause me to inhale a portion of those recently burned calories. That said, I don't skip exercise to avoid lows. I just check my blood sugars more often, use caution with my insulin dosing, and follow the advice of my doctors.

comments 22 comments - Posted Oct 21, 2011

Novo Nordisk Files for FDA Approval of New Insulin

A brand new insulin will soon be on pharmacy shelves in the United States if Danish pharmaceutical company Novo Nordisk has its way. The company has filed for approval from the Food and Drug Administration to sell insulin degludec, an original formulation that lasts an extra-long time. Insulin degludec is injected only once a day. Once under the skin, the dose of insulin is absorbed slowly and consistently, allowing for better nighttime control, according to Novo. Most importantly, test subjects had a low rate of hypoglycemia on the drug.

comments 2 comments - Posted Oct 15, 2011

Novo Says Early Use of Victoza Aids Type 2 Control

News from Danish pharmaceutical manufacturer Novo Nordisk reinforces the growing trend toward using a two-drug combination in the early treatment of type 2 diabetes. (See "A Conversation About Janumet and Earlier Combination Therapy for Type 2 Diabetes" for more discussion about this phenomenon.) In a study it released in Lisbon, Portugal, at the recent meeting of the European Association for the Study of Diabetes, Novo said that combining its recently released drug Victoza® (liraglutide) with another drug early in therapy helps recently diagnosed type 2s achieve greater blood glucose control than they can with a single drug.

comments 0 comments - Posted Oct 2, 2011

September 2011

A Type 1 Diabetes Cure in the Pipeline?

What if we could stop the body's immune system from attacking the pancreas in the first stages of type 1 diabetes? What if we could keep the pancreas producing insulin, all the while helping it recover from the autoimmune barrage?

comments 7 comments - Posted Sep 29, 2011

Protecting Yourself Against Insulin Shock in the First Trimester of Pregnancy With Diabetes

A couple of factors lead to increased risk of insulin shock comas during the first trimester.  For many, insulin sensitivity increases and the pancreas isn't yet producing the hormones associated with insulin resistance.  In addition, many type 1s will be taken off of their current basal insulin if it is not yet approved for use during pregnancy.

comments 4 comments - Posted Sep 27, 2011

Do What You Love, and It Will Never Be Work

Being a rookie driver on the fast-paced IndyCar racing circuit is pressure enough for any 26-year-old. But for Charlie Kimball, one of four wheel men on businessman Chip Ganassi's IndyCar race team, there's the added need to manage type 1 diabetes while roaring around the track at speeds that often exceed 200 miles per hour.

comments 0 comments - Posted Sep 25, 2011

Building Block of Glucose Uptake Identified for Type 2 Diabetes

Scientists have found a protein that plays an important role in allowing our bodies to absorb glucose from our blood. What's more, lower levels of that protein may contribute to type 2 diabetes.

comments 0 comments - Posted Sep 23, 2011

Do You Have a Diabetes Sick Day Plan?

It's that time of year again: flu season. I never thought much about getting a flu shot until fourteen years ago, when I ended up in the emergency room with the flu and a staggering blood sugar of over 800 mg/dL. I had been diagnosed with type 1 diabetes a few years before and had never discussed a sick day plan with my doctor. But during this experience, I discovered that diabetes and the flu get along about as well as a house cat and a junkyard dog.

comments 5 comments - Posted Sep 22, 2011

More Than Just a Number: Early Pregnancy With Type 1 Diabetes

So, you're pregnant!  Many who are in your shoes have worked very hard and diligently to begin this excursion.  Others have reached this milestone unintentionally.  Either way, you are about to embark on a journey that will completely challenge everything you know about your type 1 diabetes management.  These next few months will challenge your motives, your emotions, your determination, and everything that makes up who you are. So sink your heels in. Take each step one at a time.  

comments 4 comments - Posted Sep 20, 2011

Building Block of Glucose Uptake Identified for Type 2 Diabetes

Scientists have found a protein that plays an important role in allowing our bodies to absorb glucose from our blood. What's more, lower levels of that protein may contribute to type 2 diabetes.

comments 0 comments - Posted Sep 19, 2011

A Low-tech Diabetes Logbook

It may sound silly to say this, especially in this era of computing and high technology, but in our house, one of the most important tools in managing diabetes is a notebook, an ink pen, and three brightly colored magic markers. Of course, I'm talking about the logbook. That's not to say we don't also rely on complicated software to help track our daughter's blood sugars. But when it comes to understanding and using the data to our advantage, there is some truth to the age old belief in hands-on training.

comments 1 comment - Posted Sep 16, 2011

We Still Have Hope

My son just turned twenty. For the first time, we didn't have a cake, ice cream, friends, balloons, or presents. He spent the day in jail. With vivid memories of his heroin-addicted evening in the ICU several months ago, we had nursed high hopes that his life would be on the mend. But healing takes time, and life doesn't always deliver the happy ending we long for.

comments 9 comments - Posted Sep 14, 2011

The State of Insulin Injection

What's Being Researched Now

comments 4 comments - Posted Sep 11, 2011

Can Your Insulin Pump and CGM be Hacked?

Here's the scenario: You're a famed prosecutor who happens to be on an insulin pump. One of the criminals you put away years ago has been released from prison, and he's eager for revenge. This is a particularly cunning criminal, so he hatches a subtle plan. He hacks into your insulin pump, giving you a massive dose of insulin without warning. As you drive to work one day, you begin to feel woozy. That's odd, you think, looking down to where the pump attaches to your stomach. I just ate....

comments 1 comment - Posted Sep 10, 2011

Together, On Our Own

"If you weren't having this conversation with me, who, other than your wife, would you be having it with?"  That question, in response to something I'd said about treating my nine-year-old daughter's diabetes, was posed to me over the phone by a friend I had made less than six months earlier. She has a daughter too, the same age as mine, who also has type 1. Their diagnosis came a couple of years before ours, so I respect her experience and opinion, and so does my wife, Franca.            

comments 0 comments - Posted Sep 9, 2011

Ketones, Shmeetones.

When you live with diabetes, there's a lot to do.  Checking blood sugars.  Counting carbs.  Exercising.  Not to mention all those fun-filled doctors' appointments.  So the last time your physician or diabetes educator suggested ketone testing, it's completely understandable that your head was nodding but your mind was thinking "No way, Jack."  But before abandoning the idea completely, there are a few things you should know.

comments 5 comments - Posted Sep 8, 2011

A Conversation About Janumet and Earlier Combination Therapy for Type 2 Diabetes

Combination therapy, in which doctors prescribe more than one drug to treat type 2 diabetes, is a fairly common practice. However, most newly diagnosed type 2 patients start off with metformin or a sulfonylurea and don't go on a two-drug therapy until their first drug begins to lose its effectiveness.

But combination therapy could soon become an earlier option for people with type 2.

comments 2 comments - Posted Sep 7, 2011

9 Safe Driving Tips

An estimated 34 million Americans will be on the road during Labor Day weekend, many of them with type 2 diabetes. Road travel can interfere with blood sugar management and lead to low blood sugar, which can cause serious complications, such as loss of consciousness, if not treated quickly.

comments 1 comment - Posted Sep 6, 2011

When It Comes to Diabetes, Knowledge Truly Is Power

When people are diagnosed with diabetes, things can seem pretty overwhelming. In a short time, they have to absorb a daunting amount of information and start making significant decisions about the way they live their lives.

comments 0 comments - Posted Sep 3, 2011

August 2011

Utah Firm Develops Emergency Supplies Case for People With Diabetes

Utah-based Essential Preparedness Products (EPP) offers an emergency storage case for people with diabetes, called Diabetic med-EcaseTM. The yellow cases, made of high-impact material, are waterproof, airtight, and can float. Buyers of the $69.99 product receive foam inserts for both type 1 and type 2 needs and can outfit the case accordingly.

comments 5 comments - Posted Aug 30, 2011

Sex and Diabetes

Dear Diabetes Health,

comments 2 comments - Posted Aug 29, 2011

Adding Spices to High-Fat Meals Can Knock Down Triglycerides

Spices not only add zing to meals, but they may also reduce the high levels of triglycerides produced by eating high-fat meals.

comments 0 comments - Posted Aug 28, 2011

Metformin Helped My Type 1 Diabetes

My name is Katherine Marple, and I've had type 1 diabetes for 13 years. I'm the first in my family to have the disease, so I've done most of the research and made most of the discoveries on my own. One of those discoveries was the power of metformin (in addition to insulin) to help me control my diabetes.

comments 16 comments - Posted Aug 18, 2011

Readers: Type 1 Indy Racer Charlie Kimball Needs Your Votes NOW!

Charlie Kimball, the first and only driver with type 1 diabetes in the history of the Indy Racing League to race cars at its highest level, needs your help: Just as when he's racing, Kimball finds himself neck-in-neck in a competition. In this case, he's looking to win the Firestone Tire-iffic Award and you can help him out by voting for him---but you only have till Thursday, August 11, to do so.

comments 2 comments - Posted Aug 10, 2011

Drug Combo Slows Onset of Type 2 Diabetes

Low doses of metformin and rosiglitazone seem to delay the onset of type 2 in prediabetic people who have impaired glucose tolerance, according to a Canadian study. However, although the drug combination was effective over the first year of the study in helping to control glucose levels and insulin resistance, it was not effective subsequently in delaying the onset of insulin resistance and pancreatic beta cell deterioration.

comments 0 comments - Posted Aug 7, 2011

Vitamin D May Reduce Risk for Type 2

A Boston-based study has found that vitamin D supplements can reduce the risk of developing type 2 diabetes in people with prediabetes by improving their beta cell functioning.

comments 3 comments - Posted Aug 3, 2011

Insulin Injections for Type 2s Could Drop to Three per Week

A study in the British medical journal The Lancet shows that type 2s who received once-daily or thrice-weekly injections of degludec, a very long-acting insulin, maintained blood glucose levels similar to patients receiving daily doses of insulin glargine. The results point the way to a possible reduction in the number of injections that type 2s who take insulin would need over any seven-day period. In both the United States and the United Kingdom currently, about one in every three type 2 patients injects insulin at least once daily.

comments 0 comments - Posted Aug 1, 2011

July 2011

Tradjenta, a Drug for Type 2s, Now on U.S. Market

Boehringer Ingelheim and Eli Lilly have begun sales of Tradjenta, a drug for type 2 diabetes, in U.S. pharmacies. The drug (generic name linagliptin) comes in tablet form and is intended to compete with Amylin Pharmaceuticals' Byetta, which is injected, and Merck's Januvia, which also competes with Byetta. Both are well-established in the U.S. market.

comments 2 comments - Posted Jul 27, 2011

Lipodystrophy Patients Benefit From Amylin Drug

Patients who have partial lipodystrophy, a condition that often leads to diabetes and high triglycerides, are benefiting from metreleptin, an investigational treatment being developed by Amylin Pharmaceuticals.

comments 0 comments - Posted Jul 24, 2011

Before Disaster Strikes

With severe weather predicted for Tuscaloosa, Alabama, Meredith Cummings thought carefully about where to park her car-eyeing the large trees in her historic neighborhood-when she arrived home on the afternoon of April 27. As she walked to her door, she reassured herself: Those trees had been there for more than 100 years. What were the odds of them coming down today?

comments 0 comments - Posted Jul 22, 2011

Omega-3 Could Help Block Diabetes Onset

Italian researchers have found that increased consumption of omega-3 fatty acids leads to a decrease in insulin resistance, a common precursor to the development of type 2 diabetes. It also improves lipid profiles and adiponectin levels. (Adiponectin is a protein that is involved in metabolizing glucose and fatty acids. Low levels are associated with insulin resistance, diabetes, atherosclerosis, and obesity.)

comments 0 comments - Posted Jul 21, 2011

Once a Spokesperson for Juvenile Diabetes, Erin Now Suffers From Diabulimia

Erin lay on a bed in the emergency room, finally serious about getting help. Her second episode of diabetic ketoacidosis in a single year had sent her to the hospital shaking and vomiting. For the past seven years, she had been driven by one desire: to lose forty pounds. She refused to give herself her full dose of insulin, fearing weight gain. She hadn't seen her endocrinologist or checked her blood sugar for a year or two.

comments 6 comments - Posted Jul 18, 2011

NeuroMetrix and Nipro Team Up to Market Neuropathy Test

Nipro Diagnostics, Inc., and NeuroMetrix, Inc., have announced that they will seek opportunities to sell their soon-to-be-introduced NC-stat® DPNCheckTM neuropathy test in retail medical clinics nationwide. The test, conducted onsite, evaluates neuropathies, including diabetic peripheral neuropathy (DPN).

comments 1 comment - Posted Jul 16, 2011

Aussies Take Step Toward Vaccine for Type 1

Immunologists at a research institute in Melbourne, Australia, say they have successfully tested a nasal spray that suppresses an immune response in people who are genetically disposed to type 1. The test, performed by scientists at the Royal Melbourne Hospital, is the first time that the spray has been tried on humans.

comments 3 comments - Posted Jul 13, 2011

Type 2 Drug Victoza Helps Type 1s, Too

Victoza, a drug aimed at type 2 diabetes, may turn out to be a boon for type 1 diabetes patients as well. A small clinical study shows that patients with well-controlled type 1 who took Victoza daily for just one week experienced a 15 percent drop in their blood sugar levels. Patients who took the drug over a full 24-week test period needed less and less insulin, decreasing their average mealtime dose by seven units and their all-day insulin requirement by eight.

comments 2 comments - Posted Jul 11, 2011

A Brand-New Bottle of My Insulin Went Missing

As I write this, my nineteen-year-old son is in the intensive care unit because of a heroin addiction. He is trying to stop, and the withdrawal is wreaking havoc. His body is bruised and battered beyond belief.

comments 15 comments - Posted Jul 10, 2011

RPI Hopes to Create a Vital Artificial Pancreas Component

Rensselaer Polytechnic Institute in upstate New York is working on a new approach to blood sugar monitoring that could open the door to an artificial pancreas. The plan is to develop an automated monitoring system so sophisticated that it can take into account the often great differences in blood sugar levels and insulin sensitivity among people with type 1 diabetes.

comments 4 comments - Posted Jul 9, 2011

Counterfeit Diabetes Medications

The Internet allows consumers to shop for deals on anything imaginable, even prescription drugs. The economic struggles that many currently face, paired with the increasing cost of healthcare and prescription drugs, have created an environment in which counterfeit drug makers can prosper.

comments 1 comment - Posted Jul 7, 2011

Righteous About a Diabetes Diet

Recently, we published an article by Hope Warshaw, MMSc, RD, CDE, titled "From Old Dogmas to New Realities. "In the article, Hope voiced the opinion that a low carb diet is not the only dietary option for people with diabetes, and that, in fact, such thinking is an "old dogma." In response, we received a number of strongly worded comments advocating the low carb diet as the only way to go.

comments 48 comments - Posted Jul 6, 2011

Diabetes and Depression Offers Big Challenges

If you have diabetes, you're more likely to be depressed than people without the disease.

comments 5 comments - Posted Jul 5, 2011

June 2011

Looking at Cannabis Based Type 2 Treatment

One of the classic effects of cannabis on people is raging hunger-the "marijuana munchies." The drug has been used to good effect on people with diseases that diminish appetite, helping them to regain a healthy interest in food. So it is a bit ironic that British drug maker GW Pharmaceuticals has created a cross-bred cannabis plant whose appetite-suppressing qualities could be used to treat type 2 diabetes.

comments 2 comments - Posted Jun 30, 2011

No Difference in Effect When Combining Type 2 Drugs

You can add any third drug you want to the standard metformin-sulfonylurea combination used to treat type 2 diabetes, including insulin, alpha-glucosidase inhibitors, thiazolidinediones, glucagon-like peptide-1 agonists, or dipeptidyl peptidase-4 inhibitors. None of them provides a decisive superiority in blood glucose control. That's the conclusion of a Brazilian meta-study of 18 drug trials published in the May 17, 2011, issue of the Annals of Internal Medicine.

comments 0 comments - Posted Jun 23, 2011

Father's Day Reflections

With Father's Day just around the corner, I thought it would be nice to stop for a moment and reflect on what dads do for us, especially dads who have diabetic children. The pressure and emotional aspects of diabetes can be overwhelming, not to mention the stress it can put on a family. For every needle prick, shot, and counted carb my father (and mother) helped me with, I want to say thanks.

comments 21 comments - Posted Jun 19, 2011

Type 2 Diabetes: From Old Dogmas to New Realities

Over the last decade, dramatic changes have occurred in our understanding of the onset and progression of prediabetes. Lightning speed changes have also occurred regarding the therapies available to achieve optimal blood glucose control. Even with all of this change, however, many old dogmas hang on. It's time to become aware of the new realities.  In this article, I focus on two common old dogmas and the new realities.

comments 2 comments - Posted Jun 16, 2011

Diabetes Seen as Biggest Driver in Increased Spending on Drugs

Statistics from the 2011 Medco Drug Report show that diabetes drugs accounted for 16.1 percent of the overall increase in U.S. spending on therapeutic drugs in 2010. The report states that the increase is due to the growing number of Americans who have diabetes.

comments 5 comments - Posted Jun 15, 2011

Specialized Diabetes Camps

More than ten million kids head off to summer camp each year.  Just because your child has diabetes doesn't mean that he or she must be left out of this rite of passage.  Wherever you live, there are specialized camps to help your child have a great and safe experience.

comments 2 comments - Posted Jun 12, 2011

FDA Moves to Restrict Access to Three GSK Diabetes Drugs

The U.S. Food and Drug Administration has said that starting on November 18, 2011, it will restrict retail pharmacy sales of three diabetes drugs manufactured by GlaxoSmithKline: the stand-alone Avandia (rosiglitazone) and the combination drugs Avandamet (rosiglitazone and metformin) and Avandaryl (rosiglitazone and glimepiride).

comments 0 comments - Posted Jun 11, 2011

Insulin, Skin, and Needles: Oh My!

Whenever I tell someone that I have type 1 diabetes, the first words that I typically hear are "I'm terrified of needles! I could NEVER give myself a shot!" But needles are the least of my fears when it comes to my disease. I have bigger fish to fry. Concerns about daily management, combined with fears of heart problems, blindness, and kidney failure, equal one very stressful disease.

comments 5 comments - Posted Jun 10, 2011

Telemed Service Integrates Physician-Pharmacy-Patient Interactions

The makers of "PhoneMyDoctor," a new telemedicine service, say it offers the ability integrate patient calls, doctor feedback, pharmacy ordering, and follow-up instructions into one documented record, using a medical practice's existing telephone equipment.

comments 0 comments - Posted Jun 7, 2011

Your Glucose Meter Number?

A few months ago, I had the privilege of traveling to Australia to present at a conference of athletes with diabetes.  During the meeting, prizes were awarded to everyone who scored exactly 5.5 mmol/L (99 mg/dL) on their glucose meter. You should have seen it! Anyone who measured close to 5.5 was testing again and again, hoping for that magic number to pop up. Fingers were suffering, but the test strip manufacturers were making out like bandits.

comments 1 comment - Posted Jun 5, 2011

Amylin, JDRF Team to Test Symlin/Insulin Combo for Type 1

Amylin Pharmaceuticals has announced that it will collaborate with the Juvenile Diabetes Research Foundation to test a combination of Symlin and insulin in injectible form as a type 1 therapy.

comments 0 comments - Posted Jun 3, 2011

Type 2s on Sulfonylureas Less Likely to Take Anti-Depressants

Type 2 patients who use only a sulfonylurea are less likely to take anti-depressant drugs than diabetes patients on other medications. That's the conclusion of a report delivered recently in Honolulu at the annual meeting of the American Psychiatric Association.

comments 0 comments - Posted Jun 1, 2011

May 2011

New App Shows Which Prescriptions Can Drain Nutrients

"Nutrient Depletions" is a new smart phone app that allows users to see which of their prescription medications may be draining nutrients from their body. The app, available at iTunes stores for $1.99, works on Apple's iPhone, iTouch, and iPad products.

comments 4 comments - Posted May 31, 2011

Gene Linked to Type 2, Cholesterol and Obesity

Here's news that has been receiving big play in U.S. and European media: British scientists have found that a gene called KLF14 acts as a "master switch" that controls other genes found in body fat-genes that are major factors in such conditions as type 2 diabetes, obesity, high cholesterol levels, and levels of glucose and insulin. The finding, by researchers at King's College London and Oxford University, could lead to treatments for diabetes, obesity, and related metabolic disorders by targeting the gene.

comments 2 comments - Posted May 30, 2011

As LifeScan-Medtronic Exclusivity Pact Ends, Medtronic Expands Alliance With Bayer

U.S. insulin pump maker Medtronic and blood glucose monitoring system maker LifeScan have reached the end of their three-year contract in which LifeScan was an exclusive provider to Medtronic.

comments 1 comment - Posted May 29, 2011

Cheaper Generic Medication for Lipitor, Actos and Plavix

A recent article in the Chicago Tribune reports that patients using Lipitor, Actos, or Plavix may start enjoying savings of up to 90 percent as patents on those drugs expire. The three drugs comprise a significant percentage of the $300 billion brand-name U.S. pharmaceutical market, according to the Tribune.

comments 2 comments - Posted May 27, 2011

Insulin Tumors

Swimsuit season lasts for at least five months in the South. The good news is that we live close to the beach, but the bad news is that after 25 years of living with diabetes (and three Caesareans), my body is starting to read like a map of my medical journey.

comments 8 comments - Posted May 25, 2011

Sanofi Says Late-Stage Trial of Type 2 Drug a Success

French drug maker Sanofi-aventis says that results from a Phase III trial of its experimental type 2 diabetes drug lixisenatide show that the drug successfully lowered patients' blood glucose levels and body weight, but did not increase the risk of hypoglycemia.

comments 0 comments - Posted May 23, 2011

N.J. Hospital Teams With Ricordi to Find Cure for Type 1

New Jersey's Hackensack University Medical Center has announced that it will partner with Dr. Camillo Ricordi to test a surgical procedure that could hold the key to a cure for type 1 diabetes.

comments 10 comments - Posted May 18, 2011

The Evolution of UltiMed’s 50-Count Pen Needle Box

There's more to that little box of pen needles than meets the eye, according to Holly Hartshorn of UltiMed. In early March, UltiMed launched a 50-count box of UltiCare pen needles into the marketplace. We spoke to Holly to find out exactly what kind of thought goes into such a product before it appears on pharmacy shelves.  

comments 3 comments - Posted May 17, 2011

Danish Study Reports Three Diabetes Drugs Best for Lowering Cardiovascular Risk

A Danish study of 107,806 adults taking various diabetes medications has found that three drugs are the most effective at lowering the risk of cardiovascular disease and death: metformin, gliclazide (not marketed in the US), and repaglinide (Prandin). Other common diabetes medications, including glimepiride, glibenclamide (glyburide), glipizide, and tolbutamide, were linked to a higher risk of death both from all causes and from heart attack and stroke.  

comments 1 comment - Posted May 13, 2011

Profiles in Type 1: Dr. Jonathan Beach

Dr. Jonathan Beach is a 35-year-old emergency medicine physician who has had type 1 diabetes for 31 years. He owns and operates Urgicare, a wellness center that includes The Northeast Center for Diabetes Care and Education in Plattsburgh, New York, an isolated rural community that has few other resources for diabetes. This is his story of his life with diabetes and his professional experience with the insulin pump.

comments 4 comments - Posted May 12, 2011

Profiles in Type 1: Gene Thornton

Gene Thornton was in the Army in Germany when he got type 1 diabetes. It was 1965, 46 years ago, and he was 24 years old. This is his story, in his own words.

comments 5 comments - Posted May 10, 2011

Medtronic Responds to "A Miracle Technology for Type 1s: Can It Be Saved?"

Recently, we published an article about the implantable pump "A Miracle Technology for Type 1s: Can It Be Saved?" Following the appearance of this article on the Diabetes Health website, over 100 readers commented, most of them expressing a heartfelt desire for access to this technology in the U.S.A. To read the original article click on link below:
A Miracle Technology for Type 1s: Can It Be Saved?

comments 35 comments - Posted May 5, 2011

Molly Martin, Motocross Racer

Molly Martin is a vibrant and energetic 18-year-old from Texas who's had type 1 diabetes since the age of two. Five years ago, Molly took up motocross racing. She says, "I love riding motocross---it's just you and the bike. I feel free when I ride, like I don't have to think about diabetes. I do have to make sure that I test before I get on and during breaks, to make sure my sugar is doing what it's supposed to be doing. But when I get out there, it's just me and the bike, going."

comments 1 comment - Posted May 5, 2011

Ryan Shafer: Pro Bowler With Type 1

Ryan Shafer is a 44-year-old professional bowler from Elmira, New York, who was 19 when he developed type 1 diabetes. For a couple of weeks, he experienced the usual symptoms of weight loss, lethargy, extreme thirst, and frequent urination, as well as vision problems.  "Being that age," he says, "I was afraid to go to the doctor. I thought it would just go away." When he finally saw his family physician and was diagnosed, he says, "I was actually relieved--not that I thought diabetes was a piece of cake, but I was glad to know what was wrong with me."

comments 3 comments - Posted May 1, 2011

April 2011

Substance in Tangerines Blocks Diabetes in Mice Fed High-Sugar, High-Fat Diets

Canadian scientists have found that nobiletin, a substance found in high concentrations in tangerines, thwarted obesity and the onset of diabetes in lab mice. The researchers at the University of Western Ontario fed the mice a high-sugar, high-fat diet that mimicked the diet of many people in Western societies. One group of animals became obese, developing fatty livers and elevated levels of cholesterol and insulin-typical precursors to type 2  diabetes and cardiovascular disease. But a second group of mice, given the flavonoid nobiletin, did not develop the symptoms of the first group. The nobiletin prevented fatty buildup in the liver by blocking the genes that control the production of fat.

comments 4 comments - Posted Apr 30, 2011

Profiles in Type 1: Kent David

Kent David is a 47-year-old licensed civil engineer who has had type 1 diabetes since 1981. This is Kent's diabetes story in his own words.

comments 5 comments - Posted Apr 29, 2011

Chase Pelletier, Competitive Kart Racer

Chase Pelletier is an up-and-coming kart racer from Canada who is 14 years old. When he got type 1 diabetes just before his eleventh birthday, he recalls, "It was pretty overwhelming at first. But me and my family decided early on that we're not going to get down on diabetes in general, and we're going to try to think of positive ways to deal with it."

comments 0 comments - Posted Apr 28, 2011

Safflower Oil Cuts Heart Disease Risk for People With Type 2 Diabetes

We all know by now that fat isn't necessarily a bad thing. Enough advertisements and recommendations for fish oil and omega-3 supplements have appeared over the past few years to make that clear. But what if "good fat" isn't just about eating fish or a taking a fishy-tasting supplement? What if that good fat can be found in a common cooking oil?

comments 0 comments - Posted Apr 27, 2011

Highlights From the Barbara Davis Center's July Keystone Conference

Recently I had the pleasure of attending the Barbara Davis Center's "Management of Diabetes in Youth" conference, held every other year in beautiful Keystone, Colorado. The focus is on all of the latest and greatest in type 1, and it's a real treat to have so many of the best names in this field gathered in one place. The Barbara Davis Center (BDC) is one of the premier programs in the world focusing on type I diabetes management, and the one (Dr. Peter Chase, to be precise) who brought us the famed" Pink Panther" book, Understanding Diabetes - the reliable handbook of type 1 diabetes that many parents of newly diagnosed kids rely on.

comments 3 comments - Posted Apr 25, 2011

Store Your Teeth in a Stem Cell Bank

Every year four million baby teeth fall out, and 1.4 million wisdom teeth are pulled out of our collective mouth. Until recently, the only entity really interested in all those teeth was the tooth fairy. But all that changed in the year 2000, with the discovery that dental pulp contains adult stem cells. In the not-too-distant future, those stem cells might be used for growing new islet cells to cure diabetes. The problem is, how to keep the teeth nice and fresh until that hoped-for day. That's where Provia Laboratories comes in, with their Store-A-Tooth service.

comments 1 comment - Posted Apr 24, 2011

Researcher Looks Into Protein That May Prevent Type 2 in Obese People

The National Institutes of Health has awarded a $1.15 million grant to a researcher at Eastern Virginia Medical School to investigate a protein that may prevent obese people from developing type 2 diabetes.

comments 0 comments - Posted Apr 22, 2011

Medtronic Announces Mac-Compatible Diabetes Management Software

Medtronic, Inc., says that the U.S. Food and Drug Administration has approved the marketing of the company's CareLink® Personal 5.4 Therapy Management Software for the Mac OS platform.

comments 4 comments - Posted Apr 21, 2011

Phil Southerland’s Not Dead Yet: Memoir of a Bike Racer With Diabetes

Phil Southerland's autobiography is an inspirational coming-of-age memoir about a type 1 baby who wasn't supposed to live. But his doctor's dismal prediction didn't take into consideration his mother's indefatigable determination that her baby would thrive no matter what, and Phil's own fierce drive to conquer every single challenge he encountered, including his diabetes. It's an engrossing book, a sports adventure story with a medical subplot and a roster of dynamic characters, the most dynamic of whom is Phil himself. If we could harness his energy, our dependence on foreign oil would be a thing of the past.

comments 2 comments - Posted Apr 20, 2011

A Miracle Technology for Type 1s: Can It Be Saved?

What if there were a technology that could make people with type 1 diabetes feel absolutely wonderful, completely healthy, better than they ever realized was possible? And what if it were about to disappear? Well, there is such a technology, and it is in serious jeopardy. It's called the implantable insulin pump, currently made by Medtronic. This is the story of four people who have been using this device for 20 years, and their desperate crusade to keep it from disappearing forever.

comments 116 comments - Posted Apr 17, 2011

Diabetes Linked to Higher Risk for Parkinson’s

Researchers at the U.S. National Institute of Environmental Health have found that people with diabetes have a significantly increased risk of developing Parkinson's disease. Despite that finding, they say that there are too few data to support a causative link between diabetes and Parkinson's.

comments 0 comments - Posted Apr 16, 2011

The Unique Challenges of Being a Woman With Diabetes

Three weeks out of every month, my diabetes is well controlled. But the fourth week, the one before my period, is a nightmare. My sugars are astronomically high--I can't even look at a carbohydrate without my sugar spiking.  I'm exhausted and cranky, and I can't get comfortable.       

comments 8 comments - Posted Apr 15, 2011

Fitness the New-Fangled Way

Greetings from Philadelphia International Airport!  Airports are fascinating places...great for seeing what people look like and how they act under unusual circumstances.  At this moment, I see a lot of truly overweight people. Most folks are treating the moving walkway like a ride at Disney World–just standing there, inching slowly along and staring blankly at the passing drywall.  I don’t know…maybe the two sights are related.  Have we really become this lazy?  Have we “convenienced” our way out of being in shape?  Have electronic toilet flushers, soap dispensers, and water faucets taken away our last opportunity to burn any calories at all?

comments 0 comments - Posted Apr 14, 2011

Can Beta Blockers Encourage Weight Gain? Aussie Study Says Yes

Beta blockers, which many people with diabetes take to control high blood pressure, may be one of the reasons why type 2s often tend to gain and keep weight. That's the conclusion of a study from St. Vincent's Hospital in Sydney, Australia.

comments 0 comments - Posted Apr 8, 2011

Jeff and Natalie Kolok: The Definition of Parenting

Jeff and Natalie Kolok live in northwestern Vermont with their three children: Naomi, 16, and Johanna and Nicholas, each ten years old. Both Johanna and Nicholas have type 1 diabetes, Johanna since age four and Nick since age six.  

comments 1 comment - Posted Apr 7, 2011

A Prodigious Future for Prodigy Diabetes Care

Prodigy Diabetes Care is an aptly named company, a very young enterprise with the talents of a much older organization and a future that promises prodigious rewards. It was founded in 2006 by Ramzi Abulhaj and Rick Admani, two brothers from Palestine who are its sole owners. In the five years since then, they have built a company that is successfully competing against the diabetes old guard by focusing on engineering and a unique marketing strategy.

comments 8 comments - Posted Apr 2, 2011

The EndoBarrier Is Approved for Sale in the EU

As we wrote back in 2008, the EndoBarrier is a very clever way to simulate the effect of a gastric bypass without the unpleasant scalpel part. It looks like a long clear plastic stocking, and it's simply threaded through the patient's mouth and stomach, down to the small intestine, where it lines the intestine's upper section (the same part that is bypassed in traditional surgery). Food slips right through it, but digestive enzymes are trapped on its other side. The two don't get to join forces until a couple of feet further downstream, so the effect on diabetes is a lot like that of a bypass: It resolves the symptoms of type 2 diabetes.

comments 0 comments - Posted Apr 1, 2011

March 2011

Pre-Diabetes Glossary

This List defines terms that people with prediabetes commonly encounter as they learn more about the condition.

comments 2 comments - Posted Mar 29, 2011

FDA Accepts Application to Review Dapagliflozin, a Type 2 Treatment

The U.S. Food and Drug Administration has accepted an application to review dapagliflozin, a drug for the treatment of type 2 diabetes that is being developed by Bristol-Myers Squibb and AstraZeneca.

comments 0 comments - Posted Mar 22, 2011

Did We Evolve to Get Type 2 Diabetes?

Evolution works in strange ways. What serves as an advantage at one point in time can sometimes prove a problem later, when the world has changed. It looks like that might be the case with type 2 diabetes, according to researchers from San Diego, California.

comments 2 comments - Posted Mar 21, 2011

Alcohol and Sex

Dear Diabetes Health,

comments 0 comments - Posted Mar 20, 2011

Type 2 Profile: Tony Flores

Tony Flores is a 50-year-old native of El Salvador who works as a construction foreman. He was diagnosed with type 2 diabetes about 12 years ago, after an eye doctor told him it would be a good idea to get his blood sugar checked. He recalls, "I did the test, and they got all freaked out and told me, ‘Oh my god, your A1C is at 12%. You have diabetes type 2. You've got to cut the sugar, you've got to stop drinking orange juice and soda."

comments 1 comment - Posted Mar 15, 2011

The Nutrisystem D Plan for Safely Losing Weight With Diabetes

Weight loss can help people with type 2 diabetes control their blood sugar and avoid potential health risks associated with the disease.  Did you know that losing even seven percent of your body weight can lower blood sugar, reduce blood pressure, and improve cholesterol levels1?
  
"Consider diabetes as a disease that has different phases--with the central feature a disorder of insulin production and insulin use," said Roberta Anding, MS, RD/LD,CSSD,CDE. Anding is a clinical dietitian and certified diabetes educator at Baylor College of Medicine, as well as a national spokesperson for the American Dietetic Association.  "To better control and lose weight safely with type 2 diabetes, it is important to consider the type and amount of food on your plate."

comments 4 comments - Posted Mar 12, 2011

Living With Type 1 Diabetes Since 1931

Edward Danielson developed type 1 diabetes 79 years ago, in 1931, only a decade after the discovery of insulin. Edward's wife of 67 years, Dorothy, recalls, "In the spring of 1930, when Edward was ten, his teacher told his mother that he ought to be checked by a doctor because something seemed to be wrong. His mother got on the streetcar with Edward and they went down to see the doctor, who said, ‘There's nothing wrong with him. He's just slow.' So they went home. In the fall of the same year, his new teacher said, ‘Something's wrong with Edward--he ought to be checked out by a doctor.' So they went back, and that doctor diagnosed him with diabetes. They kept him in the hospital for a month because the doctors then didn't know that much about diabetes 1."

comments 1 comment - Posted Mar 10, 2011

The Thrill of the Syringe

"Shot, mommy?"

comments 0 comments - Posted Mar 9, 2011

STEVIA: Can Nature’s Sweetener Help Your Blood Sugar?

You know that awful feeling when a sugar low is coming. I break out into a cold sweat, feel panicky, get nauseated, and have trouble answering extremely simple questions like "Do you need to eat?" Well, I was feeling it again, and again, and I didn't know why. That's what I hate the most: When things go wrong, but I think I've been doing everything right.

comments 2 comments - Posted Mar 8, 2011

The Great Lancing Debate

My almost 20 years as a diabetes educator have been memorable in many ways, but certain moments stand out more than others.  Because blood glucose testing is an important part of diabetes management for everyone I see, I try to assess each person’s skills and habits in this key area.  I’ll never forget the time I asked a client how often he changed his lancet.  He had been diagnosed with type 1 diabetes about four years earlier and was checking regularly, so it seemed like a reasonable question.  He proceeded to look at me with a puzzled expression and say, “You mean you’re supposed to change those things?”

comments 0 comments - Posted Mar 7, 2011

Novo Nordisk Joins Nationwide Diabetes/Pre-Diabetes Treatment Alliance

Novo Nordisk, the world's largest insulin manufacturer, has joined the Diabetes Prevention and Control Alliance (DPCA), a group whose goals are to reduce people's risk of developing diabetes and to work with people who already have it.

comments 1 comment - Posted Mar 4, 2011

Diabetes: A Homeopathic Journey

Ten years ago, an astute physician diagnosed me with Type 2 diabetes. I exhibited none of the classic symptoms of rapid weight loss, extreme thirst, and frequent urination. I attributed fatigue to my job. For about a year before diagnosis, I experienced what I thought were yeast infections and treated them with over-the-counter medications. I later learned that this condition is a symptom of diabetes. I am non-insulin dependent.

comments 2 comments - Posted Mar 3, 2011

Dr. Jane Delgado, Author of The Buena Salud Guide to Diabetes and Your Life

Hispanics are almost twice as likely as non-Hispanic whites to have type 2 diabetes, and more than a third of working adult Hispanics do not have health insurance. For this audience, Jane Delgado, PhD, has written The Buena Salud Guide to Diabetes and Your Life. Available in both Spanish and English, it's a culturally sensitive and reassuring book that dispels myths and presents detailed science while gently guiding readers toward the right path in caring for their diabetes. The tone is conversational, as Dr. Delgado speaks to her readers like a family member who knows them well and has their best interests at heart.

comments 0 comments - Posted Mar 2, 2011

Diabetes Drug Prompts Charges, Calls for Reform in France

Scandal swirling around a former diabetes drug has upended medical regulation in France, with the country's health minister promising tough new reforms.

comments 0 comments - Posted Mar 1, 2011

February 2011

Roche and Animas Recall

A couple of diabetes recalls are in the works, one for a group of insulin cartridges manufactured by Animas and another for the entire line of ACCU-CHEK® FlexLink Plus infusion sets, manufactured by Roche.

comments 0 comments - Posted Feb 28, 2011

Keeping the Weight Off: An Interview with Ellen Granberg, PhD

Ellen Granberg is an obesity sociologist who studies the processes that people go through when they lose weight and keep it off. As she says, "If the problem were that we don't know what people should eat to lose weight, that would be one thing, but we don't have that problem. There are a hundred weight loss plans out there that are perfectly good. We understand all about the physiology of weight loss maintenance and the metabolic impacts, but nothing about the social and emotional impacts. People who sustain weight loss over time move through a lot of different challenges."

comments 1 comment - Posted Feb 27, 2011

Regulatory Protein Lowers Blood Sugar

Researchers at the Children's Hospital in Boston, led by Umut Ozcan, MD, have found a regulatory protein that lowers blood sugar when it is high due to either lack of insulin or a decreased sensitivity to insulin.

comments 0 comments - Posted Feb 24, 2011

Statins May Prevent Diabetic-Related Blindness

New University of Georgia research has found that a statin drug that is often known by the brand-name Lipitor may help prevent blindness in people with diabetes. In a study using diabetic rats, lead author Azza El-Remessy, assistant professor in the University of Georgia College of Pharmacy, and her colleagues found that statins prevent free radicals in the retina from killing nerves important to maintaining vision. The results of the study are published in the March edition of the journal Diabetologia.

comments 0 comments - Posted Feb 23, 2011

New Clinical Trial Needs Type 2 Patients for Gastric Bypass Surgery

In order to undergo gastric bypass surgery, you must have a BMI of at least 35. If you have type 2 diabetes and would like to undergo the surgery to alleviate your diabetes symptoms, you are out of luck unless you are also morbidly obese. A few less weighty type 2 patients have taken matters into their own hands by deliberately gaining enough weight to qualify, but now there is a less drastic way to qualify for the operation.

comments 0 comments - Posted Feb 23, 2011

Tyler Stevenson on Going Away to College with Diabetes

When a young person with type 1 diabetes leaves home for the first time, it's often a difficult adjustment for the parents as well as their child. Tyler Stevenson is 20 years old, in his second year at Florida State. This is what he told us about his life in college with diabetes.

comments 3 comments - Posted Feb 22, 2011

A New Kind of Pharmacist

Ross Valley Pharmacy, tucked away inside a larger building of clinics, is not a big place, but it's very very busy. Its owner, Paul Lofholm, PharmD, has a vision of the pharmacist's role that goes far beyond simply putting pills in bottles. He sees pharmacists as integral members of the healthcare team who can fill the gaps in patients' education about their conditions and their medications.

comments 0 comments - Posted Feb 21, 2011

A New Kind of Pharmacist

Ross Valley Pharmacy, tucked away inside a larger building of clinics, is not a big place, but it's very very busy. Its owner, pharmacist Paul Lofholm, has a vision of the pharmacist's role that goes far beyond simply putting pills in bottles. He sees pharmacists as integral members of the healthcare team who can fill the gaps in patients' education about their conditions and their medications.

comments 0 comments - Posted Feb 20, 2011

Tyler's Ten Objectives for Staying Healthy

Everywhere you look, there seems to be a great tasting high carb meal, dessert, or snack staring back at you. While away at college last fall, I found a t-shirt picturing a cupcake above a skull and crossbones. For me, that image really sums up how we need to deal with being diabetic while being constantly tempted by sugary treats.

comments 4 comments - Posted Feb 16, 2011

Mouse Study Eliminates Need for Insulin by Eliminating Glucagon

Can't make insulin? That might not be a problem, according to Dr. Roger Unger, the lead researcher on a mouse study out of UT Southwestern Medical Center. As Dr. Unger stated in a press release, his findings "suggest that if there is no glucagon, it doesn't matter if you don't have insulin....In adulthood, at least with respect to glucose metabolism, the role of insulin is to control glucagon. And if you don't have glucagon, then you don't need insulin...If diabetes is defined as restoration of glucose homeostasis to normal, then this treatment can perhaps be considered very close to a ‘cure.' "

comments 1 comment - Posted Feb 16, 2011

Need Medicine and Have No Insurance for Your Diabetes?

Nearly one in six people in the United States has no health insurance. If you have diabetes, that's a very tough position to be in. There are, however, resources that can cut the costs that you have been paying out of pocket for medicines and supplies.

comments 0 comments - Posted Feb 14, 2011

Breast Cancer and Diabetes

A new analysis from Johns Hopkins University shows that women with diabetes are 50 percent more likely to die if they have breast cancer. Why? The challenges of diabetes management play a role, as well as women's overall health.

comments 0 comments - Posted Feb 14, 2011

Vascular Complications of Diabetes: Due to One Missing Enzyme?

Many tragic complications of diabetes, including amputations, heart attack, stroke, and blindness, are due to blood vessel damage. According to Xiaochao Wei, PhD, of the Washington University School of Medicine in St. Louis, all that vascular damage may be caused by a shortage of one enzyme: fatty acid synthase, or FAS.

comments 0 comments - Posted Feb 11, 2011

“Artificial Pancreas” Helps Pregnant Mothers With Diabetes

It's hard enough to be pregnant, but pregnancy with diabetes is especially challenging because it's so difficult to keep blood sugar within a normal range at a time when hormones are surging. All women try their best with the tools that they have, but even so, about half of all babies born to mothers with type 1 diabetes are overweight or obese at birth because of too much sugar in their mothers' blood. Mothers with high blood glucose levels also increase their child's risk of congenital malformation, stillbirth, neonatal death, preterm delivery, and neonatal admission.

comments 0 comments - Posted Feb 9, 2011

Lilly and the JDRF Partner to Fund Regenerative Medicine Research in Type 1 Diabetes

INDIANAPOLIS and NEW YORK - Eli Lilly and Company and the Juvenile Diabetes Research Foundation (JDRF) today announced that they have signed an agreement to fund early-stage research that could enable patients with type 1 diabetes to regenerate insulin-producing cells destroyed by the disease.

comments 0 comments - Posted Feb 4, 2011

Insulin Needle Wins Design Prize, But You Can't Buy It in the States

The Chicago Athenaeum: Museum of Architecture has announced its 60th annual Good Design Awards, which honor "quality design of the highest form, function, and aesthetic." Guess which paragon of contemporary design won an award this year? An insulin needle. Called the NovoTwist and made by Novo Nordisk for use with insulin pens, this marvel of design has a bayonet fitting that allows "just twist" attachment and detachment to compatible pens, and an audible and tactile "click" that confirms attachment of the needle.

comments 4 comments - Posted Feb 1, 2011

January 2011

Insulin's Partner: Amylin

Insulin has a companion, and it's called amylin. Amylin is a small hormone that is released along with insulin by the beta cells of the pancreas in response to a meal. When people are insulin-deficient, they are amylin-deficient as well. Amylin wasn't even discovered until 1970, and it was not until the 1990s that scientists began to figure out what amylin does. But they now know that it partners with insulin to help control blood sugar levels, each in its own way:

comments 1 comment - Posted Jan 28, 2011

Getting Personal With Bret Michaels

It's Labor Day weekend in Pittsburgh, just outside of the Steelers' Heinz Field, and the Bret Michaels Band has come home for some hard-driving rock and roll.  The 20,000 screaming fans are a generational mix, shrieking 16-year-old girls side-by-side with moms and dads who have temporarily abandoned their parental roles to dance, sing the familiar words to "Look What the Cat Dragged In," and howl into the nighttime air. On stage is Bret Michaels, the boy from Butler, Pennsylvania, a coal mining town just an hour north.

comments 16 comments - Posted Jan 27, 2011

New Jersey - Florida Partnership to Speed Diabetes Research: A Cure for Diabetes is One Step Closer

The MOLLY and LINDSEY Diabetes Research Foundation at Hackensack University Medical Center (HUMC) and the Diabetes Research Institute (DRI), a Center of Excellence at the University of Miami Miller School of Medicine, have joined forces to find the cure for Type 1 Diabetes.  Together they will form the Hackensack-Miami DRI Federation Project, a think tank of East Coast specialists who will fast-track the best research ideas coming out of the labs and put them to the test in clinically meaningful ways, thus shortening the path to a cure for those with type 1 diabetes.  

comments 5 comments - Posted Jan 26, 2011

New Primary Care Physicians Haven't Learned Enough About Diabetes

Your young primary care doctor may not know a lot about diabetes, according to a study led by Stephen Sisson, MD, of the Johns Hopkins School of Medicine.  "When I graduated from residency here, I knew much more about how to ventilate a patient on a machine than how to control somebody's blood sugar, and that's a problem," said Sisson in a press release.  "The average resident doesn't know what the goal for normal fasting blood sugar should be. If you don't know what it has to be, how are you going to guide your diabetes management with patients?"

comments 2 comments - Posted Jan 26, 2011

Kombiglyze Komes to a Pharmacy Near You

The kuriously named Kombiglyze XR, a combination of Onglyza (saxagliptin) and the old reliable metformin, has arrived at pharmacies and is available by prescription to people with type 2 diabetes. It's similar to Janumet, an older medication that's a combination of Januvia (sitagliptin) and metformin.

comments 0 comments - Posted Jan 25, 2011

The Lowdown on Downloading

It doesn't matter if you're a computer geek or complete technophobe: If you've ever made the effort to download your blood glucose meter, you probably don't have a clue about what to do with the data once you've gotten it.  That needs to change. Those of us who live with diabetes need to become more adept at analyzing our own data, to see what's working and what isn't both for our own sake and that of our time-strapped healthcare providers. .

comments 2 comments - Posted Jan 25, 2011

Mannkind's Inhalable Insulin, Afrezza, Put Back on Hold by the FDA

MannKind Corporation has finally received a complete response letter from the FDA regarding its inhalable insulin, Afrezza. (The FDA issues a complete response letter when it completes its review of a New Drug Application, but cannot yet approve the application as is.) What the FDA wants now is a couple more clinical trials with the new form of the inhaler (one in patients with type 1 diabetes and one in patients with type 2 diabetes), with at least one trial including a treatment group using the older form of the inhaler, in order to obtain a head-to-head comparison of the two devices.

comments 0 comments - Posted Jan 24, 2011

What do I do now, Coach?

Self-management is the key to healthy living with diabetes, but there are always challenges to maintaining optimum blood glucose levels.  Lagging motivation and focus can be obstacles, and adjusting diet and medications to meet changing conditions is challenging. If you have ever wished for a person to help you improve your skills, someone who could offer informed guidance between appointments with your doctor - you may have been wishing for a diabetes coach. Diabetes coaches are personal trainers for individuals with insulin-dependent diabetes. This unique branch of diabetes education delivers ongoing, one-on-one consulting from a trained certified diabetes educator.

comments 0 comments - Posted Jan 24, 2011

One More Time: Walking A Lot Is Good For You

Taking 10,000 steps a day, or walking about five miles, is very, very good for you. It's even better than walking 3,000 steps a day, which is also extremely beneficial if you walk briskly enough to do it in 30 minutes. The 10,000 steps philosophy is not new--there's even a weight-loss book or two on the topic. But now the 10,000 step regimen has also been linked to an increase in insulin sensitivity in middle-aged adults.

comments 1 comment - Posted Jan 20, 2011

Flushing Away High Blood Sugar

Most type 2 meds work by increasing insulin production in one way or another. The extra insulin lowers blood sugar by ushering it out of your bloodstream and into your cells, where it may, unfortunately, make you fat. Wouldn't it be nice if instead, you could lower your high blood sugar by just flushing it right down the toilet?

comments 2 comments - Posted Jan 17, 2011

Fatty Liver: It's Serious

"Fatty liver" doesn't sound very threatening. In fact, it sounds almost cute, like Fatty Arbuckle. Unfortunately, like Fatty Arbuckle, it's not what it seems. Nonalcoholic fatty liver disease is the most common liver disease in the United States, comprising a quarter of all liver disease and responsible for a rising number of liver transplants. Approximately 20 percent of Americans may be lugging around a fatty liver.

comments 1 comment - Posted Jan 13, 2011

Walgreens in South Florida and Diabetes Research Institute Foundation Announce Unique Partnership

The Diabetes Research Institute Foundation (DRIF) announced a new, first-of-its-kind partnership aimed at helping the more than 200,000* Broward County, Florida, residents affected by diabetes. Diabetes Research Institute Live Well Broward County is a joint effort of the Diabetes Research Institute Foundation, Walgreens in South Florida, LifeScan and a cadre of local physicians that will help residents "Manage Well, Stay Well and Live Well" with diabetes.

comments 0 comments - Posted Jan 12, 2011

Diabetes Management in Flu Season

The crowd in the small Boston theater laughed and clapped. The comedy show was a good one, and I was enjoying it from a cramped seat in the balcony. It was October 29, a Friday, and while it was brisk outside, winter hadn't yet clamped down.

comments 0 comments - Posted Jan 11, 2011

Type-1 University Now Open for Enrollment

Introducing "Type-1 University" (T1U) - the online school for people with diabetes who use insulin, including parents and caregivers.  The school can be found only in cyberspace - at www.type1university.com

comments 2 comments - Posted Jan 7, 2011

Sitagliptin (Januvia) Lowers Blood Sugar in People With Type 1 Diabetes

Sitagliptin (Januvia) has long been used to reduce blood sugar in people with type 2 diabetes, but a new study indicates that it can do the same for those with type 1 diabetes. Sitagliptin is a DPP-4 inhibitor; that is, it inhibits, or temporarily prevents, the enzyme DPP-4 from destroying a helpful hormone called GLP-1. GLP-1, which is released by the gut when food arrives there from the stomach, lowers blood sugar by causing the release of insulin, reducing the secretion of glucagon, and slowing stomach emptying and nutrient absorption.

comments 3 comments - Posted Jan 7, 2011

Herbs, Sex, and Diabetes

Talk about a win-win situation! It seems that many aphrodisiacs--herbs that boost sexual energy and function--can also bring down blood sugar, cholesterol, and/or blood pressure.  At least four herbs have shown these double benefits in scientific studies.

comments 1 comment - Posted Jan 6, 2011

A Personal Journey to the New York Historical Society's Diabetes Exhibit

My trip began as I flew from Dallas to my home town of Philadelphia and then caught an early Amtrak train to New York City.  Growing up in the Philadelphia area had given me an appreciation for U.S. history, but today I was going to learn something new: the history of diabetes.  My daughter, Sarah, was diagnosed with type 1 diabetes in 2003, yet I didn't know much about the history of the disease. Living every day with the stress and worry that many parents have, I felt I had no time to spend learning how we got to the modern treatments we have today.  I had focused only on doing my job as caregiver and supporter of my daughter.  I was looking forward to learning something new.

comments 10 comments - Posted Jan 3, 2011

December 2010

Einstein College of Medicine Receives $600,000 Grant to Study Resveratrol's Impact on Pre-Diabetes

The Albert Einstein College of Medicine at Yeshiva University in New York City has received a $600,000 grant from the American Diabetes Association to study the effects of resveratrol on lowering impaired glucose tolerance in older adults.

comments 2 comments - Posted Dec 30, 2010

Lorcaserin Shows Statistically Significant Weight Loss in Patients With Diabetes

Arena Pharmaceuticals and Eisai Inc. recently released results of a phase 3 clinical trial for lorcaserin, a weight-loss drug they are developing in partnership. The trial, called BLOOM-DM (Behavioral modification and Lorcaserin for Overweight and Obesity Management- Diabetes Management), targeted patients with type 2 diabetes who are overweight or obese.

comments 2 comments - Posted Dec 28, 2010

Combining exenatide with insulin may be ‘best result ever' for diabetes patients

A new study finds that combining the newer diabetes drug exenatide with insulin provides better blood sugar control in patients with type 2 diabetes than insulin alone and helps promote weight loss.

comments 1 comment - Posted Dec 27, 2010

Traveling With a Pump: TSA Regulations

Most holiday stories are comforting and familiar, wrapped up with the happiest of endings. But the tales that swept the nation this Thanksgiving were sometimes distressing and strange, and the one told by Laura Seay has no resolution or simple solution. Seay was one of the travelers caught in the center of the debate over the Transportation Security Administration's forceful new screening methods.

comments 6 comments - Posted Dec 23, 2010

Abbott Diabetes Care Announces Recall of Certain Lots of Blood Glucose Test Strips in the United States and Puerto Rico

Abbott Diabetes Care today announced that it has initiated a recall of 359 lots (approximately 359 million strips) of Precision Xtra®, Precision Xceed Pro®, MediSense® Optium, Optium, OptiumEZ and ReliOn® Ultima Blood Glucose Test Strips in the United States and Puerto Rico.

comments 1 comment - Posted Dec 22, 2010

Alarming Study Regarding Oral Health Care of Those With Diabetes

Being diagnosed with type 2 diabetes means a lot of change in your daily life. From blood glucose monitoring to watching what you eat to losing weight, it's hard to keep track of the changes you need to make to keep diabetes under control. One aspect of diabetes care that sometimes falls through the cracks is oral health care, which, if ignored, can lead to serious health complications.

comments 2 comments - Posted Dec 22, 2010

Pepex Trio One-Click Blood Glucose Meter

Research firm Frost & Sullivan, a leading international healthcare consulting company, released a market study analyzing and estimating the demand for Pepex Biomedical Inc.'s new biosensor technology for blood glucose monitoring for diabetes sufferers worldwide.  The researchers interviewed diagnosed diabetics, diabetes educators, endocrinologists, and manufacturers of biosensors, blood glucose meters, or other clinical diagnostic or patient monitoring equipment suppliers for the study.  The Frost & Sullivan report concluded that the Pepex Trio technology has the "potential as a new standard for measuring blood glucose levels."

comments 6 comments - Posted Dec 21, 2010

Diabetes-Depression Connection

A 10-year study by Harvard University scientists found that diabetes puts people at risk for depression and that depression puts people at risk for type 2 diabetes. The two-way connection between the diseases was discovered in 55,000 nurses surveyed over the decade.

comments 1 comment - Posted Dec 17, 2010

Charlie Kimball to Pilot New IndyCar Entry

Novo Nordisk, a world leader in diabetes care, has partnered with Chip Ganassi Racing, LLC to create the Novo Nordisk Chip Ganassi Racing team for the 2011 IZOD IndyCar season. The team will sponsor a new entry in the series driven by American racecar driver Charlie Kimball. This partnership makes Kimball one of the first drivers from the 2010 Firestone Indy Lights series to move up the official "Road to Indy" with a full season sponsorship.

comments 0 comments - Posted Dec 16, 2010

Almonds May Help Reduce Risk of Type 2 Diabetes and Cardiovascular Disease

With nearly 16 million Americans living today with pre-diabetes, a condition that is the precursor to type 2 diabetes, and half of all Americans expected to have some form of diabetes by the year 2020, healthy eating is more important than ever (1,2).  But here is some good news: a recent scientific study shows that incorporating almonds into your diet can help treat and possibly prevent type 2 diabetes, as well as cardiovascular disease.

comments 0 comments - Posted Dec 15, 2010

Stem cells used to make pancreas, gut cells

(Reuters) - Stem cells can be transformed into the pancreatic cells needed to treat diabetes and into complex layers of intestinal tissue, scientists demonstrated in two experiments reported on Sunday.

comments 6 comments - Posted Dec 13, 2010

JDRF Applauds Congress for Passage of $300 Million for Type 1 Diabetes Research and Thanks Supporters for Advocacy Efforts for Special Diabetes Program Renewal

"Congress passed a multi-year renewal of the Special Diabetes Program (SDP), ensuring that studies on promising diabetes treatments and avenues toward a cure continue uninterrupted. As the father of a son living with type 1 diabetes, and as CEO of JDRF, one of the leading advocates for the renewal of this program, I applaud the U.S. government for its continued commitment to end this disease.

comments 2 comments - Posted Dec 13, 2010

Holiday Travel Tips for People With Diabetes

"Don't leave home without it" has a whole new meaning this holiday season. With holiday travel up from last year and increased security- and consequent delays- at airports, it's more important than ever for those with diabetes to properly prepare for their holiday travel.

comments 0 comments - Posted Dec 10, 2010

Valeritas Receives FDA Clearance for the V-Go Disposable Insulin Delivery Device

Valeritas, Inc., a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today that the US Food and Drug Administration has cleared the company's V-Go Disposable Insulin Delivery Device for the continuous subcutaneous delivery of insulin in preset basal rates and with on-demand bolus dosing for adult patients requiring insulin.  V-Go devices will be available in a preset basal rate to deliver 20, 30 or 40 Units of insulin in one 24-hour period (0.83 U/hr, 1.25U/hr or 1.67U/hr respectively) and on-demand bolus dosing in 2 Unit increments (up to 36 Units per one 24-hour time period).

comments 1 comment - Posted Dec 9, 2010

November 2010

When Diabetes Steals Your Livelihood

Too often our preconceptions of work-limiting disabilities are confined to suddenly devastating conditions, such as spinal cord injury or stroke. We rarely consider how diseases such as diabetes can be just as debilitating and just as costly to a family. With November being recognized as National Diabetes Awareness Month, we should remember the people who are unable to work due to the complications of diabetes and who need the benefits to which they are entitled under Social Security Disability Insurance (SSDI).

comments 4 comments - Posted Nov 30, 2010

Drug Shortage Worries the Medical Community, Calls for Emergency Action

The newest threat to patient health may not be the flu or other epidemics. It could be a major shortage of prescription drugs. The shortage has reached the level of a "national public health crisis," according to a survey conducted by the Institute for Safe Medication Practices (ISMP) this summer. Survey respondents said shortages in the past year were "the worst ever, without a glimmer of hope for any improvement in the near future."

comments 0 comments - Posted Nov 27, 2010

Christopher Gorham Grabs Silver and Bronze Medals At International Karate/Kickboxing Championships

Insulet Corp., the leader in tubing-free insulin pump technology with its OmniPod® Insulin Management System, recognizes the outstanding achievements of Christopher Gorham, age 12, of Waterford, Michigan for bringing home both silver and bronze medals in the Sparring and Forms competitions at the 2010 World Karate/Kickboxing Council World Championships held in Albufeira, Portugal. Chris is a 2nd degree black belt in training for a 3rd degree black belt; he has been in martial arts since he was four years old, competing all over the world.

comments 0 comments - Posted Nov 25, 2010

A New Approach for Type 2 Diabetes

A new drug for type 2 diabetes started showing up in drugstores this week, according to manufacturer Santarus. The FDA-approved drug, called Cycloset, takes an distinctive -- and not well understood -- approach to reducing blood sugar levels. The pill apparently works by increasing dopamine activity in the hypothalamus, a part of the brain. Dopamine is a brain chemical that plays a big role in people's behavior, mood, and ability to sleep. Scientists theorize that glucose intolerance and insulin resistance may in part result from abnormal activity of this chemical, and that upping dopamine activity may iron out these problems.That's the theory, at least: the drug's exact workings aren't known.  But it seems to do the trick.

comments 0 comments - Posted Nov 24, 2010

At a Loss?

A friend of mine recently remarked that she wants her family to eat healthier, but she just doesn't know that much about nutrition. Though I can sympathize with her in some ways (nutritional education is a daunting and never-ending process), I do feel that the overall American attitude toward food is that ignorance is bliss. It reminds me of the preteen character in the movie Son-In-Law, who puts his sister's bra cups over his ears and tells his parents in a taunting voice, "I can't hear you!"  Unfortunately, what you don't know CAN hurt you, and not just you, but also your family. 

comments 3 comments - Posted Nov 22, 2010

Open Enrollment for 2011 Medicare prescription drug and health plans begins Nov. 15th

The Centers for Medicare & Medicaid Services (CMS) is encouraging all Medicare beneficiaries to take advantage of the annual Open Enrollment period to make sure they have the best coverage available to meet their health care needs in 2011.

comments 1 comment - Posted Nov 16, 2010

Screening Practices and Management of Celiac Disease and Type 1 Diabetes

Both celiac disease (CD) and type 1 diabetes (T1D) are autoimmune diseases. In CD the immune response is triggered by the ingestion of gluten, resulting in chronic inflammation and villous atrophy in the small intestine. Treatment requires permanent elimination of gluten from the diet. In T1D, pancreatic islet beta cells are damaged resulting in loss of endogenous insulin production. Treatment includes daily insulin injections combined with meal planning and exercise. Nutrition management of the individual with both T1D and CD can be challenging for both the patient and the dietitian.

comments 0 comments - Posted Nov 15, 2010

This World Diabetes Day, Measure Your Risk of Type 2 Diabetes

Imagine a pandemic. A disease comes into a community and then spreads across borders, causing disability and death in its path.  Scientists fight to contain its spread, and doctors try to mitigate its effects.  Most people associate this kind of scenario with a pathogen: a virus or bacteria, like HIV or avian flu, that has found a way to exploit the human body.  In fact, however, the overwhelming majority of pandemics are the result of noncommunicable diseases that are not spread by pathogens: conditions like cancer, heart disease, and type 2 diabetes. 

comments 1 comment - Posted Nov 12, 2010

JDRF Clinical Panel Recommends Next Steps for Artificial Pancreas Clinical Testing

WASHINGTON, D.C., Nov. 10, 2010 --- Diabetes experts at a meeting convened by the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) took the next step in advancing efforts toward the development of an artificial pancreas: putting forth clinical recommendations to ensure the safe and effective testing of artificial pancreas technology in real-life situations. We are pleased at today's meeting there was a strong consensus among leading clinicians, researchers and industry leaders regarding the path toward outpatient studies for both low-glucose suspend and artificial pancreas systems. 

comments 5 comments - Posted Nov 10, 2010

Is Correcting Low Blood Sugars Caused by Exercise Making You Fat?

Over the years, I have had many exercisers with diabetes ask me why they're gaining weight instead of losing it. There are two possible answers to that question. One answer is that muscle is heavier than fat, so if you are gaining muscle while losing fat-especially in the early stages of a new exercise program-your scale weight probably doesn't reflect your positive changes in body composition (i.e., less fat, more muscle).

comments 2 comments - Posted Nov 10, 2010

Activity roundup. Australia, Ireland and the Big Blue Test

With just a few days left to 14 November, we imagine that a lot of you are making those final touches to your World Diabetes Day celebrations or have already started your awareness activities. Here's a further look at what will be taking place around the world to mark the day:

comments 0 comments - Posted Nov 6, 2010

"Be Part of the Cure" Campaign Kicks Off National Diabetes Awareness Month

HOLLYWOOD, FL- Beginning today, thousands of people who want to help put an end to diabetes can be part of the cure by participating in the Diabetes Research Institute Foundation's online campaign at BePartoftheCure.org.  Kicking off National Diabetes Awareness Month, the Be Part of the CURE campaign is a fun and meaningful way for people living with diabetes, their family and friends, and anyone concerned about curing this devastating disease to literally participate in the "CURE."

comments 1 comment - Posted Nov 1, 2010

October 2010

Exercise Often Raises Blood Glucose in Type 1 Diabetes

Regular physical activity and exercise are recommended for the general population for overall improved health. However, exercise of moderate intensity increases the risk of hypoglycemia during and following exertion in those with type 1 diabetes mellitus (T1DM). Accordingly, exercise guidelines for T1DM focus on prevention of exercise-induced hypoglycemia.

comments 2 comments - Posted Oct 31, 2010

Surgeons Create Functional Artificial Pancreatic Tissue

In a proof-of-concept study presented at the 2010 Annual Clinical Congress of the American College of Surgeons, the researchers note that the matrix not only helps to understand the micro-architecture of the pancreas, but also prolongs the survival and preserves the function of the islets. Islets survived longer in the bio-artificial matrix than in conventional transplantation sites, and they produced significantly more insulin when challenged with glucose.

comments 0 comments - Posted Oct 30, 2010

Diabetes Alert Dogs

Tarra Robinson was afraid that she was going to lose her job. Diagnosed with type 1 diabetes when she was 18 months old, Tarra had recently developed hypoglycemic unawareness, which  affects about 17% of type 1 diabetics. Tarra was passing out at work, and once she even crashed her car when her blood sugar dropped unexpectedly. She went on a pump and tried a CGM, but nothing seemed to help. She was still having frequent, dangerous lows.

comments 0 comments - Posted Oct 28, 2010

Diabetes and the Flu

As flu season approaches, many people are debating whether they should get a flu shot. As everyone knows, getting the flu is not fun. In fact, it can be downright miserable. But for those with diabetes, the flu can mean more than a cough, running nose, and body aches--it could mean more severe complications, and sometimes even death.

comments 0 comments - Posted Oct 27, 2010

Trapped Underground for 70 Days with Diabetes

Imagine that you're a miner. Imagine you have diabetes (that, at least, shouldn't be too hard). Now, imagine that you have to spend two months trapped underground with other miners. How would you do?

comments 0 comments - Posted Oct 24, 2010

Diabetes Risk May Fall as Magnesium Intake Increases

Getting enough magnesium in your diet could help prevent type 2 diabetes. Dr. Ka He of the University of North Carolina at Chapel Hill and colleagues have found that people who consumed the most magnesium from foods and vitamin supplements were about half as likely to develop diabetes over the next 20 years as people who took in the least magnesium.

comments 0 comments - Posted Oct 22, 2010

Transplanted Feces from Thin People Improve Insulin Sensitivity in People with Pre-Diabetes

European researchers have reported that when they transplanted fecal matter from healthy thin people into obese people with pre-diabetes, the latter group's insulin sensitivity notably increased. (Insulin sensitivity is the body's ability to properly use the insulin hormone to regulate the amount of glucose in the bloodstream. Pre-diabetes exists when increasing resistance to insulin creates higher-than-normal blood sugar levels, a precondition to the onset of full-blown type 2 diabetes.)

comments 1 comment - Posted Oct 19, 2010

Calibra Gains FDA Clearance to Market Finesse

Calibra Medical has announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its FinesseTM insulin patch-pen for up to three-day use with Novo Nordisk's Novolog® rapid-acting insulin. This much-anticipated step closer to market release follows the announcement in January that Calibra received FDA clearance for the device for use with Eli Lilly's Humalog® rapid-acting insulin.

comments 0 comments - Posted Oct 18, 2010

Early Research Reveals New Clues to Origin of Diabetes

University of Michigan scientists have identified events inside insulin-producing pancreatic cells that set the stage for a neonatal form of non-autoimmune type 1 diabetes, and may play a role in type 2 diabetes as well. The results point to a potential target for drugs to protect normally functioning proteins essential for producing insulin.

comments 0 comments - Posted Oct 15, 2010

Can You Keep A Secret?

The day I learned that I had type 1 diabetes was no doubt one of the most heart-wrenching, confusing, and angry days of my life. But I quickly decided that I had to channel those feelings into something productive, something worthwhile. I gained confidence as a person with diabetes, and even though, yes, the shots stung, I wasn't going to flinch. Welcome to my life.

comments 0 comments - Posted Oct 11, 2010

The Cost of Diabetes

In July, I went to order a refill of my pump and was refused. My account was overdue, and my pump company wouldn't issue a refill until I could pay at least $400 of the $1200 I owed. I didn't have $400. I am a freelance writer and stay-at-home mom with a knack for stretching my husband's paycheck. I'd been making small monthly payments of about $50 because that was all we could afford, but now they wouldn't send me any more. So I went to the pharmacy and bought a box of syringes for $25. I didn't want to go back to multiple daily injections, but I didn't see that I had a choice.

comments 1 comment - Posted Oct 9, 2010

Dancing for the Health of It

Dance Out Diabetes is a non-profit organization that addresses a critical component missing in most diabetes programs: PHYSICAL ACTIVITY! Our mission is to help individuals prevent or manage diabetes through dance and education.

comments 0 comments - Posted Oct 6, 2010

Paul and Mira Sorvino Partner with sanofi-aventis to Launch Diabetes Co-Stars

We all know of Paul and Mira Sorvino, the legendary father and daughter actors who have graced the small and big screens for decades. Paul has played such classic characters as Paulie Cicero in the film Goodfellas and Sgt. Phil Cerreta on the TV series Law & Order and is a well-known chef and singer, while Mira has starred in over 30 movies and won an Academy Award in 1995 for her role as Linda Ash in Mighty Aphrodite.

comments 0 comments - Posted Oct 5, 2010

Sanofi-Aventis Announces Coming Release of BGStar and iBGStar Blood Glucose Meters

Last week, sanofi-aventis announced the upcoming launch of the blood glucose meters BGStar® and iBGStarTM (developed by sanofi and its partner AgaMatrix), which should be available in early 2011.

comments 1 comment - Posted Oct 4, 2010

Diabetes Awareness: Just for a Month, or All Year Long?

Twenty years ago, when I opened Sugar Happy Diabetes Supplies in San Francisco, people would open the front door, lean in, and ask, “I’m curious. Are there enough people with diabetes for you to stay in business?”  My reply was always, “You would be surprised by how many people have diabetes.”

comments 0 comments - Posted Oct 1, 2010

Link Between Diabetes and Air Pollution Discovered

A national epidemiologic study finds a strong, consistent correlation between adult diabetes and particulate air pollution that persists after adjustment for other risk factors like obesity and ethnicity, report researchers from Children's Hospital Boston. The relationship was seen even at exposure levels below the current EPA safety limit.

comments 0 comments - Posted Oct 1, 2010

September 2010

Meetings, Medications, and Meters

I’m back. I started working with Diabetes Health 10 years ago.  At that time, Diabetes Health was the one publication open enough to talk about a subject that was controversial at that time… Lower Carb Options.  That was my column, and I got a lot of slack from it. I didn’t understand why. People with diabetes want and need lower carb options. What was the problem with giving people options? That’s what Diabetes Health is all about – teaching people there are healthy options. Now it’s common to see lower carb options for people who have diabetes. 

comments 0 comments - Posted Sep 29, 2010

UCSF Diabetes Symposium Marks Decade of Research Advances

Diabetes research is on the cusp of new advances in treatment options and in understanding the underlying causes of both type 1 and type 2 diabetes. Among those are potential treatments using stem cells to regenerate a patient's ability to produce insulin, as well as upcoming clinical trials of a vaccine that potentially could prevent type 1 diabetes.

comments 2 comments - Posted Sep 27, 2010

The Scarlet 'D'

Do you ever wish you could leave your diabetes at home?  Maybe you're at a holiday party, chit chatting with your buds gathered around the bar enjoying an adult beverage (or two), maybe grazing at the table of cookies, cakes and other tempting morsels.  "Oh, I think I'll try one of those.  Maybe one of those too.  I didn't bring my diabetes with me, so I don't have to think about it tonight."  Diabetes is not last year's outfit you can leave at home, or a bad relationship you can dump and move on.  It is more like a tattoo.  It goes everywhere with you.

comments 0 comments - Posted Sep 24, 2010

FDA Significantly Restricts Access to the Diabetes Drug Avandia

The U.S. Food and Drug Administration today announced that it will significantly restrict the use of the diabetes drug Avandia (rosiglitazone) to patients with Type 2 diabetes who cannot control their diabetes on other medications. These new restrictions are in response to data that suggest an elevated risk of cardiovascular events, such as heart attack and stroke, in patients treated with Avandia.

comments 0 comments - Posted Sep 23, 2010

Blueberries Improve Pre-diabetic Condition

New research findings reveal that one of America's favorite colorful fruits, blueberries, have properties that help to improve factors related to pre-diabetes and decrease inflammation in obese men and women. Chronic low-grade inflammation related to obesity contributes to insulin resistance, a major factor in the development of type 2 diabetes. "This is an excellent example of the importance of clinical trials to building our knowledge-base in helping to improve public health," said Steven Heymsfield, PBRC Executive Director

comments 0 comments - Posted Sep 21, 2010

Rogue Protein May Trigger Diabetes

The presence of amyloid protein may produce a chain reaction which destroys vital insulin-producing cells. Researchers based in Dublin, writing in the journal Nature Immunology, say future drugs could target this process. Amyloid is implicated in many other diseases - most notably Alzheimer's.

comments 0 comments - Posted Sep 17, 2010

Insulindependence

In late July, five teenagers and five adults hiked to the summit of Mount Shavano, one of Colorado's famed 14,000-foot peaks.  For this particular group, the journey to the top of Shavano was designed to be an intensive educational experience on the topic of diabetes management.  Each teenager had type 1 diabetes, and the adults were mentors dedicated to helping the teens feel more in control of the disease. The team made it to the summit by performing countless blood sugar tests, counting carbs, and experimenting with insulin pump basal rates. The outfit behind the expedition was Testing Limits, an outdoor adventure club just for people with diabetes, operated by the non-profit Insulindependence. 

comments 0 comments - Posted Sep 17, 2010

Diabetes and Autoimmunity

The JDRF is celebrating its 40th anniversary this year. A lot has changed in the past four decades. One change has to do with the organization's name. JDRF stands for Juvenile Diabetes Research Foundation. Years ago we called what we now know as type 1 diabetes, Juvenile Onset Diabetes Mellitus (JODM). We called it that because we knew (or thought we knew) it was the kind of diabetes that occurred in children. We now know that type 1 diabetes occurs in people of all age groups. There was a lot we didn't know 40 years ago, one of which was that type 1 diabetes is an autoimmune disease.

comments 0 comments - Posted Sep 16, 2010

Diabetes and Alcohol: What You Need to Know

If you are meeting a friend for a drink after work or attending a holiday party where alcohol is being offered, is it a health risk or a benefit?  The medical and nutrition literature reports that moderate consumption of alcohol can offer some health benefits, particularly for your heart. The Dietary Guidelines for Americans 2005 defines drinking in moderation as no more than one drink per day for women or two drinks per day for men. One drink, by definition, is a 12-ounce beer, eight-ounce glass of malt liquor, five ounces of wine, or 1.5 ounces of hard liquor.  Moderate alcohol consumption may reduce the risk of having a heart attack or stroke, lower the risk of developing gallstones, and prevent the development of type 2 diabetes in people with pre-diabetes. Studies show  that those benefiting from moderate consumption are middle-aged and older adults.  It is not recommended, however, that anyone begin drinking or drink more frequently on the basis of health considerations.

comments 0 comments - Posted Sep 15, 2010

Joslin 50-Year Medalists Give Clues to Cures

In type 1 diabetes, the body relentlessly attacks and destroys its own insulin-producing pancreatic beta cells. But a study by Joslin Diabetes Center scientists now has firmly established that some of these cells endure for many decades in a small group of people with the disease-offering clues to potential treatments for preserving and even restoring the crucial cell population.

comments 0 comments - Posted Sep 14, 2010

Living His Dream of Law Enforcement: Lt. Jose Lopez

On July 2, 2010, when Lt. Jose Lopez took the podium at the recent Children With Diabetes Friends for Life Annual International Conference in Orlando to speak to the parents of children with diabetes, his goal was to use his own story to reassure them about their children's future. "What I most wanted to convey to them was that people with diabetes, especially children, can do normal stuff and live their dreams. I am not a super hero - and I did it."

comments 0 comments - Posted Sep 14, 2010

Immune System Genes Show Links to Type 1 Diabetes

The exact cause of type 1 diabetes is still unknown, but international researchers have found a link between the blood sugar disorder and a network of immune system genes.

comments 0 comments - Posted Sep 13, 2010

The Highs and Lows of Going Back to School

Going back to school can be a little scary for someone with diabetes. There are a lot of things to think about when it comes to making it through the school day without having problems with your blood sugar levels. In school, we strive for that all important "A" on a test; to score 100. The same is true about blood sugar/glucose levels; the closer I come to keeping my blood sugar level at "100," the better for my health and the better for my grades; high and low blood sugars aren't helpful in keeping a clear, quick-thinking mind. 

comments 0 comments - Posted Sep 10, 2010

No BG Deal: Today's Meter Innovations Leave Many Yawning for More

In my office, there is a box.  Nothing fancy, just a plain brown box filled with a collection of "old school" diabetes stuff:  "boil and re-use" syringes, urine test tape, screw-driven insulin pumps, medieval injection aids and lancing devices, and so on.  Of course, no such collection would be complete without an array of classic blood glucose meters.  The oldest one I have is a plug-in-the-wall model called a "Dextrometer" that featured test strip rinsing solution and a red LED display that could burn the retina of anyone within six feet.  

comments 0 comments - Posted Sep 9, 2010

Your Meds and Your Love Life

Dear Diabetes Health, I am 62 years old. I was diagnosed with type 2 diabetes in 1997, and I am doing OK on metformin. My last A1c was 7.2 %. About a year ago, they put me on medicine for my blood pressure (which was 142/90) and for cholesterol.  I started having less interest in sex, which I had really liked before.

comments 0 comments - Posted Sep 7, 2010

Type 2 Diabetes Raises Alzheimer's Disease Risk

Type 2 diabetes and Alzheimer's disease are two distressing, but increasingly common, diseases seen in our aging population. At some point in the future, they may well overwhelm the healthcare system.

comments 0 comments - Posted Sep 5, 2010

Bone Breakdown Helps Regulate Blood Sugar

The routine breakdown of old bone during skeletal growth has an important role to play in regulating blood sugar, according to Columbia University Medical Center researchers. The process, known as resorption, goes on throughout life. It stimulates insulin release and sugar absorption, helping healthy people maintain normal blood glucose levels. The new study, published in Cell, suggests that skeletal changes could causes diabetes for some and that possible treatments for type 2 diabetes could come from the bone-insulin connection.

comments 0 comments - Posted Sep 4, 2010

As the Quest for an Artificial Pancreas Continues, Europeans Look at a Novel Approach

The Holy Grail pursued by all diabetes researchers is a complete cure for both the type 1 and type 2 forms of the disease. But until then, the "artificial pancreas," a combination of glucose monitoring and insulin dosing technology, may be as close as they get to a final breakthrough in treating diabetes.

comments 0 comments - Posted Sep 3, 2010

Brain Surgery Results Could Portend New Approach to Treating Type 2

Results of brain surgery on a small group of type 2 diabetes patients point the way to a possible new approach for treating the disease.

comments 0 comments - Posted Sep 1, 2010

August 2010

THE Diabetes Dude Ramps Up an Innovative Diabetes Awareness Campaign

The Flamingo Flock diabetes awareness campaign is the brainchild of 9-year-old Noah Brokmeier, "The Diabetes Dude."  Noah's blue flamingos are landing on lawns nationwide and appearing at big events like the Boston Marathon. Wherever they go, the birds pose for pictures, which are then posted on Noah's website, www.thediabetesdude.com. The location of the birds is also flagged on his "official flamingo tracking map," to show the progress and growth of the campaign.

comments 0 comments - Posted Aug 30, 2010

MannKind Corporation Providing AFREZZA to JDRF for Artificial Pancreas Project

MannKind Corporation announced that the company will supply its novel, ultra rapid acting insulin AFREZZATM (insulin human [rDNA origin]) for use in a study being conducted by the Juvenile Diabetes Research Foundation (JDRF) as part of its Artificial Pancreas Project. The planned two-year study in patients with type 1 diabetes will leverage the unique rapid action of AFREZZA for use in a closed-loop blood sugar monitoring and insulin delivery system, termed the "artificial pancreas" by the JDRF. The study will be managed in conjunction with the Sansum Diabetes Research Institute and the University of California, Santa Barbara.

comments 0 comments - Posted Aug 29, 2010

iGlucose

Working toward the goal of unifying patients' diabetic treatment information in a single place, the PositiveID Corporation hopes to patent a new device that monitors insulin pens. The Insulin Tracker would attach to a user's insulin pen and record the times and amounts of injections. That information would then be sent to a database that allows for comprehensive monitoring. Insulin pens come in disposable and cartridge-replaceable flavors; the tracker can be moved easily from one pen to another.

comments 0 comments - Posted Aug 27, 2010

'Sugar Crush' (Diabetes Dietary Supplement) Clinical Research Presented at the 37th Annual AADE Meeting

NaturEra, (http://www.NaturEra.com) a dietary supplements emerging leader, this month announced the launch of its new Sugar Crush dietary supplements would take place at the American Association of Diabetes Educators meeting in San Antonio, Texas.  Sugar Crush research has been accepted for Poster presentation at the AADE meeting.  The full clinical research study (http://www.naturera.com/Manuscript.pdf) shows that NaturEra's 'Sugar Crush' and 'Sugar Crush Daily' dietary supplement formulas used in combination lower and maintain healthy blood sugar levels for people with diabetes. 

comments 1 comment - Posted Aug 26, 2010

The Fruit Factor

In the early days after my type 1 diabetes diagnosis, I sentenced a lot of foods to what I came to think of as my personal DO-NOT-EAT list, often with only slight provocation.

comments 1 comment - Posted Aug 25, 2010

Novo Nordisk Creates "App" to Help Doctors Dose Insulin

Novo Nordisk announced today the availability of NovoDoseTM - the first-ever mobile insulin dosing guide for physicians to look up dosing guidelines and blood glucose goals for their patients with diabetes, a disease that affects nearly 24 million Americans. The guide is available as an application on iTunes and is specific to Novo Nordisk's modern insulin analog portfolio: Levemir® (insulin detemir [rDNA origin] injection), NovoLog® (insulin aspart [rDNA origin] injection), and NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]).

comments 0 comments - Posted Aug 24, 2010

Type 2-Induced Brain Changes May Hinder Learning in Obese Kids

Results of a recently published study show that type 2 diabetes in obese adolescents can affect their ability to learn by altering the amount of sugar that reaches their brains to fuel thinking.

comments 0 comments - Posted Aug 24, 2010

Controlling a Fat-Regulating Protein Dramatically Increases Insulin Sensitivity

PPARy is a protein that regulates the body's production of fat cells. However, obesity can modify how PPARy works, leading to decreased insulin sensitivity and the development of metabolic syndrome. (Metabolic syndrome is the cluster of factors, including insulin resistance, overweight, high blood pressure, and abnormal blood sugar levels, that is a precursor to type 2 diabetes.)

comments 0 comments - Posted Aug 22, 2010

Evolution May Have Pushed Humans Toward Greater Risk for Type 1 Diabetes

Gene variants associated with an increased risk for type-1 diabetes and rheumatoid arthritis may confer previously unknown benefits to their human carriers, say researchers at the Stanford University School of Medicine. As a result, the human race may have been evolving in the recent past to be more susceptible, rather than less, to some complex diseases, they conclude.

comments 0 comments - Posted Aug 21, 2010

Joslin Diabetes Center 50-Year Medalist Program

Since 1970, Joslin Diabetes Center has awarded a 50-year bronze medal and certificate to recognize the remarkable achievement of a successful life with insulin-dependent diabetes for half a century or more. To date there have been approximately 2,663 50-Year Medals awarded by Joslin Diabetes Center.  Joslin Diabetes Center has awarded medals to recipients throughout the world, including individuals from Australia, Brazil, Canada, England, Hungary, Japan, Netherlands, Pakistan, Philippines, Russia, South America, Spain, Sweden, and Switzerland. 

comments 0 comments - Posted Aug 21, 2010

Gene testing could have saved weight-loss drug

(Reuters) - Genetic testing might have helped identify people who would become depressed or suicidal while taking Sanofi-Aventis' weight loss drug Acomplia, which might have helped keep the drug on the market, U.S. researchers said on Thursday.

comments 0 comments - Posted Aug 19, 2010

Finally, the Pump.

"Absolutely not. I'm not going to mess with that."

comments 0 comments - Posted Aug 18, 2010

The Sanford Project Launches Research Study to Find a Cure

"The objective of this clinical trial (research study) is to determine if the medications can rescue the few beta cells that remain soon after the diagnosis of type 1 diabetes; and whether new beta cells can even be regenerated," commented Alex Rabinovitch, MD, Principal Investigator of the trial and Associate Director of The Sanford Project. "The investigational combinations of these medications could possibly allow patients to decrease or no longer need to inject insulin to keep their blood levels under proper control."

comments 0 comments - Posted Aug 12, 2010

Wouldn’t it be Great if You Could Pop a Pill and Lose Weight?

And wouldn't it be great if that pill weren't something advertised on late-night TV, but rather a legitimate treatment? A drug called rimonabant, introduced in Europe, seemed to fit the bill at first, but it was pulled from the market in late 2008 due to concerns about psychiatric side effects.

comments 0 comments - Posted Aug 10, 2010

Kids' Fructose Consumption Can Lead to Big Adult Bellies

Children who consume a lot of high-fructose corn syrup in soft drinks and processed foods as they're growing up may run the risk of turning many of their fat cells into belly fat when they reach adulthood.

comments 0 comments - Posted Aug 10, 2010

Obesity Intervention Study Produces Mixed Results

The HEALTHY program, a three-year government-funded intervention in middle schools that was designed to lower overall rates of overweight and obesity among students, has produced mixed results.

comments 0 comments - Posted Aug 8, 2010

Lower-Carb Diet Better Than Low-Fat for Obese Insulin-Resistant Women

Insulin-resistant obese women lost more weight after 12 weeks on a low-carbohydrate diet than they did on a low-fat diet, according to a study conducted by the University of Nevada School of Medicine in Reno. (The study was funded by Jenny Craig, a company that sells diet foods.)

comments 0 comments - Posted Aug 7, 2010

Red Wine Ingredient Increases Insulin Sensitivity, Works Against Retinal Disease

Two recent research studies on humans indicate that resveratrol, a chemical found in red wine and peanuts, increases insulin sensitivity in older and obese people. A third study, done on mice, shows that resveratrol may someday become a powerful tool in therapies directed at macular degeneration and other retinal maladies.

comments 0 comments - Posted Aug 6, 2010

Victoza® Achieved Improved Blood Sugar Control in African-Americans With Type 2 Diabetes

Novo Nordisk presented results demonstrating that once-daily Victoza® (liraglutide [rDNA] injection) achieved significantly greater improvements in blood sugar control compared to placebo among African-American patients with type 2 diabetes. The meta-analysis of phase 3 data from the Liraglutide Effect and Action in Diabetes (LEAD) trials were presented at the 2010 National Medical Association Annual Convention & Scientific Assembly.

comments 0 comments - Posted Aug 5, 2010

Early Predictors of Metabolic Syndrome in Healthy Kids

Children as young as seven years old can show markers for metabolic syndrome, a condition that raises their risk for type 2 diabetes and a host of other health problems, according to university researchers.

comments 0 comments - Posted Aug 4, 2010

July 2010

Implanted Glucose Sensor Works for More than One Year

Bioengineers at the University of California, San Diego and GlySens Incorporated have developed an implantable glucose sensor and wireless telemetry system that continuously monitors tissue glucose and transmits the information to an external receiver. The paper, published in the July 28, 2010 issue of the journal Science Translational Medicine, describes the use of this glucose-sensing device as an implant in animals for over one year. After human clinical trials and FDA approval, the device may be useful to people with diabetes as an alternative to finger sticking, and to short-term needle-like glucose sensors that have to be replaced every three to seven days.

comments 0 comments - Posted Jul 31, 2010

Diabetes Heroes Come In All Ages

Last summer, I led the third annual swim-run biathlon for the Barton Center for Diabetes Education, which hosts two Massachusetts camps for children with type 1-Camp Joslin for boys and Camp Clara Barton for girls. It was at Camp Joslin that I met a memorable eight-year-old boy who exemplifies what being a diabetes hero is all about. I'll call him "Adam."

comments 0 comments - Posted Jul 29, 2010

Explaining Health Care Reform: Key Changes to the Medicare Part D Drug Benefit Coverage Gap

On March 23, 2010, President Obama signed the Patient Protection and Affordable Care Act into law (P.L. 111-148). The health care reform law, which incorporates changes made by the Health Care and Education Reconciliation Act of 2010, makes several important changes to the Medicare Part D drug benefit to reduce Part D enrollees' out-of-pocket liability when they reach the coverage gap, known as the "doughnut hole."

comments 0 comments - Posted Jul 29, 2010

New York Historical Society Brings to Life the Dramatic Story of the Discovery of Insulin

NEW YORK, NY, July 26, 2010 - Recalling the desperate fight for life that used to be waged by juvenile diabetes patients, and commemorating the events of 1921 that inaugurated a new era of hope for them and their families, the New York Historical Society will present the exhibition Breakthrough: The Dramatic Story of the Discovery of Insulin from October 5, 2010 through January 31, 2011. Exploring the roles of science, government, higher education and industry in developing and distributing a life-saving drug, the exhibition will bring to life the personalities who discovered insulin and raced to bring it to the world and will tell the story of one extraordinary New York girl-Elizabeth Evans Hughes, daughter of the leading statesman and jurist Charles Evans Hughes-who was among the very first patients to be saved.

comments 0 comments - Posted Jul 26, 2010

The Power of Being Positive

I was in the parking lot of the mall, walking past wheelchair parking, when I noticed a man using the lift gate of his specially equipped van. There he was, lowering himself and his motorized wheelchair down to the ground all by himself. As I walked through the mall that day, I couldn't get the man in the wheelchair off my mind.

comments 0 comments - Posted Jul 26, 2010

Type 2 Risk Information to Share with Your Friends and Loved Ones

Learn Your Risk for Diabetes and Take Steps to Protect Your Health. If you are diagnosed in the early stages of diabetes, you can take better care of yourself and get treatment. If you have pre-diabetes, you can take steps to prevent or delay the onset of type 2 diabetes.

comments 0 comments - Posted Jul 23, 2010

FDA Freezes Long-Term Study on Diabetes Drug Avandia

A long-term study on the safety of a popular diabetes drug was put on hold Wednesday by the Food and Drug Administration, while the FDA considers whether it's too dangerous to continue.  Several large studies have linked the drug, Avandia, to a higher risk of heart attacks and other heart problems. While other studies have not found the same risk, last week an FDA advisory panel recommended that the drug not be sold without a stronger warning label or possibly limits on who could receive it.

comments 0 comments - Posted Jul 23, 2010

Hepatitis C and Insulin Resistance

We have known for several years that Hepatitis C, a common cause of liver cirrhosis and cancer, also makes people three to four times more likely to develop Type 2 diabetes. In studying the insulin resistance of 29 people with Hepatitis C, Australian researchers have confirmed that they have high insulin resistance, a precursor to diabetes. However, almost all insulin resistance occurs in muscle, with little or none in the liver, a very surprising finding given that Hepatitis C is a liver disease.

comments 0 comments - Posted Jul 21, 2010

Nutraceuticals and Natural Supplements for Treating Type 2 Diabetes: An Overview

From environmentally friendly hybrid cars and heating with solar power to organic or natural foods, our culture is increasingly embracing green strategies. "Using natural dietary supplements to support healthy blood sugar levels and minimize the impact of glycation is a rational continuation of this green philosophy," says Steven Joyal, MD, vice president of Scientific Affairs and Medical Development for the Life Extension Foundation in Ft. Lauderdale, Florida (www.lef.org). He is also author of the book What Your Doctor May Not Tell You About Diabetes.

comments 0 comments - Posted Jul 20, 2010

U.S. Advisers Reject Vivus' Fat Pill

(Reuters) - The first new prescription weight-loss pill in more than a decade failed to win backing from U.S.health advisers, who said safety concerns about the drug outweighed its ability to help obese patients shed pounds.

comments 0 comments - Posted Jul 19, 2010

The Johnson & Johnson Diabetes Institute Meets the Challenge of Training Diabetes Educators Across the Globe

Looking for novel ways to help improve patient outcomes, the Johnson & Johnson Diabetes Institute is using innovative adult education techniques to train diabetes educators around the world.  While the cultural and epidemiological differences in each region can be challenging, David L. Horwitz, M.D., Ph.D., FACP, Chief Medical Officer of the Johnson & Johnson Diabetes Institute, feels confident this program can make a positive impact to help improve patient outcomes.

comments 0 comments - Posted Jul 17, 2010

Avandia and the FDA Panel: Scientific Leaders Urge Diabetes Patients to Talk with their Doctor before Making Changes to their Medication Use

The U.S. Food and Drug Administration's (FDA) Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee has completed their evaluation of the scientific research available on the safety of rosiglitazone. The deliberations of the panel reflected the complexity of the issues, with several members voting to add additional warnings or to withdraw the drug from the U.S. market. Ultimately, the final recommendation was to allow Avandia to remain on the market. Now that the expert panel has concluded its meeting, the FDA will review their recommendations and make the final decision on whether the drug remains available to patients.

comments 0 comments - Posted Jul 15, 2010

Medtronic Launches First Free Safe-Driving Program for Teens with Diabetes in Los Angeles July 19

Medtronic, Inc. announced today that Test B4U Drive, the first-ever, free program for teens with diabetes combining advanced driver skills training with diabetes management education, will be held July 19-21 at The Forum in Los Angeles. In partnership with the Juvenile Diabetes No Limits Foundation, Medtronic will continue the program throughout the summer across the country to teach teens with diabetes that good diabetes management is a key to staying safe behind the wheel.

comments 0 comments - Posted Jul 14, 2010

Sweet Escape

There's nothing quite like a dip in the Mediterranean Sea at sunset. The warm, clear water, shimmering clouds, and sound of families enjoying aperitifs at beachside cafes--it was the perfect start to a late-summer Italian holiday. We were visiting my boyfriend's brother, who had moved from England to Genoa a few years prior. It was my first time across the Atlantic, so my boyfriend Dunstan and I tried to make it count with 10 days filled with dinners, family celebrations, a road trip to Rome, hiking, and plenty of swimming.

comments 0 comments - Posted Jul 13, 2010

Pump and Sensor Combo Beats MDI Decisively in Medtronic’s STAR 3 Study

A massive study involving 485 people with type 1 diabetes at 30 locations across North America shows that the combination of an insulin pump and a continuous glucose monitor helps patients achieve significantly lower A1c levels than multiple daily insulin injections.

comments 0 comments - Posted Jul 13, 2010

Traveling With Diabetes

My diabetes and I have traveled a lot of miles together in nineteen years.  Racing Ironman triathlons in Australia, Europe, the Carribean and all over North America, climbing and camping at the top of 14,000 foot Mt. Whitney, and of course dozens of family vacations and business trips.  Packing equipment and supplies for an Ironman triathlon and 3 weeks in Australia requires a bit of planning and preparation, but when you have diabetes you feel like you do that for just a weekend out of town.  Meters, strips, insulin, syringes, infusion sets, pump supplies, snacks . . . a simple weekend trip becomes a lunar expedition.

comments 1 comment - Posted Jul 10, 2010

Intensive BG Control and the Onset of Organ Damage in Type 2s

Data from the massive ACCORD study on intensive blood sugar control shows that lowering blood sugar levels in people with longstanding type 2 diabetes to near-normal may delay the appearance of signs that point to damage to nerves, eyes, and kidneys, but does not stop their progression toward it.

comments 0 comments - Posted Jul 9, 2010

Study Says Byetta and Januvia Do Not Pose Extra Risk for Pancreatitis

A study released in late June has brought some welcome news to the makers of Byetta and Januvia: Users of the two diabetes drugs run no greater risk of developing pancreatitis than people with diabetes who take other drugs. In fact, both drugs seem to put users at slightly less risk for the condition.

comments 0 comments - Posted Jul 8, 2010

Testosterone Gel in Older Men Leads to Increased Cardiovascular Problems

A clinical trial that used testosterone gel, a topically applied ointment, to increase muscle strength in older men with low testosterone levels was stopped because adverse cardiovascular events increased significantly among patients receiving the treatment.

comments 0 comments - Posted Jul 7, 2010

AFREZZA Demonstrates Long-Term Efficacy with Type 2s

AFREZZA TM (insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, investigational ultra rapid acting mealtime insulin, as part of a diabetes treatment regimen, provides long-term glucose control comparable to usual insulin therapy but with a significantly reduced incidence of hypoglycemia and less weight gain in patients with Type 2 diabetes, according to a two-year study presented at the American Diabetes Association's 70th Scientific Sessions.

comments 0 comments - Posted Jul 6, 2010

Vitamin D Deficiency Common in People With Poor Diabetes Control

In a recent study of the relationship between vitamin D deficiency and glucose intolerance in people with type 2 diabetes, more than 90 percent of the type 2 diabetes patients were found to be deficient in vitamin D, with their control over the disease worsening as their deficiency increased.

comments 0 comments - Posted Jul 4, 2010

Traveling Wisely With Diabetes

Summer has arrived, and for many, that means it's time to take that long-awaited vacation. Visions of sunny beaches, gourmet meals, mountain resorts, adventurous excursions, and campgrounds dance in our minds. The word "vacation" is typically a synonym for "letting it all go."  No worries. No cares. Just pure indulgence. But for people with diabetes, an upcoming vacation can bring on anxiety and stress. For many of us, our disease thrives on routine and predictability, and vacations do not adhere to our everyday lives.  

comments 0 comments - Posted Jul 3, 2010

Coconut Oil Could Reduce The Symptoms Of Type 2 Diabetes

A diet including coconut oil, a medium chain fatty acid (MCFA), helps combat insulin resistance. Insulin resistance is the inability of cells to respond to insulin and take in glucose for energy. The pancreas tries to compensate for insulin resistance by producing even more insulin, but eventually glucose accumulates in the bloodstream. Over time, insulin resistance and obesity can lead to pre-diabetes or full-blown type 2 diabetes. 

comments 0 comments - Posted Jul 1, 2010

GLUMETZA: Extended Release Metformin

Depomed, Inc. and Santarus, Inc. announced new data suggesting that patients previously intolerant of metformin may be able to tolerate higher doses of metformin when treated with GLUMETZA® (metformin HCl extended release tablets).  The finding will be presented at the 70th Scientific Sessions of the American Diabetes Association (ADA) in Orlando. GLUMETZA is a once-daily, extended release formulation of metformin, and is approved for use in adults with type 2 diabetes mellitus. It is promoted in the U.S. by Santarus.

comments 0 comments - Posted Jul 1, 2010

June 2010

Lonely Nights

Dear Diabetes Health, I have been married for 14 years.  I am 36 and my husband is 39, and we have a seven-year-old daughter. About six months, ago my husband found out that he has type 2 diabetes.

comments 0 comments - Posted Jun 29, 2010

Malfunctioning Pancreatic

A malfunction in the pancreas's "circadian clock*," the built-in timer found in all living things that regulates major biological processes, may be one of the reasons that people develop diabetes.

comments 0 comments - Posted Jun 29, 2010

Harvard Study Says Brown Rice Twice Weekly Can Reduce Diabetes Risk by 10 Percent

White rice and brown rice are reminiscent of those old dramas about identical twins, wherein one turns out to be angelic and the other turns out to be bad news.

comments 0 comments - Posted Jun 28, 2010

Getting Back to Basics When Life Gets In the Way

One day as I was multi-tasking (making dinner, washing dishes, supervising my daughter, returning phone calls), I suddenly grew very annoyed at the music we were listening to. I had recently purchased a children's CD for my daughter, and it hit me that all the songs sounded the same.  What a waste of twelve dollars, I thought, as I headed toward the CD player to shut it off.   As I reached down to hit the "off" button, I noticed a small, unfamiliar icon on the display screen. I crouched down to further examine and then laughed aloud.

comments 0 comments - Posted Jun 26, 2010

Judge Rules Only Nurses Can Administer Insulin Shots to California Schoolchildren

A Sacramento Superior Court judge has ruled that only school nurses can give insulin shots to children in public schools who have diabetes. The decision by Judge Lloyd Connelly overturned a 2007 California State Department of Education decision that allowed trained school staff, as well as nurses, to administer such injections.

comments 1 comment - Posted Jun 25, 2010

Double Transplantation Treatment for Type 1 Diabetes

City of Hope researchers have found that bone marrow transplantation with islet cell transplantation shows promise as a treatment for late-stage type 1 diabetes. This combination may enable patients to make their own insulin again.  Results from laboratory research led by Defu Zeng, MD, associate professor in the departments of Diabetes Research and Hematology & Hematopoietic Cell Transplantation at City of Hope, were published online this month in the journal Diabetes.

comments 0 comments - Posted Jun 25, 2010

Scientists Have Found the Peptide Trigger for Type 1 Diabetes in Animal Tests

Researchers from the National Jewish Health and University of Colorado Anschutz Medical Campus have found a specific protein fragment, or peptide, that stimulates an immune system attack resulting in diabetes. Their experiments in mice contradict conventional wisdom about such peptides and support work by scientists studying autoimmune diseases.

comments 0 comments - Posted Jun 24, 2010

Diabetes and Cancer: A Consensus Report

The American Diabetes Association and the American Cancer Society have issued a joint consensus statement that acknowledges some links between diabetes and cancer but also notes there are numerous questions that have yet to be answered.

comments 0 comments - Posted Jun 23, 2010

Depomed recalls 52 lots of diabetes drug

(Reuters) - Drug developer Depomed Inc (DEPO.O) said it will recall 52 lots of its diabetes drug Glumetza due to the presence of traces of a certain chemical in the tablet's 500 mg bottle.

comments 0 comments - Posted Jun 22, 2010

Wholly Healthy

Diabetes is often perceived as a physical disease, an issue with one's body.  But those of us with diabetes know that it affects every area of our lives, including our emotional, spiritual, and mental health. People with diabetes are more likely to experience depression than the average person, and it doesn't take a doctor to explain why. Diabetes is daunting, complicated, and confusing.  There's no one-size-fits-all explanation or treatment plan, and even when we arrive at something that works, diabetes throws us a curveball and we are forced to reinvent our treatment regimen---time, and time, and time again. 

comments 0 comments - Posted Jun 18, 2010

Academia, Biotech and the Pharmaceutical Industry Have Joined Forces to Fight Diabetes

IMIDIA ("Innovative Medicines Initiative for Diabetes"), a public private consortium funded by the Innovative Medicines Initiative (IMI), announced today the launch of a project focusing on pancreatic islet cell function and survival. Academia, biotech and pharma industry have joined forces to develop biomarkers and tools to pave the way for improved disease management and ultimately provide a cure for diabetes.

comments 0 comments - Posted Jun 18, 2010

Dieting to Reduce Diabetes Risk May Not Work in People With Low Muscle Mass

One of the factors that increases the risk of acquiring type 2 diabetes is excess body fat. So it makes sense that losing weight has always been one of the first lines of defense against the disease. Yet people who are slender -skinny, even- sometimes develop type 2. Why is that? Does the fact that a slender person can acquire type 2 negate the need for weight control?

comments 0 comments - Posted Jun 18, 2010

Tyler's Guide for a Successful Vacation

As a type 1 diabetic, I have found that it's a good idea to plan for the unexpected when traveling. Life is full of surprises, and so are vacations. The flight is late. The flight has been cancelled.  We had a flat tire or ran out of gas. There is an accident on the highway, and the traffic isn't moving. Who would have ever thought that airline flights would be grounded for five days in most of Eastern Europe because of volcanic ash from an erupting volcano in Iceland? If a diabetic had planned on going for a week-long vacation in England or France and had taken limited insulin, syringes, or infusion sets, he might have been in big trouble. Trying to replenish medical supplies in a foreign country could prove to be very difficult.

comments 0 comments - Posted Jun 16, 2010

Medifast: Healthy Weight Loss for Type 2 Diabetes?

There are so many weight loss programs out there, sometimes it is hard just to keep track of them, let alone choose one that will work. Add in the factor of diabetes, and the path to weight loss becomes harder to navigate and often contains land mines that we never even knew existed.

comments 0 comments - Posted Jun 15, 2010

Metformin-Avandia Combo Slows Progression to Type 2 in Two-Thirds of At-Risk Patients

A Canadian study that tracked 207 patients suggests that a low-dose combination of metformin and Avandia can reduce the development of type 2 diabetes by 66 percent in people at high risk for the condition.

comments 0 comments - Posted Jun 15, 2010

Olympic XC Skier Kris Freeman Brings Story of Spirit and Tenacity to Campers with Diabetes

One of the most inspiring personalities of the 2010 Vancouver Games, Olympic cross-country skier Kris Freeman sheds his skis and poles this week to kick off his 6th annual diabetes summer camp tour with Eli Lilly and Company (Lilly Diabetes). Freeman, diagnosed with type 1 diabetes 10 years ago at age 19, will share his amazing comeback story from coast to coast and encourage children with diabetes to continue pursuing their dreams.

comments 0 comments - Posted Jun 14, 2010

Low-Dose Aspirin May Not Benefit Younger Diabetes Patients

New guidelines from the American Diabetes Association and two other major medical associations advise not prescribing low-dose aspirin therapy for women under 60 or men under 50 who have diabetes but no other risks for heart disease.

comments 0 comments - Posted Jun 12, 2010

I Can't Look at Chips as Just Chips

I am that mom.  The one who buys organic foods, bakes her own bread, bans high fructose corn syrup and trans fats, and always totes around healthy snacks.  I don't drink soda, my toddler has never consumed fish sticks, and not once since her birth have we visited McDonalds for a "value" or Happy Meal.  

comments 0 comments - Posted Jun 10, 2010

BD Launches World's Smallest Pen Needle

BD (Becton, Dickinson and Company), a leading global medical technology company, announced today the launch of BD Ultra-FineTM Nano-the world's smallest pen needle. The BD Nano pen needle is proven to be as effective as longer needles for patients of all body types and proven to offer a less painful injection experience for the more than 5 million people in the United States who inject insulin or GLP-1 to manage their diabetes.[1]

comments 0 comments - Posted Jun 10, 2010

Safe Chemicals Act of 2010 and You

We all know that certain chemicals in everyday products are harmful:  mercury and lead, just to name a couple. But how harmful, and what can we do about it?

comments 0 comments - Posted Jun 9, 2010

The Other: How Spouses of Diabetics Deal

It's a cool Sunday evening, and I'm sitting in a lively Italian restaurant. My husband is across the table.  We've just placed our orders, and we're engaged in easy conversation.

comments 0 comments - Posted Jun 8, 2010

MACUGEN® Improved Vision in Patients with Diabetic Macular Edema

Results from a Phase 3 study demonstrate MACUGEN® (pegaptanib sodium) significantly improved vision in patients with diabetic macular edema (DME), a complication of diabetes that is a leading cause of blindness in people of working age.¹ In the study, 37 percent of patients treated with MACUGEN gained two lines, or 10 letters, of vision on the ETDRS eye chart at 54 weeks, compared to 20 percent of patients who received a sham (placebo-like) procedure which consists of anesthesia and a simulated injection in the eye (p=0.0047). The data were presented at the World Ophthalmology Congress in Berlin by Frank G. Holz, an investigator in the trial and director of the University Eye Hospital at the University of Bonn in Germany.

comments 0 comments - Posted Jun 7, 2010

U.K. Study Links Metformin to B-12 Deficiency

If you take metformin to control your type 2 diabetes, ask your doctor to take a look at your vitamin B-12 levels when you get a chance. A recent British study shows that metformin may cause a deficiency in the vitamin, which is necessary for the regeneration of red blood cells and the maintenance of nervous system health.

comments 0 comments - Posted Jun 5, 2010

FREE iPhone Diabetes Applications

With the rise of the iPhone and the creation of hundreds of thousands of iPhone applications, it's only natural that several wonderful apps have appeared to make life easier for diabetes patients. Here is a quick look at 10 FREE applications, in no particular order, to help you choose the right ones for you.

comments 1 comment - Posted Jun 2, 2010

Ironman Jay

It's early on a Thursday morning in a hotel ballroom in downtown Oakland, and attendees at a breakfast of the annual meeting of the California Dietetic Association are still working on getting fully awake. That problem is solved two minutes after Jay Hewitt, the breakfast's inspirational speaker, takes the stage. Hewitt, a 41-year-old lawyer who was diagnosed with type 1 in 1991, knows his audience is an experienced group of professional dietitians that has dealt with every type of patient and heard every kind of excuse for failure.

comments 0 comments - Posted Jun 1, 2010

May 2010

Environmental Factors In Diabetes

Both genetic components and environmental factors play a role in most chronic diseases, including type 2 diabetes. In the same way that researchers use a Genome-Wide Association Study (GWAS) to evaluate the role of genetic factors in disease, scientists at Stanford University have used an Environmental-Wide Association Study (EWAS) to evaluate environmental factors on diabetes.

comments 0 comments - Posted May 29, 2010

Bret Michaels - Type 1 Diabetes Patient and Celebrity Apprentice Winner

It was a great win for diabetes on Sunday night as Bret Michaels, lead singer for the rock band Poison and reality TV star, was crowned the latest Celebrity Apprentice winner after struggling with several medical scares in the past month. Just as impressive is that throughout the season, Michaels' various wins raised more than $390,000 for the American Diabetes Association, including the final challenge prize from Snapple, worth $250,000. The 47-year old Michaels has lived with type 1 diabetes since he was six years old.

comments 0 comments - Posted May 29, 2010

Abbott Receives FDA Clearance for New, Easier-to-Use FreeStyle Lite® Test Strips

Abbott announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new FreeStyle Lite blood glucose test strips. The new FreeStyle Lite test strips minimize interference during blood glucose testing and are designed to offer a better testing experience.

comments 0 comments - Posted May 27, 2010

Skimping on Sleep Linked to Diabetes and Higher Mortality Rates

As awareness of pre-diabetes grows, the list of conditions that can lead to it seems to be growing. Along with obesity and a sedentary lifestyle, researchers may start listing lack of sleep as another danger signal. Two recently published studies conclude that sleep deprivation can lead to insulin resistance-a precursor for diabetes-and even increase the risk of early death.

comments 0 comments - Posted May 26, 2010

Abnormal Heart Rhythm Risk Increases with Diabetes and Diabetes Medications

A Seattle-based study has found that people with diabetes run a 40 percent increased risk of developing a common type of abnormal heart rhythm known as atrial fibrillation*. The study also shows that as people with diabetes take drugs for the disease, their risk for developing atrial fibrillation increases three percent for each year that they use such medications.

comments 0 comments - Posted May 25, 2010

Attending Weight Watchers® Meetings Helps Reduce the Risk for Type 2 Diabetes

The 57 million Americans currently living with "pre-diabetes" could benefit from a group weight loss program, like Weight Watchers, according to a new study published in this month's American Journal of Lifestyle Medicine. Researchers found that after a 6-month Weight Watchers group program, overweight or obese adults who attended at least two thirds of the weekly sessions, not only lost weight, but also significantly reduced fasting glucose and insulin levels - important indicators of diabetes risk.

comments 0 comments - Posted May 22, 2010

Health Literacy and Safety Risks

People with diabetes who have limited health literacy are at higher risk for hypoglycemia or low blood sugar, according to a new study from researchers at the University of California, San Francisco and the Kaiser Permanente Division of Research in Oakland, CA.

comments 0 comments - Posted May 20, 2010

Ethnic Disparities Found in A1c Test

A new study released by the Children's Hospital of New Orleans has found that black children with type 1 diabetes scored higher on A1c tests than white children who had similar blood glucose levels. Such ethnic disparity has already been shown in previous studies with adults.

comments 0 comments - Posted May 18, 2010

IDF Launches World Diabetes Day 2010 Campaign

The International Diabetes Federation (IDF) has kicked off its World Diabetes Day campaign under the slogan "Let's take control of diabetes. Now."  Led by the International Diabetes Federation and its member associations, World Diabetes Day is celebrated every year on November 14. Created in 1991 by IDF and the World Health Organization (WHO) in response to growing concerns about the escalating threat of diabetes worldwide, it reaches a global audience of over 1 billion people. World Diabetes Day became an official United Nations Day in 2007.

comments 0 comments - Posted May 18, 2010

Team Type 1 Cyclers Race Against Diabetes

Phil Southerland was diagnosed with Type 1 diabetes when he was seven months old. Now 28, he has always taken an aggressive approach to managing the disease. He recalls, "My mom scared the daylights out of me when I was six years old by letting me know about the severe complications of diabetes if you don't take care of it. That has motivated me to never let those complications fall on my shoulders."

comments 0 comments - Posted May 17, 2010

CVS Loyalty Program for People with Diabetes

Rhode Island-based CVS/pharmacy, which operates more than 7,000 pharmacies and drug stores in the United States, has announced three diabetes-related initiatives:

comments 0 comments - Posted May 15, 2010

Beware the Perils of Severe Hypoglycemia

Over 80 years ago, famed diabetologist Elliot Joslin said about the treatment of patients with type 1 diabetes: "Ketoacidosis may kill a patient, but frequent hypoglycemic reactions will ruin him."  Unfortunately, hypoglycemia continues to be the most difficult problem facing most patients, families, and caregivers who deal with the management of type 1 diabetes on a daily basis. Frequent hypoglycemia episodes not only can "ruin," or adversely impact the quality of life for patients, but also, when severe, can cause seizures, coma, and even death.

comments 12 comments - Posted May 13, 2010

FDA’s Bad Ad Program

The Food and Drug Administration (FDA) has launched a "Bad Ad Program," an outreach effort aimed at educating healthcare providers and urging them to report misleading drug advertisements. The Division of Drug Marketing, Advertising, and Communications (DDMAC), in the FDA's Center for Drug Evaluation and Research, administers the program.

comments 0 comments - Posted May 13, 2010

Recruiting Patients with Newly Diagnosed Type 1 Diabetes

Dr. Richard Hays announced today that he is now recruiting children with newly diagnosed type 1 diabetes for Protégé Encore, a randomized, placebo-controlled Phase III clinical trial. This is the second of two Phase III studies testing the safety and efficacy of an investigational drug called teplizumab. The first study, known as Protégé, has completed enrollment of more than 530 subjects with type 1 diabetes. There is currently no approved therapy to slow the progression of type 1 diabetes.

comments 0 comments - Posted May 12, 2010

New Agents That Keep Insulin Working Longer

Scientists at the Mayo Clinic have developed a molecule that can block the breakdown of insulin. Their discovery could lead to development of a new class of drugs to help treat diabetes. 

comments 0 comments - Posted May 10, 2010

Avoiding Post-Race Hypoglycemia

I woke up on the floor of my living room, soaked in sweat.  I could not stand, or even sit up.  I could not raise my arms or control my hands enough to grasp anything. Forget reaching for the telephone, even if my brain could have formulated the thought to try.  I could not speak, but I lived alone, so there was no one to hear anyway.  I did not know what day it was, but the hot July 4th late afternoon sun was shining brightly through the windows.  After an unknown period of time, my brain must have had a flash of coherence that I was having severe hypoglycemia. 

comments 8 comments - Posted May 8, 2010

Stem Cell Treatment for Type 1 Diabetes

Osiris Therapeutics announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to promote the development of treatments for underserved patient populations. To be eligible for Orphan Drug designation, the treatment must target a disease that affects fewer than 200,000 new patients per year in the United States.

comments 0 comments - Posted May 7, 2010

Decreased Sleep Means Increased Insulin Resistance

A new study to be published in the June issue of the Journal of Clinical Endocrinology & Metabolism (JCEM) says that a single night of too little sleep can induce insulin resistance. 

comments 2 comments - Posted May 6, 2010

Tyler’s Top Ten Sports Tips

My last ten tips were meant to give you an idea of what to think about before you plan your day (Tyler's Top Ten Tips). Now I'm going to give you my top ten tips for how to manage your blood glucose levels while playing sports. These should help you keep everything in control and allow you to relax and have fun while playing.

comments 4 comments - Posted May 5, 2010

Surprise! Metformin Works Differently Than Thought

CINCINNATI - The popular diabetes medication metformin works in different fashion than the current widely accepted view. This new finding could lead to wider use of the drug-particularly in people with cancer.

comments 1 comment - Posted May 4, 2010

April 2010

SafeSittings Diabetes Babysitting Service

Are you the parent of a child with type 1 diabetes? Do you often wish that you could find a babysitter who understands the "ins-and-outs" of type 1 so that you could enjoy an evening out, assured that your child is in good hands? Or are you a teenager with type 1 who is looking for a way to help children manage their disease, while making a little extra money at the same time?  Then look no further than www.SafeSittings.com. Launched over six years ago in Manhattan by teenager Kimberly Ross, www.SafeSittings.com is a free online service that matches type 1 families with babysitters who also have the disease. 

comments 4 comments - Posted Apr 30, 2010

Insulin-Producing Cells Derived from Specially Bred Pigs

NEW YORK, April 27, 2010 - The Juvenile Diabetes Research Foundation announced today that it is partnering with Living Cell Technologies (LCT), a New Zealand-based biotechnology company focused on developing cell based therapeutics, in a Phase II clinical trial to study the safety and effectiveness of transplanting encapsulated insulin-producing cells from pigs as a treatment for type 1 diabetes with significant hypoglycemia unawareness.

comments 1 comment - Posted Apr 28, 2010

FDA Launches Initiative to Reduce Infusion Pump Risks

Last week the U.S. Food and Drug Administration announced an initiative to evaluate safety problems that may occur with external infusion pumps.  These devices are used to deliver fluids or medications to patients in a controlled manner. Insulin pumps, for example, release insulin into the body at a controlled rate to compensate for a lack of insulin production in people with type 1 diabetes.

comments 8 comments - Posted Apr 27, 2010

Sex and Diabetes: Diabetes for Couples

Dear Diabetes Health, I am a 60 year old married woman who was diagnosed with type 2 diabetes eight years ago.  In the last two years, I have lost interest in sex. I just don't feel like it, although I still like hugs.

comments 3 comments - Posted Apr 26, 2010

Smart Insulin

A team of researchers from Case Western University published an article revealing their invention of a "smart" insulin molecule that binds considerably less to cancer receptors and self-assembles under the skin. To provide a slow-release form of insulin, the compound self-assembles under the skin by "stapling" itself together with zinc ions. Zinc staples connect the pieces of the insulin puzzle together to create a functional protein.

comments 0 comments - Posted Apr 23, 2010

Emergency Checklist

In the early hours of Saturday, February 27th, an 8.8-magnitude earthquake hit Chile, eventually leaving 1.5 million displaced from their homes. At 6 a.m. that same morning, Hawaiians awoke to the news that a tsunami was barreling towards them and evacuation was necessary. Within minutes, many had left their homes for safe ground.

comments 0 comments - Posted Apr 23, 2010

Diabetes Drug Tied to Reduced Breast Cancer Risk

The study, published in the journal Diabetes Care, adds to evidence that metformin, a generically available drug commonly used for type 2 diabetes, may have anti-cancer effects.

comments 0 comments - Posted Apr 22, 2010

What People with Type 1 Diabetes can Learn from Type 2s

Admit it, Type 1s. In weaker moments, you look down your noses at the Type 2 diabetics. You know that their disease can result from poor lifestyle choices. You know that their treatment regimen, compared with yours, is simple.

comments 36 comments - Posted Apr 19, 2010

Artificial Pancreas for Type 1 Diabetes Works in Clinical Trials

The first human trials of the latest design of an artificial pancreas for people with type 1 diabetes found the device worked without causing low blood sugar (hypoglycemia).

comments 8 comments - Posted Apr 18, 2010

Roche acquires Medingo Ltd., makers of the Solo MicroPump

Roche and Elron Electronics Ltd. announced that they have signed an agreement under which Roche will acquire 100% of Medingo Ltd., a majority-owned subsidiary of the Elron group. Medingo Ltd. is engaged in the development of a semi-disposable insulin patch pump (Solo MicroPump). Under the terms of the agreement, Roche will pay Medingo Ltd.'s shareholders an upfront payment of US$ 160 million as well as up to 25% of the upfront payment in performance related milestones.

comments 5 comments - Posted Apr 14, 2010

Insulin-Producing Beta Cells Can Be Reborn

Healthy, insulin-producing beta cells in the pancreas have a relatively long life and typically do not replicate under normal conditions. Any loss of beta cells, therefore, is usually permanent. In the case of type 1 diabetes, for example, the destruction of beta cells by the body's own immune system is permanent.

comments 2 comments - Posted Apr 9, 2010

Nanoparticle Vaccine Stops the Progression of Type 1 Diabetes in Mice

Using a sophisticated nanotechnology-based "vaccine," researchers were able to successfully reverse type 1 diabetes in mice and slow the onset of the disease in mice at risk for the disease.  The study, co-funded by the Juvenile Diabetes Research Foundation, provides new and important insights into understanding how to stop the immune attack that causes type 1 diabetes, and could even have implications for other autoimmune diseases.

comments 2 comments - Posted Apr 9, 2010

Synthetic Molecule That Stops Diabetic Inflammation Could Become a Type 2 Therapy

Tests of an experimental drug called CPSI-1306 at Ohio State University were so successful at lowering inflammation and blood sugar levels in lab mice with type 2 diabetes that scientists consider it a prime candidate to become a new therapy for the disease. 

comments 0 comments - Posted Apr 8, 2010

Soy Supplements Show No Diabetes Benefit in Study

(Reuters Health) - Adding soy supplements to the diet may not improve blood sugar control in older women who are at high risk of or in the early stages of type 2 diabetes, a new study suggests.

comments 0 comments - Posted Apr 7, 2010

Antidote to Guilt About Not Doing Enough Exercise Is a HIT

Most people who have pre-diabetes know that exercise is a key element in successfully avoiding full-on diabetes. But lack of time-either for real or as an excuse-often gets in the way.

comments 2 comments - Posted Apr 6, 2010

Our Kids and Camps: April/May Digital Edition Is Now Available

While the words "diabetes" and "camp" may not sound like they belong in the same sentence for most people, they sure do for thousands of kids across the country. Diabetes camp is their time to share experiences, learn, and have fun with other kids who have diabetes. You'll find the usual camping activities like hiking, arts and crafts, boating, swimming, and sitting around the campfire, but also lessons on adjusting your insulin pump to compensate for sports and how to give yourself an injection.

comments 0 comments - Posted Apr 1, 2010

March 2010

Developing Youngsters' Power in Diabetes Self-Care: Dr. DeLoach Talks about Campamento Diabetes Safari

Dr. Stan De Loach is a bicultural, trilingual, Certified Diabetes Educator (one of the first 13 in Mexico) and clinical psychologist, not to mention a pianist, composer, and writer. Born and educated in the U.S., he has been a resident of Mexico for decades, and his first love is the annual bilingual diabetes camp that he co-founded, the four-day Campamento Diabetes Safari in Mexico.. 

comments 3 comments - Posted Mar 30, 2010

FDA Hedges Approval of Long-Acting Byetta, Asks Amylin for More Information

The U.S. Food and Drug Administration has withheld approval of Bydureon, the once-weekly version of the popular type 2 diabetes drug Byetta.  The agency has asked its manufacturer, Amylin, for more information regarding Bydureon's manufacture, labeling, and risk management plan. It did not, however, request further information on tests of the drug itself-an indication that the agency probably intends to grant marketing permission once it has dotted all the i's and crossed all the t's involved in the approval process.

comments 0 comments - Posted Mar 29, 2010

Texas Researcher Poised to Test Leptin as a Replacement for Insulin Among Type 1s

A University of Texas researcher who genetically modified mice with type 1 diabetes to control their disease with leptin instead of insulin is now ready to extend his experiment to human test subjects. Dr. Roger Unger, a researcher at the UT Southwestern Medical School in Dallas, will begin the tests as soon as leptin manufacturers can assure him of a steady supply of the hormone.

comments 2 comments - Posted Mar 27, 2010

Intestinal Bacteria May Contribute to Obesity and Metabolic Syndrome

According to researchers at the Emory University School of Medicine, obesity and metabolic syndrome may be partially brought on by intestinal bacteria that increase appetite and insulin resistance. The two can lead to overeating and high blood sugar levels - both important factors in the eventual onset of type 2 diabetes. Perhaps even more interesting, the scientists found that the bacteria can be transferred from one mouse to another, creating increased appetite and insulin resistance in an animal that had previously experienced neither.

comments 0 comments - Posted Mar 26, 2010

Revised Criteria Could Triple Reported Cases of Gestational Diabetes

Suggested revisions in the benchmarks used to assess dangerously high blood sugar levels in pregnant women could lead to a doubling or tripling of the number of women diagnosed with gestational diabetes*. That's the conclusion of an international study led by the Northwestern University Feinberg School of Medicine in Chicago.

comments 0 comments - Posted Mar 24, 2010

The Story of GAD

You may not have heard of GAD, but it's a hot topic in the world of type 1 diabetes research. GAD, which stands for glutamic acid decarboxylase, is an enzyme in the brain and the pancreas that plays several roles in the body. As an enzyme, it converts the excitatory amino acid glutamate into the inhibitory neurotransmitter GABA, which nerve cells use to communicate.  But it also has a less helpful role, as an autoantigen (an element of self that provokes the generation of antibodies) in autoimmune diabetes.

comments 4 comments - Posted Mar 23, 2010

Medtronic Receives FDA Approval for Industry's Most Advanced Integrated System for Diabetes Management

MINNEAPOLIS - March 17, 2010 - Medtronic, Inc. today announced it has received U.S. Food and Drug Administration (FDA) approval for the MiniMed Paradigm® REAL-Time RevelTM System, the next generation of the industry's only integrated diabetes management system (insulin pump therapy, continuous glucose monitoring (CGM) and diabetes therapy management software). The system incorporates new innovative CGM features including predictive alerts that can give early warning to people with diabetes so they can take action to prevent dangerous high or low glucose events.

comments 3 comments - Posted Mar 22, 2010

Our Journey to Hope and Beyond

I grew up around the corner from the National Institutes of Health (NIH). In high school, long ago, I thought that NIH scientists were "bad guys" who mistreated animals in the name of medical research. I later moved to the West Coast and became a registered obstetrical nurse. Over the years, along with sharing the joys of new moms and new babies, I cared for patients with devastating conditions like cancer and quadriplegia, people whose lives could potentially be saved or improved by medical research., Yet it wasn't until many years later, after moving back to the DC area, that I really began to see the NIH in a new light.

comments 4 comments - Posted Mar 20, 2010

Mutation That Affects Response to Smell and Taste Could Lead to Type 2 Diabetes

According to Duke University researchers, a mutation that causes the lack of an insulin-controlling molecule may be a factor in the development of type 2 diabetes. The molecule, ankyrin B, is activated in response to the smell and taste of food and leads to the production of insulin in preparation for food intake.

comments 1 comment - Posted Mar 19, 2010

FDA eyes improvements for diabetics' glucose devices

At a two-day meeting (March 16 and 17, 2010) to review blood glucose meters, Food and Drug Administration officials and staff pointed to a number of issues that can prevent people from getting proper treatment and sought input from medical experts and industry on ways to improve test results with the widely used devices.

comments 1 comment - Posted Mar 18, 2010

Depression or Sex?

Dear Diabetes Health, I am a 55-year-old man who was diagnosed with type 2 diabetes two years ago, and I think it made me depressed. The depression eventually got so bad that I didn't want to get out of bed in the morning. My doctor referred me to the psych clinic, where they put me on Paxil (paroxetine). The medication is helping my depression, but ruining my sex life.  Basically, I can't get an erection, but I don't really care because I'm not interested anyway. I have no desire. My wife is still interested, however, and she is really upset about my lack of desire for sex.  I don't like hurting her, and I don't want us to break up over this, but the depression was awful. I don't want to go back to that. What can I do? 

comments 4 comments - Posted Mar 16, 2010

Mom Says 'Just a Phone Call Away', Just Not Good Enough

Allen, Texas - When Pam Henry's daughter was diagnosed with type 1 diabetes in 2003, she never even thought she would be part of something that could revolutionize health care. "When Sarah was diagnosed, my only goal was to do all I could to keep her as healthy as possible.  What I created was something just to help keep her that way." 

comments 4 comments - Posted Mar 13, 2010

Starting Treatment Early Doubles Chance of Success for People with Diabetes

The sooner people with diabetes start taking metformin, the longer the drug remains effective, according to a Kaiser Permanente study published in the March issue of Diabetes Care, a journal of the American Diabetes Association.

comments 2 comments - Posted Mar 12, 2010

Northern California's Biggest County Sues Glaxo Over Avandia

Santa Clara County, the largest county in Northern California (nearly 1.9 million people), has filed a federal lawsuit against pharmaceutical company GlaxoSmithKline, alleging that Glaxo knowingly sold its type 2 diabetes drug Avandia for several years despite indications the drug causes heart attacks and strokes.

comments 0 comments - Posted Mar 8, 2010

Insulin Used to Treat Diabetes May Be Linked to Increased Cancer Risk, Review Suggests

The benefits of using insulin to treat diabetes far outweigh the risks, but a review just published online by IJCP, the International Journal of Clinical Practice, suggests that commonly used diabetes therapies may differ from each other when it comes to their influence on cancer risk.

comments 1 comment - Posted Mar 5, 2010

Does Something Smell Fishy? It Could Be Your Metformin

If you regularly take metformin, one of the oldest and most respected tools in doctors' anti-diabetes kits, chances are that you don't detect the unpleasant odor that turns some type 2s against the drug.  Some think it has fishy smell, while others say that it reminds them of the inside of an inner tube.

comments 9 comments - Posted Mar 4, 2010

Amylin Hopes to Begin U.S. Sales of Long-Acting Byetta Early This Year

Amylin Pharmaceuticals has announced that it expects to begin selling a once-weekly version of its diabetes drug, Byetta, by the end of the year. The company reports that the FDA is nearing final inspections of its manufacturing plant and could give the go-ahead for U.S. sales in early March.

comments 2 comments - Posted Mar 4, 2010

Money Money Money: Diabetes Research Funding

The demand for diabetes research funding clearly exceeds the funds available. In the United States, 23.6 million children and adults (7.8 percent of the population) have diabetes, and we spent $174 billion on diagnosed diabetes alone in 2007 (the most recent year for which data are available). It is imperative that we take action, but where is the research funding coming from? Can it possibly be sufficient, and how is it being spent? 

comments 3 comments - Posted Mar 3, 2010

Mind, Body, and. . . Spirit?

When I was undiagnosed and sick, I was very angry with God.  I didn't understand why I was weak, fatigued, constantly thirsty and hungry, scarily thin, and mentally foggy.  I prayed and prayed for an answer.  I cried, I cursed, and I yelled.  Nothing.  For a year and a half.  When I received my diagnosis in a local emergency room, I felt instant relief.  Finally, I had an answer, a name, and some hope.  But soon after, the anger reappeared, this time because God had failed to pass over me.  I had done nothing to earn this fate. Why me? 

comments 18 comments - Posted Mar 2, 2010

Discovery of a Suspect Enzyme in Humans Could Lead to Powerful Type 1 Therapy

An enzyme that destroys pancreatic beta cells in lab mice has now been observed in human beta cells. Because scientists already know how to delete the mouse gene that produces the enzyme, they are hopeful that the same therapy can eventually be applied to people with type 1 diabetes. If so, it would be one of the most powerful therapies yet for addressing the destruction of insulin-producing beta cells that causes type 1.

comments 4 comments - Posted Mar 1, 2010

February 2010

FDA Gives Novo the Go-Ahead to Market Victoza® in the U.S.

Danish pharmaceutical company Novo Nordisk has received Food and Drug Administration permission to begin marketing its type 2 drug Victoza® in the United States.
Victoza, the brand name for liraglutide, is a GLP-1* analog that is taken one a day by injection to help control blood sugar-and in some cases, help with weight loss-in patients with type 2 diabetes.

comments 5 comments - Posted Feb 27, 2010

Happy (?) Anniversary

My four-year-diabetes-diagnosis anniversary is almost here.   It falls on March 24th, a day just like any other to most people, but a day full of sadness, loss, and victory for me.  Will I celebrate?  I'm not sure if reflection is a form of celebration.  I'd much prefer a birthday-like affair featuring balloons, cards, and, of course, something sweet to eat. But I also feel as if the impending date is much like a funeral on the calendar, a time for mourning as well as reflection.

comments 28 comments - Posted Feb 26, 2010

JDRF Launches Program to Support Adults with Type 1 Diabetes

As part of an extensive program to support the needs of adults with type 1 diabetes, the Juvenile Diabetes Research Foundation International announced the introduction of a key support program, the JDRF Adult Type 1 Toolkit, to meet an immediate need for resources and community for adults more recently diagnosed with type 1 diabetes - a chronic autoimmune disease often first diagnosed in children.

comments 3 comments - Posted Feb 24, 2010

GSK rejects conclusions of Senate Committee on Finance Staff Report on Avandia

The Staff Report of the Senate Committee on Finance draws conclusions on the safety of Avandia (rosiglitazone) that are based on analyses that are not consistent with the rigorous scientific evidence supporting the safety of the drug. In addition, the report cherry-picks information from documents, which mischaracterizes GlaxoSmithKline's comprehensive efforts to research Avandia and communicate those findings to regulators, physicians and patients. In fact, the safety and effectiveness of Avandia is well characterized in the label approved by the FDA.

comments 1 comment - Posted Feb 23, 2010

JDRF-Funded Research Advances Potential for Regeneration as a Possible Cure for Type 1 Diabetes

A hormone responsible for the body's stress response is also linked to the growth of insulin-producing cells in the pancreas, according to JDRF- funded researchers at the Salk Institute for Biological Studies in California. The findings are the latest advances to underscore the potential for regeneration as a key component of a possible cure for type 1 diabetes.

comments 2 comments - Posted Feb 22, 2010

U.S. Senate Report Says Glaxo Knew that Avandia Increases Risk of Heart Attacks

A U.S. Senate Finance Committee report released on February 20 says that Avandia, GlaxoSmithKline's drug for type 2 diabetes, may have caused as many as 83,000 heart attacks between 1999, when the drug was introduced, and 2007. The Senate report, culminating a two-year inquiry into the drug, also says that Glaxo knew about the drug's potential risks years before suspicions began to form regarding a connection between Avandia and heart problems.

comments 2 comments - Posted Feb 22, 2010

Handing down the Genes. Part 3 (of 3)

This is the third - and final - installment of our three-part series "Handing Down the Genes."  Part III: "Nutrition and Exercise Tips"

comments 1 comment - Posted Feb 19, 2010

Artificial Pancreas Project Update

Feb. 11, 2010 - At the 3rd International Conference on Advanced Technologies and Treatments for Diabetes (ATTD) in Basel, Switzerland, Roche Diabetes Care, the University of California Santa Barbara (UCSB), and Sansum Diabetes Research Institute announced their expanded collaboration in the Artificial Pancreas Project sponsored by the Juvenile Diabetes Research Foundation (JDRF).

comments 3 comments - Posted Feb 18, 2010

Eating Low-Carb Meals After Exercise Increases Insulin Sensitivity

A university study says that aerobic exercise, a known means of increasing insulin sensitivity, is most effective if the meals following it are low in carbohydrates. The study also revealed that consuming a low-calorie meal after exercising does not increase insulin sensitivity any better than eating a low-carb meal after a workout. In addition, it found that the beneficial effects of exercise are immediate and do not build up over time or last very long. Improvements in metabolism, including insulin sensitivity and lowered blood pressure, occur directly as a result of the latest exercise session, but taper off within hours or days. There is no "storing up" the benefits of exercise.

comments 3 comments - Posted Feb 17, 2010

Handing Down the Genes. Part 2 (of 3)

This is the second installment of our three-part series "Handing Down the Genes."  Part II: "Preventing Type 2 in Children"

comments 1 comment - Posted Feb 13, 2010

California Parents of Children with Diabetes and Care Advocates Hail Isadore Hall, III Legislation to Fight Diabetes

Sacramento- February 10, 2010 -- Assistant Speaker pro Tempore Isadore Hall, III (D- Compton) today introduced AB 1802, which would clarify existing law by allowing, but not requiring, a parent/guardian-designated teacher, administrator or school employee to administer insulin to a diabetic student while on a school campus.

comments 4 comments - Posted Feb 11, 2010

UK Study Finds That People With A1c's of 7.5% Run Less Risk of Death Than Those With Lower A1c's

Results of a 22-year study by researchers at Cardiff University School of Medicine in Wales indicate that older type 2s who try too hard to drive their A1c's down to "normal" (4.5% to 6%) may significantly increase their chances of early death. In fact, the study, just published in the British medical journal The Lancet*, found that type 2s with the lowest risk of death had A1c's of 7.5% -- a figure that few authorities on the disease have recommended as ideal.

comments 15 comments - Posted Feb 11, 2010

Study Suggests Extended Release Metformin May Reduce Body Mass Index in Teens

A California study that tracked 77 obese adolescents for almost two years indicates that metformin XR, an extended-release version of the popular anti-diabetic drug, may help lower body mass index in overweight teens who do not have diabetes.

comments 1 comment - Posted Feb 10, 2010

Researchers Discover Protein that Triggers Islet Cell Rejection

Researchers at RIKEN and Fukuoka University have pinpointed the mechanism responsible for early rejection of transplanted pancreatic islet cells in the treatment of type 1 diabetes. A new system based on this mechanism has been shown to vastly increase transplant efficiency, setting the stage for the development of powerful new treatment techniques.

comments 5 comments - Posted Feb 9, 2010

What’s the Deal with Steel-Cut Oats?

Steel-cut oats are whole grains, made when the groats (the inner portion of the oat kernel) are cut into pieces by steel. Also known as coarse-cut oats or Irish oats, they are golden and look a little like small pieces of rice. They gain part of their distinctive flavor from the roasting process after being harvested and cleaned. Although the oats are then hulled, this process does not strip away their bran and germ, allowing them to retain a concentrated source of their fiber and nutrients.

comments 4 comments - Posted Feb 9, 2010

Scared of Lows

Dear Diabetes Health, I'm 26 years old and engaged to a woman I've known since college.  We live together, love each other, and have good sex, but now I'm having doubts. A year ago, she was diagnosed with type 1 diabetes. She started taking insulin, and it has been rough. Four times now she has started sweating and shaking and saying strange things. Twice this happened during sex. 

comments 11 comments - Posted Feb 3, 2010

Severe complications of diabetes higher in depressed patients

Depression raises risks of advanced and severe complications from diabetes, according to a prospective study of Group Health primary-care patients in western Washington. These complications include kidney failure or blindness, the result of small vessel damage, as well as major vessel problems leading to heart attack or stroke.

comments 3 comments - Posted Feb 2, 2010

Novo, Upping the Ante in the Race for an Oral GLP-1 Drug, Tests a Pill Version of Victoza

Denmark-based Novo Nordisk has begun a Phase 1 trial of a pill form of a GLP-1 drug very similar to its Victoza product. The trial will involve  155 British patients with type 2 diabetes. The test on human subjects, although very early-stage,  puts the company in the lead to develop an oral form of a GLP-1 drug.

comments 0 comments - Posted Feb 1, 2010

January 2010

DiabetesHealth Feb-March Print and Digital Edition Available Now!

On Monday, take a look at our new Feb\March digital edition. DiabetesHealth sat down to talk with Kris Freeman, the first Olympian with type 1 diabetes to compete in the endurance sport of cross country skiing. He has shared his story about what it is like to follow your dreams regardless of the obstacles in place. Working with Eli Lily, Kris spends time traveling around the country talking with kids about their aspirations and diabetes. He wants his story to inspire other people with type 1 diabetes to follow their own dreams. "Diabetes doesn't have to hold you back."

comments 0 comments - Posted Jan 30, 2010

Kris Freeman Skis for Gold at the Vancouver Olympics

Thousands of elite athletes from around the world are making their final preparations for the 2010 Winter Olympics in Vancouver, British Columbia. Every snowboarder, short track speed skater, ski jumper and hockey player shares a dream of standing on the medium wearing an Olympic gold medal.

comments 7 comments - Posted Jan 29, 2010

Let's take care of one another: random acts of kindness

Altruism is unselfish concern for the welfare of others. It is a traditional virtue in many cultures, and a core aspect of various religious traditions such as Judaism, Christianity, Islam, Hinduism, and Buddhism among others.

comments 0 comments - Posted Jan 29, 2010

Novo Nordisk's Victoza Receives FDA Approval for the Treatment of Type 2 Diabetes

Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza (liraglutide injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.

comments 4 comments - Posted Jan 28, 2010

Changes in the Position of Conventional Insulin Pumps Shown to Significantly Impact Accuracy of Insulin Delivery

Researchers at Sansum Diabetes Research Institute and University of California, Santa Barbara have concluded that changing the height of a conventional insulin pump in relation to its tubing and infusion set can significantly impact expected insulin delivery rates. Such changes can occur during routine daily activities like dressing, sleeping or showering. The study, "Siphon Effects of Continuous Subcutaneous Insulin Infusion Pump Delivery Performance," evaluated the siphon or hydrostatic pressure action effects on continuous subcutaneous insulin infusion and was published in the January issue of Journal of Diabetes Science and Technology.

comments 11 comments - Posted Jan 27, 2010

Newly identified genes influence insulin and glucose regulation

An international research consortium has found 13 new genetic variants that influence blood glucose regulation, insulin resistance, and the function of insulin-secreting beta cells in populations of European descent. Five of the newly discovered variants increase the risk of developing type 2 diabetes, the most common form of diabetes.

comments 2 comments - Posted Jan 23, 2010

JDRF and BD Collaborate to Improve Insulin Pump Delivery

The Juvenile Diabetes Research Foundation (JDRF) and BD (Becton, Dickinson and Company) announced today an innovative program aimed at improving the treatment of type 1 diabetes by developing novel insulin delivery products to enhance the use of insulin pumps. 

comments 0 comments - Posted Jan 22, 2010

Meditation Medication

Living with a chronic condition like diabetes can be a challenging and stressful experience. Unfortunately, all the worry about blood glucose and the constant effort to balance insulin against food intake and exercise can itself raise blood glucose levels. But stress management can help control the stress hormones that affect blood glucose levels. Yoga practice, for example, can have a calming effect and play a major role in stress management.

comments 1 comment - Posted Jan 21, 2010

Diabetes Ups Risk of Dementia for Mildly Impaired

NEW YORK (Reuters Health) - Diabetes may hasten progression to dementia in older people with mild thinking impairment, new research shows.

comments 2 comments - Posted Jan 19, 2010

Diabetes Success Story: Tyler Curry Stevenson

Many meaningful events, experiences, and accomplishments have gone into making me the person that I am today. In my life, most of the important milestones came and went as they do for every kid. But for some of us, life throws a curveball and introduces a trauma or an unexpected event that will forever change our lives. When my most meaningful event occurred, on May 22, 2000, there were no cheers, applause, or laughter in the room. That was the day I was diagnosed with type 1 diabetes.

comments 21 comments - Posted Jan 19, 2010

Pancreas Transplant Program Opens at Montefiore Medical Center

NEW YORK, Jan. 14 /PRNewswire-USNewswire/ -- Montefiore Medical Center continues to expand its portfolio of options for patients in need of organ transplantation. The new Pancreas Transplant Program will treat patients with severe, end-stage diabetes. As the only Pancreas Transplant Program in the Bronx and Westchester, and one of only several in Greater New York, patients will be able to receive world-class care close to home. The program currently has nine patients medically approved and waiting for a pancreas transplant.

comments 2 comments - Posted Jan 16, 2010